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Abstract 
Abstract 
 
MicroRNAs are endogenous approximately 21-nucleotide-long non-coding RNAs that 
act as post-transcriptional regulators of gene expression by base pairing to target 
mRNAs. Mature miRNAs form part of ribonucleoprotein complexes, called miRNA-
induced silencing complexes (miRISCs), that contain Argonaute (AGO) and GW182 
as core proteins. Drosophila melanogaster contains only one GW182 protein 
(DmGW182) but there are three GW182 paralogs, TNRC6A, TNRC6B, and TNRC6C, 
encoded in mammalian genomes. Proteins of the GW182 family play an important 
role in the execution of miRNA-mediated repression. However, the molecular 
mechanism of GW182-mediated repression is not entirely understood. 
In order to get a more comprehensive understanding of the mechanism of 
miRNA-mediated repression, we studied the function of GW182 proteins using 
human HEK293 cells and Drosophila S2 cells as model systems. As a result of these 
investigations, we identified the C-terminal fragment of the human GW182 protein 
TNRC6C (CED) as a key region mediating miRNA-induced repression by interacting 
with PABP via its PAM2 motif and by recruiting the PAN2-PAN3 and CCR4-CAF1-
NOT deadenylase complexes via conserved tryptophan-containing motifs (W-motifs).  
In addition, tethering assays in HEK293 cells and Drosophila S2 cells revealed 
that the C-terminal regions of GW182 proteins are able to repress not only 
polyadenylated but also poly(A)-free mRNAs. Interestingly, the W-motifs which are 
essential for interaction of the CED with the CCR4-CAF1-NOT complex, were also 
required for the repression of poly(A)-free mRNAs by the tethered CEDs of human 
TNRC6C and DmGW182. Indeed, direct tethering of CCR4-CAF1-NOT complex 
components in HEK293 or S2 cells repressed not only polyadenylated but also 
poly(A)-free mRNAs and the RNA levels of poly(A)-free mRNAs were either not 
affected or only slightly reduced, indicating that the major part of the repression was 
due to inhibition of translation. Finally, repression of poly(A)-free mRNAs in 
Drosophila S2 cells by tethered DmGW182 or its CED depended on NOT1 but 
repression by tethered CAF1 or CNOT1 was independent of GW182, indicating that 
NOT1 acts downstream of GW182 in the repression of poly(A)-free mRNAs. 
Taken together, these data indicate that recruitment of the CCR4-CAF1-NOT 
complex mediated by W-motifs of GW182 proteins, in addition to inducing 
deadenylation, also contributes to translational repression. 
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Introduction 
1. Introduction 
 
How can a single cell develop into an organism as complex as a human being? 
Although we are far from understanding this amazing process completely, it is 
apparent, that what begins as a fertilized oocyte transforms into an organism with 
approximately 1014 cells and about 400 different cell types (Azevedo et al., 2009; 
Vickaryous and Hall, 2006). This transformation is achieved by many cell divisions 
during which the DNA of a cell is faithfully replicated and is equally distributed so that 
each daughter cell receives one copy of the complete genome. Thus a neuron and a 
liver cell contain the same DNA. Why then, are these two cell types so different? The 
answer is: “Development is, by definition, epigenetic.” (Reik, 2007). In other words, 
development is possible because the readout of the genome is regulated 
epigenetically. Due to epigenetic regulation of gene expression different cell types 
can express a specific set of genes required for their functions.  
Clearly, sophisticated regulation of gene expression is of immense importance for 
the phenomenon of life. Therefore it is not surprising that a massive number of 
different regulatory mechanisms has evolved. Gene expression is a multistep 
process that involves the transcription, translation and turnover of messenger RNAs 
and proteins (Schwanhausser et al., 2011) and each of these steps has been 
demonstrated to be targeted by regulatory processes (Hochstrasser, 1996; 
Kadonaga, 2004; Parker and Song, 2004; Sonenberg and Hinnebusch, 2009).  
The central dogma of molecular biology states that information flows from DNA to 
RNA, which is then translated into protein (Crick, 1970). Crick`s statement was often 
interpreted in the sense that RNA only plays a role as an intermediate messenger 
whereas cellular functions are transacted by proteins. The central role of proteins as 
regulators of gene expression was supported by studies of the lac operon which lead 
to the identification of the lac repressor (Gilbert and Muller-Hill, 1966; Jacob and 
Monod, 1961) and by the subsequent discovery of protein transcription factors 
(reviewed in Zamore and Haley, (2005)). On the other hand, the composition and 
expression of the human genome may point to an important role of RNA as an end-
point product of gene expression. Although 98.8% of the human genome consists of 
non-protein-coding DNA, nonetheless approximately 90% of the genome is 
transcribed into non-coding RNA (Amaral et al., 2008; Birney et al., 2007). Francis 
Crick could not know about these numbers but nonetheless he noted that some 
RNAs could be end-point products of gene expression and indeed, ribosomal RNA, 
tRNA, and spliceosomal and small nucleolar RNAs were found to act in fundamental 
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cellular processes (Mattick, 2011). Furthermore, as early as in 1969, Britten and 
Davidson proposed that RNAs could also function in the regulation of gene 
expression (Britten and Davidson, 1969). 
Nowadays it is well established that RNAs do regulate gene expression (Zamore 
and Haley, 2005). One class of small regulatory RNAs, the microRNAs, is predicted 
to regulate more than 50% of all human genes (Friedman et al., 2009b). Although 
microRNAs may affect nearly all biological processes in human cells, they escaped 
notice of researchers for a surprisingly long time (Bartel, 2009). The first microRNA 
was discovered in 1993 by Victor Ambros and Gary Ruvkun (Lee et al., 1993; 
Wightman et al., 1993). Studying the lin-4 gene, which had been shown to control the 
timing of larval development in Caenorhabditis elegans (Ambros and Horvitz, 1984), 
Ambros and Ruvkun demonstrated that lin-4 does not code for a protein (Lee et al., 
1993). Instead, it codes for a short RNA species, 22 nucleotides in length, that was 
realized to have multiple complemetary sites in the 3`UTR of lin-14 mRNA 
(Wightman et al., 1993). Ambros and Ruvkun proposed a model in which the short 
lin-4 RNA base pairs to sites in the lin-14 3`UTR to repress lin-14 translation (Lee et 
al., 1993; Wightman et al., 1993). Nearly a decade later, the Ruvkun lab found that 
let-7, another gene involved in developmental timing of C. elegans, encodes a small 
RNA which negatively regulates the lin-41 gene (Reinhart et al., 2000). Based on 
their similarity, it was apparent that lin-4 and let-7 belong to the same class of post-
transcriptional regulators. They are both 21-22 nucleotides in length, both originate 
from RNA precursors forming a stem-loop structure, and both act as negative 
regulators of gene expression by binding to partially complementary sites in the 
3`UTR of a regulated RNA. When Pasquinelli and colleagues found let-7 RNAs in 
samples from various animal species, including humans, it became apparent that 
these small RNAs are more than a peculiarity of the worm (Pasquinelli et al., 2000). 
Subsequent studies by the Ambros, Bartel and Tuschl labs revealed that there a 
hundreds of small RNAs with the characteristics of lin-4 and let-7 expressed in 
metazoans (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001). 
The class of small RNAs founded by lin-4 and let-7 was named microRNAs 
(miRNAs). 
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1.1 Biological functions of microRNAs 
 
1.1.1 Biological functions in normal conditions 
 
Given the widespread impact of miRNAs on gene expression it is not surprising that 
miRNAs have important roles in a wide range of biological processes (Huntzinger 
and Izaurralde, 2011). The following sections describe a set of well characterized 
examples of miRNA-mediated regulation of biological processes. 
 
1.1.1.1 Clearance of maternal mRNAs 
In zebrafish, the miR-430 cluster is involved in the degradation of hundreds of 
maternal mRNAs during the maternal-zygotic transition (Giraldez et al., 2006). 
Zebrafish mutants that lack both maternal and zygotic Dicer activity show defects in 
embryonic morphogenesis which are rescued by the expression of mature miR-430 
family members. The clearance of maternal mRNAs by miRNAs is evolutionarily 
conserved as it has been observed also in frogs (Lund et al., 2009), Drosophila 
melanogaster (Bushati et al., 2008) and C. elegans (Wu et al., 2010). 
 
1.1.1.2 Embryonic stem cell proliferation and differentiation 
miRNAs are also involved in embryonic stem (ES) cell proliferation and differentiation. 
Dicer1 and also Dgcr8 mutant mouse ES cells show severe growth and 
differentiation defects (Kanellopoulou et al., 2005; Murchison et al., 2005; Pauli et al., 
2011; Tang et al., 2007; Wang et al., 2007). The proliferation defects of the Dgcr8 
mutant mouse ES cells can be partially rescued by the expression of so called ES 
cell-specific cell-cycle-regulating (ESCC) miRNAs of the miR-290-295/302 family 
(Wang et al., 2008c). These miRNAs silence multiple negative regulators of the G1 to 
S phase transition and thereby promote a cell cycle that is characteristic for ES cells 
(Wang et al., 2008c). The differentiation defects of the Dgcr8 mutant ES cells is 
partially rescued by the expression of let-7 miRNA (Melton et al., 2010). let-7 
represses genes that promote cell cycle progression and also genes that promote 
stem cell identity and thereby facilitates differentiation and represses self renewal 
(Johnson et al., 2007; Melton et al., 2010; Pauli et al., 2011). Thus, ESCC miRNAs 
and let-7 miRNAs seem to have opposing roles in mouse ES cell self-renewal and 
differentiation. Similarly to the role of let-7 in mouse ES cells, human miR-145 also 
3 
Introduction 
represses pluripotency in differentiating ES cells by downregulating OCT4, SOX2 
and KLF4 (Xu et al., 2009).  
 
1.1.1.3 Germ layer specification 
During germ layer specification, Nodal, a member of the transforming growth factor 
beta (TGFbeta) family, promotes mesoderm and endoderm formation. Lefty, another 
member of the TGFbeta family, blocks Nodal signaling and promotes ectoderm 
development. Zebrafish miR-430 balances Nodal signaling by targeting the Nodal 
ligand Squint and its antagonist Lefty2, leading to mesoderm formation (Choi et al., 
2007). Similarly, human miR-302 represses Lefty, which stimulates Nodal signaling 
and differentiation into mesoderm (Rosa et al., 2009). In frogs, the Nodal receptor 
activin receptor 2a (Acvr2a) is also regulated by miRNAs (Martello et al., 2007). 
Xenopus laevis miR-15 and miR-16 are ventrally enriched and restrict the expression 
of Acvr2a to the dorsal side which is thought to contribute to the dorsal-ventral 
gradient of the Nodal signaling pathway activity (Martello et al., 2007). 
 
1.1.1.4 Cell fate specification 
Regulation of cell fate specification by miRNAs has been observed in neurons, 
muscles, the haematopoietic system and other cell types (Pauli et al., 2011). The 
differentiation of neural progenitor cells into neurons involves the exchange of the 
neural progenitor specific chromatin remodeling complex BAF (npBAF) with the 
neuron-specific BAF (nBAF) complex. This transition is mediated by the repression of 
a npBAF subunit by miRNAs miR-9* and miR-124 (Yoo et al., 2009). In addition, 
miR-124 promotes neural differentiation by down regulating small C-terminal domain 
phosphatase 1 (SCP1), which acts as a cofactor of REST in suppressing 
transcription of genes that promote neural development (Visvanathan et al., 2007). 
Another prominent example of cell fate specification by miRNAs is the formation 
of a highly specialized neuronal fate regulated by miRNA lsy-6 in C. elegans (Pauli et 
al., 2011). During neuronal development the gustatory neurons ASEL and ASER 
acquire left side and right side neuronal identity, respectively. Lsy-6 is expressed only 
in ASEL neurons and is required for left side neuronal identity (Johnston and Hobert, 
2003).  
 
1.1.1.5 Control of developmental timing 
The first miRNA identified is encoded by the lin-4 gene that regulates developmental 
timing in C. elegans (Chalfie et al., 1981; Lee et al., 1993; Wightman et al., 1993). 
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Lin-4 miRNA targets the lin-14 mRNA which encodes a transcription factor that is 
required for completion of the first larval stage (Flynt and Lai, 2008). In lin-4 loss-of-
function mutants, cells reiterate early-stage specific fates, a phenotype that is also 
observed in lin-14 gain-of-function mutants that lack the lin-4 miRNA target sites 
(Ambros and Horvitz, 1984, 1987; Chalfie et al., 1981; Wightman et al., 1991). 
 
1.1.2 Biological functions in pathological conditions 
 
Generally based on animal models, miRNAs have also many reported roles in 
pathological conditions such as cardiac hypertrophy (Callis et al., 2009; Care et al., 
2007), amyotrophic lateral sclerosis (Williams et al., 2009), (potentially) Alzheimer`s 
disease (Boissonneault et al., 2009; Hebert et al., 2008; Wang et al., 2008b) and 
schizophrenia (Begemann et al., 2010; Stark et al., 2008; Xu et al., 2010). Last but 
not least, miRNAs play a role in cancer (Bou Kheir et al., 2011; Calin et al., 2008; 
Chan et al., 2005; Cimmino et al., 2005; Lee et al., 2007; Linsley et al., 2007; Liu et 
al., 2010; Ma et al., 2010; Papagiannakopoulos et al., 2008; Segura et al., 2009; Shi 
et al., 2011; Tan et al., 2011; Tian et al., 2010; Zhang et al., 2010) acting both as 
oncogenes (Bjork et al., 2010; He et al., 2005; Jiang et al., 2010) or tumor 
suppressor genes (Friedman et al., 2009a; Gandellini et al., 2009; Kano et al., 2010; 
Nohata et al., 2011).  
 
1.2 miRNA biogenesis 
 
How are miRNAs generated in cells? Primary miRNA (pri-miRNA) transcripts are 
generally produced by RNA polymerase II and contain a cap structure and a poly(A) 
tail (Figure 1.1, panel A) (Cai et al., 2004; Lee et al., 2004). Most miRNA hairpins are 
found in non-coding transcripts or in intronic regions of protein-coding pre-mRNAs 
(Kim et al., 2009). Often multiple miRNA hairpins are clustered in the same transcript 
(Lee et al., 2002). In a first step of maturation, the miRNA hairpin contained in the pri-
miRNA transcript is cleaved by the Drosha/Dgcr8 heterodimer (Han et al., 2006; Lee 
et al., 2003; Lee et al., 2002). DGCR8 recognizes the dsRNA-ssRNA junction at the 
base of the miRNA hairpin and directs cleavage near the base of the hairpin by the 
RNase III-type protein Drosha (Han et al., 2006). This process takes place in the 
nucleus and releases a small hairpin (typically ~55-70 nucleotides in length) termed 
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pre-miRNA (Lee et al., 2002). Pre-miRNAs are then exported to the cytoplasm by 
Exportin-5 and its partner Ran-GTP (Kim, 2004; Lund et al., 2004). In the cytoplasm 
the RNase III enzyme Dicer cleaves the pre-miRNA hairpin near the terminal loop 
yielding ~22 nucleotides small RNA duplexes (Bernstein et al., 2001; Grishok et al., 
2001; Hutvagner et al., 2001; Ketting et al., 2001; Knight and Bass, 2001). 
 
Figure 1.1: miRNA biogenesis pathway. (A) Primary miRNA (pri-miRNA) transcripts are 
generally produced by RNA polymerase II and processed (cropping) in the nucleus by the 
Drosha-DGCR8 complex (Microprocessor complex) that generates ~65 nucleotide pre-
miRNAs. The pre-miRNA is exported from the nucleus by the nuclear export factor exportin 5. 
In the cytoplasm, the RNaseIII Dicer catalyses the second processing step (dicing) and the 
resulting miRNA duplex is loaded onto an AGO protein, a process that also seems to involve 
TAR RNA-binding protein (TRBP). (B) A miRNA hairpin located in an intronic region can be 
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processed in a canonical manner co-transcriptionally before splicing. (C) In an alternative 
biogenesis pathway (mirtron pathway) the pre-miRNA is generated by splicing, lariat 
debranching and eventually trimming of the 5`- or 3` end. Figure from Kim et al., (2009). 
 
The resulting 22nt RNA dupex is transferred from Dicer to an Argonaute (AGO) 
protein on a way to form the effector complex called miRNA-induced silencing 
complex (miRISC). The final step in RISC formation involves the selection of one of 
the two strands of the small RNA duplex to remain in the AGO protein (miRNA guide 
strand) whereas the other strand (miRNA* or passenger strand) is degraded (Kim et 
al., 2009). Usually the strand with a thermodynamically less stable 5` end is selected 
to remain in the AGO complex, although this rule may not apply to all miRNAs (Han 
et al., 2006; Khvorova et al., 2003). Removal of the passenger strand may be 
facilitated by its endonucleolytic cleavage when the AGO protein (e. g., AGO2) 
contains nuclease activity. When the miRNA duplex is loaded into cleavage 
incompetent AGO1, AGO3 or AGO4, or when the duplex forms mismatches at the 
cleavage site removal of the passenger strand may require RNA unwinding activity 
(Forstemann et al., 2007; Kawamata et al., 2009; Kim et al., 2009; Yoda et al., 2010). 
MiRNAs may also be generated by alternative biogenesis pathways that function 
independently of Drosha/DGCR8 or Dicer. In a biogenesis process that is called 
mirtron pathway, the pre-miRNA is generated by splicing instead of the 
Drosha/DGCR8 cleavage (Figure 1.1, panel C) (Okamura et al., 2007; Ruby et al., 
2007). After splicing and lariat debranching, the intron (mirtron) is recognized as pre-
miRNA and is further processed by the canonical miRNA-biogenesis pathway. 
Whereas the 5` and 3` ends of conventional mirtrons are determined by splicing, the 
5` or 3` ends of alternative mirtrons require trimming by exonucleases (reviewed in 
Yang and Lai, (2011)).  
The biogenesis of miR-451 involves Drosha/DGCR8-mediated cleavage but is 
independent of Dicer (Cheloufi et al., 2010; Cifuentes et al., 2010; Yang et al., 2010). 
Instead, the pre-mir-451 consisting of a hairpin with a stem that is too short to be 
processed by Dicer, is loaded into AGO2 protein and the 5` arm of the hairpin guides 
cleavage of the 3` arm of the hairpin by AGO2. The resulting 30 nucleotide product is 
trimmed at its 3` end yielding the mature 23 nt miR-451. 
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1.3 Principles of target recognition by miRNAs 
 
To exert their repressive effect on gene expression, miRNAs base-pair with their 
target mRNAs. Extensive pairing complementarity leads to the AGO2-catalyzed 
cleavage of the target mRNA (Hutvagner and Zamore, 2002; Song et al., 2004; Yekta 
et al., 2004). More commonly, miRNAs interact with their targets via partial base-
pairing complementarity which characteristically involves perfect Watson-Crick 
pairing of the nucleotides 2-7 from the 5` end of the miRNA, the so called seed 
region (Bartel, 2009; Doench and Sharp, 2004; Lewis et al., 2005; Lewis et al., 2003). 
Extended contiguous Watson-Crick base-pairing of positions 2-8 of the miRNA as 
well as an adenosine residue across position 1 of the miRNA improve its activity 
(Baek et al., 2008; Bartel, 2009; Lewis et al., 2005; Nielsen et al., 2007). 
Supplemetary pairing of the 3` portion of the miRNA has been suggested to usually 
play a modest role in target recognition (Grimson et al., 2007) but there are examples 
where pairing of the 3` portion of the miRNA compensates for a single nucleotide 
bulge or mismatch in the seed region (Reinhart et al., 2000; Yekta et al., 2004). 
Several studies reported examples of miRNA target sites that are functional despite 
imperfect seed pairing, suggesting that more potential miRNA regulatory sites exist 
than those predicted when applying only conventional “seed pairing rules” (Chi et al., 
2012; Didiano and Hobert, 2006; Ha et al., 1996; Tay et al., 2008; Vella et al., 2004). 
The efficacy of miRNA target sites is also influenced by features of the 3`UTR 
(Bartel, 2009). Target sites within the 3`UTR positioned at least 15 nucleotides from 
the stop codon are more effective, likely because miRNAs bound to these sites are 
not displaced by the translating ribosome (Grimson et al., 2007). Further, AU-
richness near the target site and other measures of site accessibility positively 
correlate with site efficacy (Grimson et al., 2007). Sites positioned away from the 
center of long UTRs are generally more efficient, likely because of favorable site 
accessibility (Grimson et al., 2007). Finally, sites that are close together tend to act 
cooperatively (Grimson et al., 2007; Saetrom et al., 2007). Although target sites in 
the 3`UTR appear to induce more robust repression, miRNAs can also target the 
5`UTR and the coding regions of mRNAs (Easow et al., 2007; Gu et al., 2009; Hafner 
et al., 2010; Kloosterman et al., 2004; Lytle et al., 2007). 
Computational studies revealed that highly conserved miRNAs have very many 
conserved targets (Bartel, 2009; Brennecke et al., 2005; Lewis et al., 2005; Xie et al., 
2005), a finding that was supported by experimental approaches which demonstrated 
that a miRNA can affect the mRNA levels of hundreds of targets (Baek et al., 2008; 
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Guo et al., 2010; Lim et al., 2005; Selbach et al., 2008). In sum, more than 60% of 
human protein coding genes appear to have been under selective pressure to 
maintain pairing to miRNAs (Friedman et al., 2009b). 
 
1.4 Protein components of the miRNA 
ribonucleoprotein complex 
 
MiRNAs interact directly with proteins of the AGO family which form the core of the 
miRISC (Peters and Meister, 2007) and are therefore thought to be the key 
components of the miRNA-mediated silencing pathway (Fabian et al., 2010). There 
are two subclasses of Argonaute proteins, the Ago subfamily which resembles 
Arabidopsis AGO1 and the Piwi subfamily which has sequence homology to 
Drosophila PIWI protein (Peters and Meister, 2007). Proteins of the Piwi subfamily 
are mainly expressed in the germline where they interact with piRNAs and are 
involved in germ cell development and silencing of mobile genetic elements 
(reviewed in Juliano et al., (2011)).  
The AGO subfamily is expressed ubiquitously, interacts with miRNAs and siRNAs, 
and consists of four members in humans, AGO1, AGO2, AGO3, and AGO4 (Peters 
and Meister, 2007). All four human AGO proteins repress a reporter mRNA when 
artificially tethered to its 3`UTR and also associate with similar sets of miRNAs, 
proteins and target mRNAs (Azuma-Mukai et al., 2008; Landthaler et al., 2008; Liu et 
al., 2004; Meister et al., 2005; Pillai et al., 2004; Pillai et al., 2005; Wu et al., 2008). 
These observations indicate that all four human AGO proteins are involved in miRNA 
mediated silencing. Experiments showing that AGO2 is essential for embryogenesis 
(Liu et al., 2004) and hematopoiesis in mice indicate a paralog-specific function of 
AGO2 that cannot be complemented by other Argonautes (O'Carroll et al., 2007). 
The paralog-specific function of AGO2 may indeed involve miRNA regulation, since 
the endonucleolytic activity of AGO2 is not required for its role in hematopoiesis 
(O'Carroll et al., 2007). 
AGO proteins contain three evolutionarily conserved domains, a Piwi-Argonaute-
Zwille (PAZ) domain, a MID domain and a PIWI domain (Fabian et al., 2010). The 
crystal structures of archaeal and eubacterial AGO proteins and more recent 
structures of eukaryotic AGO proteins or their fragments revealed that the 3` end of 
small RNAs binds to a specific binding pocket in the PAZ domain and the 5` terminal 
nucleotide binds to a pocket in the junction of the MID and PIWI domains (Jinek and 
9 
Introduction 
Doudna, 2009; Parker et al., 2005; Schirle and MacRae, 2012; Wang et al., 2008d). 
Among the four human AGO proteins, only AGO2 can enzymatically cleave the 
mRNA at the center of the siRNA-mRNA duplex (Liu et al., 2004). The catalytically 
active site is located in the PIWI domain which structurally resembles the bacterial 
RNase H that was shown to cleave the RNA strand of RNA-DNA duplexes (Jinek and 
Doudna, 2009). A ternary complex structure including Thermus thermophilus 
Argonaute, a small RNA mimic and a target RNA revealed that the nucleotides at 
positions 2-6 of the miRNA contact AGO through the phosphate-ribose backbone 
and are oriented in a way that the bases are available for hydrogen bonding with the 
target (Wang et al., 2008d). These observations explain well why perfect 
complementarity in the seed region of miRNAs is crucial for target mRNA recognition 
and why the nucleotide at position 1 of the miRNA is not needed for base-pairing 
(Fabian et al., 2010). 
 
The GW182 family of proteins is another group of factors that is crucial for 
miRNA-mediated repression. Originally, GW182 was identified in human cells as 
component of discrete cytoplasmic domains which later turned out to coincide with 
mRNA-processing bodies (P-bodies) (Eystathioy et al., 2002; Eystathioy et al., 2003). 
Independent studies identified GW182 as a factor interacting with AGO proteins and 
required for miRNA-mediated repression (Ding et al., 2005; Jakymiw et al., 2005; Liu 
et al., 2005a; Meister et al., 2005; Rehwinkel et al., 2005). There are three 
mammalian GW182 paralogs named TNRC6A (Trinucleotide repeat containing gene 
6A protein), TNRC6B and TNRC6C and one homologous protein in Drosophila, 
dGW182. GW182 proteins contain two structured regions, a central ubiquitin 
associated (UBA)-like domain (only present in some GW182s) and a C-terminal RNA 
recognition motif (RRM) (Figure 1.2) (Ding and Han, 2007; Eulalio et al., 2007a). The 
dGW182 RRM adopts a canonical RRM fold but it lacks features that enable 
canonical RRMs to interact with RNA (Eulalio et al., 2009c). Other regions of GW182 
proteins including an N-terminal glycine and tryptophan (GW) repeat-rich region (N-
GW-rich), two GW-repeat-containing regions in the C-terminal part of the protein 
(termed: middle- and C-terminal GW-repeat region (M-GW and C-GW)), and a 
glutamine-rich region are predicted to be unstructured (Eulalio et al., 2009d). Another 
conserved region in the C-terminal part of GW182 proteins is called DUF (domain of 
unknown function) or PAM2 because a sequence within DUF shows similarity with 
the PAM2 motif of PABP-interacting proteins (Fabian et al., 2010).  
GW182 proteins directly interact with AGO proteins and this interaction involves 
some of the GW-repeats in the N-terminal GW-repeat region (Eulalio et al., 2009a; 
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Till et al., 2007). Interference with the AGO-GW182 interaction or depletion of 
GW182 protein by RNAi abrogates miRNA-mediated repression (Behm-Ansmant et 
al., 2006; Eulalio et al., 2008b; Rehwinkel et al., 2005; Till et al., 2007). Furthermore, 
direct tethering of GW182 proteins to an mRNA represses the mRNA even in the 
absence of AGO protein, suggesting that GW182 is the effector protein acting 
downstream of AGO (Behm-Ansmant et al., 2006). 
 
Figure 1.2: Domain structure of selected GW182 proteins. Schematic representation of 
human (Hs) TNRC6C and Drosophila (Dm) GW182 proteins. Positions of N-GW-rich, Q-rich, 
UBA, DUF/PAM2, M-GW, RRM, and C-GW domains are indicated. Figure modified from 
Zipprich et al., (2009). 
 
Mammalian mRNA deadenylation involves two cytoplasmic deadenylase complexes, 
PAN2-PAN3 and CCR4-CAF1-NOT (Yamashita et al., 2005). These two cytoplasmic 
deadenylase complexes are also involved in miRNA-mediated deadenylation. First, 
depletion of components of the CCR4-CAF1-NOT complex inhibits deadenylation 
and decay of mRNAs targeted by miRNAs (Behm-Ansmant et al., 2006; Piao et al., 
2010). Second, transcriptome analysis of Drsosophila S2 cells depleted of CCR4-
CAF1-NOT complex components revealed that approximately 60% of AGO1 targets 
are regulated by CAF1 and/or NOT1 (Eulalio et al., 2009b). Third, overexpression of 
catalytically inactive mutants of CCR4, CAF1, CNOT8 (a CAF1 homolog) or PAN2 
interferes with miRNA-mediated deadenylation (Chen et al., 2009; Piao et al., 2010).  
The CCR4-CAF1-NOT complex is a large (approximately 1 MDa in yeast) multi-
subunit complex that is highly conserved in eukaryotes (Collart and Panasenko, 
2012). In humans the complex consists of 7 core subunits. CNOT1, a large scaffold 
of the complex, interacts with CNOT2, CNOT3, CNOT6 or CNOT6L, CNOT7 or 
CNOT8, CNOT9, and CNOT10 (Figure 1.3) (Bartlam and Yamamoto, 2010). CNOT6 
and CNOT6L as well as the pair CNOT7 and CNOT8 are thought to be present in 
mutually exclusive manner in CCR4-CAF1-NOT complexes (Lau et al., 2009). 
11 
Introduction 
CNOT6 and CNOT6L are the human orthologs of yeast Ccr4p and belong to the 
exonuclease-endonuclease-phosphatase (EEP) family (Bartlam and Yamamoto, 
2010). The two human orthologs of yeast Caf1/Pop2p, a member of the family of 
DEDD-type deadenylases, are CNOT7 and CNOT8 (Bartlam and Yamamoto, 2010). 
CNOT6, CNOT6L, CNOT7 and CNOT8 have all been demonstrated to possess 
deadenylase activity in vitro (Bianchin et al., 2005; Wang et al., 2010). 
The function of the CCR4-CAF1-NOT complex has been mainly studied in yeast 
and the complex or components thereof have been connected to a multitude of 
cellular processes such as transcription, deadenylation, translational repression, 
mRNA export, and nuclear surveillance (Collart and Panasenko, 2012). Further, 
physical or functional links between the complex and the proteasome, ubiquitination, 
and DNA damage response have been reported (Collart and Panasenko, 2012). 
 
Figure 1.3: A model of the human CCR4-CAF1-NOT complex. CNOT1 acts as a scaffold 
of the complex which is thought to contain only two deadenylases: one CCR4-type (either 
CNOT6 or CNOT6L) and one CAF1-type (either CNOT7 or CNOT8). CNOT4 is not stably 
associated with the complex. Figure from Bartlam and Yamamoto, (2010). 
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Recruitment of the CCR4-CAF1-NOT complex to the 3`UTR of mRNAs via RNA 
binding proteins to regulate gene expression post-transcriptionally seems to be a 
general strategy used in eukaryotes. For example, human CAF1 is recruited by the 
zinc finger RNA binding protein Tristetraprolin (TTP) to AU-rich elements in the 
3`UTR of target mRNAs (Clement et al., 2011; Sandler et al., 2011) and the CCR4-
CAF1-NOT complex is recruited to the nanos 3`UTR by Smaug in Drosophila 
embryos (Zaessinger et al., 2006). In yeast, Pop2p is recruited to the 3`UTR of HO 
mRNA by Mpt5p, a member of the Pumilio family of RNA binding proteins 
(Goldstrohm et al., 2006; Goldstrohm et al., 2007). In the examples mentioned above, 
recruitment of the CCR4-CAF1-NOT complex induces deadenylation and decay of 
the target mRNA. However, the CCR4-CAF1-NOT complex has also been implicated 
in translational repression. In Xenopus laevis oocytes, Caf1 was found to repress 
translation of a tethered mRNA in a m7G cap dependent and poly(A) tail independent 
manner (Cooke et al., 2010). Furthermore, Mpt5p-mediated repression in yeast 
seems to involve a deadenylation independent mechanism, as in cells lacking Ccr4p, 
Mpt5p-mediated repression is only modestly affected whereas deadenylation is 
severely inhibited (Goldstrohm et al., 2006; Goldstrohm et al., 2007). Interestingly, in 
contrast to Ccr4p, Pop2p is required for this Mpt5p-mediated repression, suggesting 
that Pop2p plays a role in the deadenylation independent mechanism of repression 
(Goldstrohm et al., 2007). 
 
miRISCs interact with additional factors that have been shown to play a role in 
miRNA-mediated repression or may act as modulators of miRNA function (Fabian et 
al., 2010). One of these factors is the RNA helicase RCK/p54, a P-body component 
that is essential for inducing repression (Chu and Rana, 2006; Eulalio et al., 2007c). 
Other factors are the mammalian hyperplastic discs protein EDD, which has a critical 
function in miRNA-mediated siencing in mouse embryonic stem (ES) cells (Su et al., 
2011) and Ataxin-2 (Atx2) that is required for miRNA-mediated repression in 
Drosophila (McCann et al.). Further, Importin 8 (Imp8) functions in miRNA-mediated 
repression by targeting AGO2 complexes to distinct target mRNAs (Weinmann et al., 
2009) and the TRIM-NHL family proteins NHL-2 and TRIM32 were reported to 
enhance the activity of selected miRNAs in C. elegans (Hammell et al., 2009) and 
mouse (Schwamborn et al., 2009), respectively.  
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1.5 Cellular compartmentalization of miRNA 
repression 
 
Where does miRNA-mediated repression take place in a cell? Although clearly more 
investigation is needed to fully answer this question, some connections between the 
miRNA machinery and cellular organelles and structures have already emerged.  
 
1.5.1 The role of P-bodies and stress granules 
 
P-bodies are cytoplasmic foci that consist of aggregates of translationally repressed 
mRNAs associated with a set of proteins of the translation repression and mRNA 
decay machinery (Parker and Sheth, 2007). Among the proteins that were found in 
P-bodies are components of the CCR4-NOT deadenylase complex, the decapping 
enzyme DCP2, the decapping activators DCP1, RCK/p54, HPat1, RAP55, EDC3, 
Ge-1/Hedls, LSm1-7, and the 5`-3` exonuclease XRN1. mRNAs accumulating in P-
bodies are thought not to be engaged in translation as P-bodies lack ribosomes and 
eIF4E is the only translation initiation factor present (Andrei et al., 2005; Brengues et 
al., 2005; Ferraiuolo et al., 2005; Teixeira et al., 2005). mRNAs in P-bodies can be 
stored for later reutilization in translation but on the other hand, P-bodies are also 
believed to be a site where the final steps of mRNA decay occur (Eulalio et al., 2007a; 
Parker and Sheth, 2007). 
One of the founding components of P-bodies is the miRISC component GW182 
(Eystathioy et al., 2002), and miRNAs, AGO proteins and mRNAs targeted by 
miRNAs were all found to accumulate in P-bodies (Jakymiw et al., 2005; Liu et al., 
2005b; Parker and Sheth, 2007; Pillai et al., 2005; Sen and Blau, 2005). Moreover, a 
correlation between miRNA-mediated repression and P-body localization of 
repressed mRNAs was observed (Bhattacharyya et al., 2006; Huang et al., 2007; Liu 
et al., 2005b; Pillai et al., 2005). A connection between P-bodies and miRNA-
mediated silencing is further corroborated by the finding that knockdown of P-body 
components interferes with miRNA-mediated repression (Bagga et al., 2005; Behm-
Ansmant et al., 2006; Chu and Rana, 2006; Eulalio et al., 2007c; Rehwinkel et al., 
2005). Conversely, a functional miRNA pathway is required for P-body formation as 
the knock-down of miRNA-biogenesis components (Drosha, DGCR8, Dicer-1) or 
14 
Introduction 
factors required for miRNA-mediated repression (AGO1, GW182) resulted in a 
decline of P-bodies (Eulalio et al., 2007b; Pauley et al., 2006). 
Although some P-body components seem to be involved in miRNA-mediated 
silencing, depletion of other P-body components that results in the dispersion of P-
bodies did not affect silencing (Eulalio et al., 2007b). These findings indicate that 
microscopically visible P-bodies are not essential for miRNA-induced silencing but do 
not excluded the possibility that submicroscopic P-body-like structures contribute to 
silencing.  
Stress granules are another type of RNA granules that contain untranslated 
mRNAs and form upon global repression of translation initiation (Fabian et al., 2010; 
Parker and Sheth, 2007). Like P-bodies, stress granules may play a role in miRNA-
mediated repression as AGO proteins and miRNA mimics were observed to 
accumulate in stress granules (Fabian et al., 2010; Leung et al., 2006). However, this 
accumulation can just represent passive dragging of mRNA-associated proteins into 
stress granules upon translational repression. 
 
1.5.2 Role of Multivesicular bodies and endosomes 
 
Evidence for a role of multivesicular bodies (MVBs) in miRNA-mediated silencing 
was found in two studies using Drosophila melanogaster and human cell lines 
(Gibbings et al., 2009; Lee et al., 2009). Lee et al., (2009) linked miRNA-mediated 
silencing to endosomal trafficking. Blocking multivesicular body maturation and fusion 
with lysosomes enhanced miRNA-mediated repression and lead to an accumulation 
of GW-bodies which were found to be associated with MVBs. Conversely, blocking 
MVB formation impaired miRNA-mediated silencing. The authors proposed a model 
in which MVBs promote the turnover of RNA-induced silencing complexes (RISCs) 
which results in more effective engagement of RISCs with small RNAs and possibly 
target RNAs. Gibbings et al., (2009) reached similar conclusions after showing that 
GW-bodies congregate with endomsomes and MVBs and that the depletion of 
ESCRT (endosomal sorting complex required for transport) complex components 
required for protein sorting to MVBs compromised miRNA-mediated silencing. 
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1.6 The mechanism of miRNA-mediated 
repression 
 
miRNAs regulate gene expression post-transcriptionally by inhibiting translation of 
target mRNAs and/or by inducing their deadenylation and subsequent degradation 
(Fabian et al., 2010). First I will provide a brief overview of the mechanism of 
translation and then summarize the results of studies addressing the mechanism of 
miRNA-mediated silencing. 
 
1.6.1 Introduction to eukaryotic translation 
 
The process of translation can be divided in three steps: initiation, elongation, and 
termination (Sonenberg and Hinnebusch, 2009). In the process of translation 
initiation, the small (40S) ribosomal subunit is recruited to the 5` end of the mRNA 
and then scans in the 5`-3` direction until it encounters the first AUG start codon 
which leads to formation of the 80S ribosome by joining of the large (60S) ribosomal 
subunit. Next, the 80S ribosome moves along the mRNA while catalyzing the 
formation of an elongating peptide chain. Finally, during translation termination the 
newly synthesized protein is released and the ribosome dissociates from the mRNA. 
Efficient translation initiation of an mRNA depends on the m7GpppN group (termed 5` 
cap) at the 5` end of the mRNA and on the poly(A) tail at the 3` end. This is explained 
by the fact that the 5` cap and the poly(A) tail facilitate the recruitment of the 43S pre-
initiation complex consisting of translation initiation factors and the small (40S) 
ribosomal subunit loaded with methionly-tRNA to the 5` end of the mRNA (Figure 1.4, 
panel A) (Sonenberg and Hinnebusch, 2009). The 5` cap interacts with the 
translation initiation factor eIF4E which is part of the eIF4F complex. The eIF4F 
complex contains two more components: eIF4G, which directly interacts with and 
recruits the 43S pre-initiation complex and eIF4A, an RNA helicase which unwinds 
secondary structures in the 5`UTR and thereby facilitates scanning of the small 
ribosomal subunit. The poly(A) tail is bound by the poly(A)-binding protein (PABP) 
which directly interacts with eIF4G. The PABP-eIF4G interaction stabilizes the 
interaction of eIF4E with the 5` cap which ultimately enhances translation initiation 
(Kahvejian et al., 2005). 
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Translation initiation is not always a cap-dependent process. Originally 
discovered as part of a viral RNA (Pelletier and Sonenberg, 1988), internal ribosomal 
entry sites (IRESs) can directly recruit the ribosome and thereby circumvent the 
requirement of a 5` cap structure for translation initiation. IRESs are also found in 
many cellular mRNAs (Hellen and Sarnow, 2001). IRESs function independently of 
the cap but some utilize certain cellular translation initiation factors. For example, the 
encephalomyocarditis virus (EMCV) IRES recruits the ribosome by directly binding to 
eIF4G, functions independently of eIF4E but requires otherwise the same set of 
translation initiation factors as the canonical initiation mechanism (Figure 1.4, panel B) 
(Hellen, 2009). The hepatitis C virus (HCV) IRES directly assembles the initiation 
complex containing the 40S ribosomal subunit and eIF3 at the start codon and 
functions independently of eIFs 4A, 4B, and 4F (Hellen, 2009). In contrast, the cricket 
paralysis virus (CrPV) IRES recruits the ribosome via a mechanism that does not 
require any canonical initiation factor (Fabian et al., 2010). 
 
Figure 1.4: Cap-dependent versus internal ribosome-entry site-dependent translation 
initiation. (A) In cap-dependent translation initiation, eIF4E binds to the 5` m7GpppN cap 
structure (red). The 40S ribosomal subunit is recruited to the 5` end of the mRNA via eIF4E, 
eIF4G and eIF3. The RNA helicase eIF4A is thought to be involved in the unwinding of 
secondary structure in the 5` untranslated region. Poly(A)-binding protein (PABP) binds to the 
poly(A) tail and eIF4G which leads to mRNA circularization. (B) A 5` m7GpppN cap structure 
and eIF4E are not required for internal ribosome-entry site-dependent translation initiation. 
Translation initiation mediated by some IRESes is stimulated by internal ribosome-entry site 
(IRES) trans-acting factors (ITAFs) and eIF4G or a distant homologue thereof (p97). Figure 
from Holcik and Sonenberg, (2005). 
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Figure 1.5: Possible mechanisms of miRNA-mediated gene silencing. miRNAs have 
been suggested to silence gene expression by inhibiting translation at different steps of 
translation initiation by interfering with cap recognition, interfering with function of translation 
initiation factors or inducing deadenylation. miRNA-mediated deadenylation may be followed 
by decapping and mRNA decay. Also, miRNAs have been suggested to affect translation at a 
step after initiation by inhibiting translation elongation, promoting premature termination of 
translation or by inducing nascent polypeptide degradation. Figure based on Eulalio et al., 
(2008a) and Chekulaeva and Filipowicz, (2009). 
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1.6.2 miRNA-mediated repression of translation 
 
1.6.2.1 miRNA-mediated repression of translation at postinitiation steps 
 
The first miRNA discovered, lin-4, was found to repress lin-14 post-transcriptionally at 
the level of translation without causing degradation of lin-14 mRNA (Lee et al., 1993; 
Olsen and Ambros, 1999; Wightman et al., 1993). Because lin-4 also did not change 
the polysomal sedimentation profile of lin-14 mRNA, the authors concluded that the 
miRNA does not affect translation initiation but inhibits protein accumulation at a step 
after initiation (Figure 1.5) (Olsen and Ambros, 1999). Three lines of evidence have 
been used as arguments supporting the idea that miRNAs mediate repression of 
translation at a post-initiation step.  
First, as observed for lin-4 and lin-14, also a number of subsequent studies found 
that miRNAs repress protein synthesis without affecting the polysome association of 
target mRNAs (Gu et al., 2009; Nottrott et al., 2006; Olsen and Ambros, 1999; 
Petersen et al., 2006; Seggerson et al., 2002).  
Second, miRNAs, target mRNAs and AGO proteins were found to be associated 
with polysomal fractions (Kim et al., 2004; Maroney et al., 2006; Nelson et al., 2004; 
Nottrott et al., 2006). Although this observation was interpreted as an argument in 
favor of miRNA-mediated repression taking place at a post-initiation step (Maroney et 
al., 2006), association of miRISC components with polysomes could also be due to 
incomplete repression of translation initiation.  
Third, miRNAs (or miRNA mimics) were found to repress HCV and CrPV IRES-
driven translation (Lytle et al., 2007; Petersen et al., 2006). As IRES-driven 
translation initiation requires fewer or no (CrPV IRES) canonical translation initiation 
factors, these results are consistent with repression affecting a step other than 
canonical translation initiation (Fabian et al., 2010). In the study of Petersen et al., 
(2006) repression could also involve miRNA-mediated mRNA decay rather than 
translational repression as the authors did not measure the reporter mRNA level. 
 
What could be the mechanism of translational repression at a post-initiation step? 
Petersen et al., (2006) observed that after a block of translation initiation, miRNA 
mimics caused the target mRNA containing polysomes to dissociate more rapidly 
than in the absence of miRNA mimics. Therefore, the authors proposed that miRNAs 
promote ribosomes to dissociate prematurely from the mRNA (Figure 1.5). 
Conflicting with this model, Guo et al., (2010) observed that the number of ribosomes 
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associated with repressed mRNAs was reduced, but the reduction was constant 
along the open reading frame.  
Nottrott et al., (2006) suggested that miRNAs could cause the degradation of 
nascent polypeptides co-translationally (Figure 1.5). Arguing against this model, an 
independent study found that targeting the nascent polypeptide to the endoplasmatic 
reticulum, which should protect it from proteolysis, did not affect the degree of 
miRNA-mediated repression (Pillai et al., 2005). Furthermore, mRNAs coding for 
membrane and ER proteins were found to be overrepresented among translationally 
repressed miRNA targets (Selbach et al., 2008).  
 
1.6.2.2 miRNA-mediated repression of translation initiation 
 
In contrast to the studies mentioned above, experiments carried out in other 
laboratories indicated that miRNAs interfere with translation initiation.  
First, miRNAs were found to shift target mRNAs from heavy to lighter polysomes 
in the sedimentation gradient, indicating reduced ribosome association of repressed 
mRNAs. This was first observed in HeLa cells for reporter mRNAs regulated by 
endogenous (let-7) or artificial miRNAs (Humphreys et al., 2005; Pillai et al., 2005). 
Later, similar shifts of target mRNAs were also observed for the endogenous CAT-1 
mRNA that is repressed by miR-122 in Huh7 cells (Bhattacharyya et al., 2006), for a 
miR-16-targeted reporter mRNA in 293T cells (Huang et al., 2007) and for several 
endogenous mRNAs repressed by let-7 in HeLa cells (Clancy et al., 2011). 
Importantly, miRNAs were also observed to affect the polysome association of 
mRNAs in a whole animal, the worm C. elegans. Several endogenous targets, 
among them lin-14 and lin-28 mRNAs, were found to be associated with fewer 
ribosomes when they were repressed by miRNAs (Ding and Grosshans, 2009). 
Genomic-scale studies using polysome profile analysis or a ribosome profiling 
approach also support the notion that miRNA-mediated translational repression 
occurs at the level of initiation (Guo et al., 2010; Hendrickson et al., 2009). 
Second, mRNAs whose translation is driven in a m7G-cap independent manner 
were found to be refractory to miRNA-mediated repression or to exhibit a reduced 
extent of repression. In HeLa cells, mRNAs with an ApppG-cap structure were less 
repressed by miRNA mimics than mRNAs with a normal m7G-cap structure 
(Humphreys et al., 2005) and translation driven by the HCV (Pillai et al., 2005), 
EMCV (Karaa et al., 2009; Pillai et al., 2005) or CrPV (Humphreys et al., 2005) 
IRESs or by tethered translation initiation factors (eIf4E or eIF4G) (Pillai et al., 2005) 
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was refractory to miRNA-mediated repression. All these studies indicated that 
miRNAs target an early step of translation initiation (Figure 1.5). 
Subsequent in vitro studies using cell free extracts supported the notion that 
miRNAs inhibit translation at the step of initiation. In extracts prepared from 
Drosophila melanogaster embryos, miRNAs interfered with the formation of 48S and 
80S translation initiation complexes (Thermann and Hentze, 2007) and also in mouse 
Krebs-2 ascites cell-extracts formation of the 80S ribosomal complex was inhibited 
by miRNAs (Mathonnet et al., 2007). In the cell extracts mentioned above and also in 
cell extracts from HEK293 cells or in rabbit reticulocyte lysates, the m7G cap was 
essential for miRNA-mediated repression as EMCV or HCV IRES-dependent 
translation and ApppG-capped or uncapped mRNAs were refractory to repression 
(Mathonnet et al., 2007; Ricci et al., 2011; Thermann and Hentze, 2007; Wakiyama 
et al., 2007; Wang et al., 2006). In support of the notion that miRNAs target the m7G-
cap-recognition machinery, miRNA mediated repression was found to be affected by 
modifications of the triphosphate bridge of the cap (Zdanowicz et al., 2009) and by 
the addition of eIF4F to the cell extract (Mathonnet et al., 2007). 
 
How could miRNAs interfere with the cap-recognition machinery? Iwasaki et al., 
(2009) provided evidence that in Drosophila embryo extracts, dAGO2-RISC inhibits 
cap-dependent translation by blocking the interaction of eIF4E with eIF4G (Iwasaki et 
al., 2009). However, generally miRNAs are loaded into dAGO1 and only a subclass 
of miRNAs is loaded into dAGO2 (Czech and Hannon, 2011; Fabian et al., 2010). 
Furthermore, the mechanism of dAGO2 action is probably not evolutionarily 
conserved, since in contrast to dAGO2, human AGO2 has not been obsereved to 
interact with eIF4E (Fabian et al., 2009; Fabian et al., 2010). 
Another model suggests that AGO2 directly binds to the m7G-cap and inhibits 
translation initiation by competing with eIF4E for binding to the 5`-cap (Djuranovic et 
al., 2010; Kiriakidou et al., 2007). Kiriakidou et al., (2007) found two aromatic 
residues in the AGO2 MID domain to be required for cap interaction and translational 
repression induced by tethered AGO2 and suggested that these residues bind to the 
cap structure by stacking interactions similar to those found in eIF4E. Challenging 
this idea, a homology based structure model of AGO2 revealed that one of the 
aromatic residues is buried in the hydrophobic core of the domain (Kinch and Grishin, 
2009) and mutating the residues also abrogated interaction of AGO with GW182 and 
miRNAs (Eulalio et al., 2008b). Djuranovic et al., (2010) found that the affinity of 
Drosophila AGO1 to m7GTP-Sepharose increased in the presence of miRNAs and 
suggested that miRNA binding to the 5` phosphate binding site in AGO1 makes an 
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allosterically regulated cap-binding site available. However, this potential cap binding 
site was found to be occluded by other parts of the protein in a crystal structure of the 
MID-PIWI lobe from Neurospora Argonaute (Boland et al., 2011). Furthermore, an 
equivalent potential cap binding site as in the structure of the Neurospora Argonaute 
MID domain was not found in the structure of the human AGO2 MID domain and pull-
down experiments with human AGO2 indicated that the interaction with cap analogs 
is non-specific (Frank et al., 2011).  
 
In contrast to the studies mentioned above suggesting that miRNAs target an 
early step of translation initiation, other studies indicated that miRNAs interfere with a 
late step of translation initiation, the joining of the 60S ribosomal subunit (Figure 1.5). 
In support of this notion Wang et al., (2008a) found 40S but not 60S ribosomal 
subunits to be associated with mRNAs repressed by miRNA mimics in a rabbit 
reticulocyte lysate. Another study reported that eIF6, a protein that prevents the 60S 
ribosomal subunit to join the 40S subunit, is required for miRNA-mediated repression 
in human cells and in C. elegans (Chendrimada et al., 2007). On the other hand, 
depleting eIF6 had no effect on miRNA-mediated repression in Drosophila S2 cells 
(Eulalio et al., 2008b) and knocking-down eIF6 in C. elegans stimulated rather than 
inhibited let-7-mediated repression (Ding et al., 2008). 
 
1.6.2.2.1 miRNA-mediated repression of translational initiation and the poly(A)-
tail 
 
Since the poly(A)-binding protein, which associates with the 3` poly(A) tail of mRNAs, 
promotes cap-dependent translation initiation, miRNA-mediated deadenylation would 
be expected to inhibit translation initiation (Figure 1.5) (Fabian et al., 2010). Many 
studies have therefore addressed the role of a poly(A) tail in miRNA-mediated 
translational repression. In cell free extracts from HEK293 cells or Drosophila 
embryos, m7G-capped and poly(A) tail-free mRNAs were found to be refractory to 
miRNA-mediated repression (Wakiyama et al., 2007; Zdanowicz et al., 2009). Also, 
miRNA mimics failed to repress m7G-capped mRNAs lacking a poly(A) tail in 
nuclease-treated rabbit reticulocyte laysate (Wang et al., 2006). In HeLa cells, 
blocking deadenylation of a reporter mRNA partially prevented let-7-mediated 
translational repression, indicating that miRNA-mediated deadenylation contributes to 
translational repression (Beilharz et al., 2009). In contrast, Pillai et al., (2005) found 
no difference in the extent of let-7-mediated repression of poly(A)+ and poly(A)- 
mRNA in transfected HeLa cells. In addition, mRNA reporters in which the poly(A) tail 
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was replaced by a histone stem-loop or a self-cleavable ribozyme were still 
repressed by miRNAs (Eulalio et al., 2008b; Eulalio et al., 2009b; Wu et al., 2006). 
Thus, it seems that miRNAs can inhibit translation in poly(A) tail-dependent and -
independent ways (Fabian et al., 2010). 
 
1.6.3 Modulation of miRNA-mediated repression 
 
The repressive effect of miRNAs on their target mRNAs was found to be modulated 
by various trans-acting factors. HuR, an AU-rich element binding protein, is released 
from the nucleus upon stress of Huh7 cells and alleviates miR-122-mediated 
repression of CAT-1 mRNA by binding to its 3`UTR (Bhattacharyya et al., 2006). 
Similarly, Dead-end 1 (Dnd1), another RNA-binding protein, prevents miRNA-
mediated repression in human cells and primordial germ cells of zebrafish by 
preventing miRNAs to associate with their target mRNAs (Kedde et al., 2007). The 
protein DAZL (deleted in azoospermia-like) represents another factor that protects 
some mRNAs in zebrafish primordial germ cells from miRNA activity. DAZL 
counteracts miR-430-mediated deadenylation by promoting poly(A)-tail elongation of 
a subset of miR-430 target mRNAs (Takeda et al., 2009).  
Trans-acting factors have also been reported to enhance miRNA-mediated 
repression. Two TRIM-NHL proteins, mammalian TRIM32 and C. elegans NHL-2 
enhance miRNA activity without changing miRNA levels (Hammell et al., 2009; Krol 
et al., 2010; Schwamborn et al., 2009). NHL-2 interacts genetically and physically 
with AGO, GW182, and RCK/p54 proteins and is required for full activity of let-7 and 
lys-6 miRNAs (Hammell et al., 2009). Interestingly, both TRIM32 and NHL-2 seem to 
stimulate the activity of only a subset of miRNAs (Hammell et al., 2009; Schwamborn 
et al., 2009). 
 
1.6.4 miRNA-mediated translational activation 
 
Under certain conditions miRNAs were also found to stimulate the expression of their 
targets rather than repressing them (Henke et al., 2008; Jopling et al., 2008; Jopling 
et al., 2005; Orom et al., 2008; Vasudevan and Steitz, 2007; Vasudevan et al., 2007). 
Vasudevan et al., (2007) found that miRNAs switch from a repression to an activation 
mode upon G1/G0 growth arrest. However, upregulation of translation in quiescent 
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cells is probably not a general mechanism as in a different study miRNA-mediated 
repression was also observed in G1-arrested cells (Li and Carthew, 2005). 
Orom et al., (2008) reported that in response to stress or nutrient shortage, miR-
10a stimulates translation of 5`-TOP (5`-terminal oligopyrimidine tract) motif 
containing mRNAs which encode proteins involved in translation. To stimulate 
translation, miR-10a binds downstream of the 5`-TOP motif in the 5`UTR by 
seemingly non-canonical miRNA-mRNA base-pairing. Whether AGO proteins or 
other miRNP components are involved in this type of regulation was not investigated. 
The liver specific miR-122 was observed to positively affect expression of the 
Hepatitis C Virus (HCV) RNA (Henke et al., 2008; Jopling et al., 2008; Jopling et al., 
2005). Binding of miR-122 to the 5`UTR of HCV RNA stimulated HCV RNA 
replication (Jopling et al., 2005) and also its translation (Henke et al., 2008) in an 
AGO2-dependent manner (Wilson et al., 2011). 
 
1.6.5 miRNA-mediated mRNA deadenylation and 
decay 
 
Originally, miRNAs were thought to inhibit translation without affecting the level of 
target mRNAs. However, it is now well established that miRNAs can down regulate 
target mRNA levels (Bagga et al., 2005; Krutzfeldt et al., 2005; Lim et al., 2005; Wu 
and Belasco, 2005). Down-regulation of hundreds of miRNA targets was observed in 
genomic scale studies that measured the abundance of mRNAs after introducing a 
miRNA into cells (Baek et al., 2008; Guo et al., 2010; Hendrickson et al., 2009; Lim et 
al., 2005; Linsley et al., 2007; Selbach et al., 2008; Webster et al., 2009) and 
hundreds of miRNA targets were found to be up-regulated after depleting or inhibiting 
a miRNA (Baek et al., 2008; Krutzfeldt et al., 2005; Selbach et al., 2008). Similarly, 
depleting cells of factors essential for miRNA-mediated repression (such as Drosha, 
Dicer, AGO or GW182) increased the mRNA level of miRNA targets (Behm-Ansmant 
et al., 2006; Eulalio et al., 2009b; Eulalio et al., 2007c; Giraldez et al., 2006; 
Rehwinkel et al., 2005; Rehwinkel et al., 2006; Schmitter et al., 2006) and anti-
correlated expression changes of miRNAs and their targets were observed in 
differentiating cells (Farh et al., 2005). Furthermore, there is much evidence that 
miRNAs cause target mRNA degradation by inducing deadenylation followed by 
decapping and 5`-3` exonucleolytic digestion (Figure 1.5) (Behm-Ansmant et al., 
2006; Beilharz et al., 2009; Chen et al., 2009; Eulalio et al., 2009b; Eulalio et al., 
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2007c; Giraldez et al., 2006; Mishima et al., 2006; Piao et al., 2010; Rehwinkel et al., 
2005; Wu et al., 2006). Finally, miRNA-mediated deadenylation was also observed in 
cell free extracts (Fabian et al., 2009; Iwasaki et al., 2009; Wakiyama et al., 2007; 
Zdanowicz et al., 2009). 
 
1.6.5.1 GW182 and miRNA-mediated deadenylation and decay 
 
The two core components of the miRISC complex, AGO and GW182 proteins, are 
essential for miRNA-mediated deadenylation and subsequent mRNA decay (Behm-
Ansmant et al., 2006; Fabian et al., 2010). Knocking down Drosophila AGO1 
abrogates miRNA-mediated mRNA decay and immunodepleting AGO2 from Krebs-2 
ascites extracts prevents miRNA-mediated deadenylation (Behm-Ansmant et al., 
2006; Fabian et al., 2009). Knocking down GW182 also abrogates miRNA-mediated 
mRNA decay (Behm-Ansmant et al., 2006). Furthermore, interfering with the AGO-
GW182 interaction with point mutations or by expressing a competing GW182 
fragment or adding a competing peptide (or a GW182 fragment) to cell-free extracts, 
prevents miRNA-mediated repression and blocks miRNA-mediated deadenylation 
(Eulalio et al., 2008b; Fabian et al., 2009; Iwasaki et al., 2009; Till et al., 2007). 
Finally, direct tethering of GW182 to the 3`UTR induces deadenylation and decay of 
a reporter mRNA (Behm-Ansmant et al., 2006; Chekulaeva et al., 2009; Lazzaretti et 
al., 2009; Zipprich et al., 2009). 
Importantly, besides inducing mRNA decay GW182 proteins are also implicated 
to be involved in translational repression in human cells, Drosophila S2 cells and C. 
elegans (Behm-Ansmant et al., 2006; Chekulaeva et al., 2009; Ding and Grosshans, 
2009; Iwasaki et al., 2009; Zipprich et al., 2009). 
 
1.6.5.2 mRNA decay factors and miRNA-mediated deadenylation and 
decay 
 
miRNAs direct their target mRNAs to the canonical mRNA decay pathway where the 
mRNA is deadenylated and subsequently decapped and degraded (Behm-Ansmant 
et al., 2006; Eulalio et al., 2009b; Eulalio et al., 2007c; Giraldez et al., 2006; Piao et 
al., 2010; Rehwinkel et al., 2005; Wu et al., 2006). Two deadenylase complexes are 
involved in miRNA-mediated deadenylation and mRNA decay: CCR4-CAF1-NOT 
and PAN2-PAN3. This is supported by the findings that depleting components of the 
two deadenylase complexes or overexpressing dominant negative forms interferes 
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with miRNA-mediated deadenylation and leads to an increase of the mRNA level of 
miRNA-targets (Behm-Ansmant et al., 2006; Chen et al., 2009; Eulalio et al., 2009b; 
Fabian et al., 2009; Piao et al., 2010). miRNA-mediated deadenylation is followed by 
decapping by the DCP1:DCP2 decapping complex and 5`-3` exonucleolytic 
degradation by XRN1 (Bagga et al., 2005; Behm-Ansmant et al., 2006; Eulalio et al., 
2009b; Eulalio et al., 2007c; Rehwinkel et al., 2005). DCP2-mediated decapping is 
stimulated by decapping activators such as DCP1, GE1, PAT1 and RCK and 
depletion of these factors was shown to increase the mRNA level of miRNA targets 
or to interfere with miRNA-mediated repression (Behm-Ansmant et al., 2006; Chu 
and Rana, 2006; Eulalio et al., 2007c; Rehwinkel et al., 2005). 
 
1.6.5.3 Poly(A)-binding protein and miRNA-mediated deadenylation and 
decay 
 
The poly(A)-binding protein is another factor that is required for miRNA-mediated 
deadenylation. Immunodepletion of PABP from Krebs ascite extracts prevented 
miRNA-mediated deadenylation which could be rescued by the addition of 
recombinant PABP to the extract (Fabian et al., 2009). Supporting the idea that 
PABP plays a role in miRNA-mediated silencing two additional studies showed that 
overexpressing PABP in Drosophila S2 cells or in human cells interferes with miRNA-
mediated repression (Walters et al., 2010; Zekri et al., 2009). On the other hand, 
Fukaya and Tomari, (2011) concluded that PABP function is dispensable for AGO1-
RISC-mediated deadenylation and translational repression in a Drosophila S2 cell 
lysate, as blocking PABP function by the addition of PABP-interacting protein 2 
(Paip2) to the lysate did not affect silencing. Similarly, Mishima et al., (2012) found 
that miRNA-mediated translational inhibition and target mRNA degradation can occur 
in a PABP-independent manner in zebrafish embryos.  
 
1.6.6 Translational repression versus mRNA decay  
 
What emerges from the studies mentioned above is that there is compelling evidence 
for both miRNA-mediated translational repression and miRNA-mediated mRNA 
decay. Therefore, many studies attempted to elucidate which of the two mechanisms 
dominates and what is the mechanistic relation between the two processes. Four 
recent genomic scale studies provide evidence that target degradation is the 
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predominant mode of regulation by miRNAs in mammalian cell cultures (reviewed by 
Huntzinger and Izaurralde, (2011)). Baek et al., (2008) and Selbach et al., (2008) 
used a quantitative mass spectrometry approach to measure the effect of adding or 
depleting a miRNA from cultured cells on protein and mRNA levels. Both studies 
found that at later time points, changes in mRNA and protein levels of miRNA targets 
showed good correlation. However at an early time point after transfection of a 
miRNA, Selbach et al., (2008) found many miRNA targets that were regulated only at 
the protein level. Hendrickson et al., (2009) transfected human embryonic kidney 
cells with miR-124 and analyzed mRNA abundance and translation rate of miR-124 
targets. Their data revealed that 75% of the changes observed in protein synthesis 
are due to target mRNA degradation. Similarly, using a ribosome profiling approach 
Guo et al., (2010) reported that 84% of the change in protein production can be 
explained by a decrease of target mRNA steady-state levels. 
 
What is the relation between the different events (translational repression, 
deadenylation and mRNA decay) of miRNA-mediated silencing? Are these events 
obligatorily connected or do they occur independently (Djuranovic et al., 2011)? 
Many studies addressed the question whether target mRNA degradation is simply a 
consequence of an initial block of translation initiation. Reporter mRNAs whose 
translation was inhibited by a strong RNA secondary structure in the 5`UTR or by an 
antisense oligonucleotide blocking the start codon were still deadenylated and 
degraded by miRNAs (Eulalio et al., 2009b; Giraldez et al., 2006; Wu et al., 2006). 
Similarly, A-capped reporter mRNAs were found to undergo miRNA-mediated 
deadenylation (Fabian et al., 2009; Iwasaki et al., 2009; Mishima et al., 2006; 
Wakiyama et al., 2007; Zdanowicz et al., 2009) and miRNA-mediated deadenylation 
was also observed in the presence of translation inhibitors such as cycloheximide or 
hippuristanol (Eulalio et al., 2007c; Fabian et al., 2009; Iwasaki et al., 2009; 
Wakiyama et al., 2007). Thus, these studies suggested that deadenylation and 
subsequent degradation are not obligatorily coupled to active translation (Huntzinger 
and Izaurralde, 2011). Another interesting question that remains to be addressed is 
to what extent a miRNA-mediated block in translation influences deadenylation of a 
targeted mRNA. 
Conversely, other studies suggested that miRNA-mediated silencing can occur 
independently of target mRNA deadenylation indicating that besides miRNA-
mediated deadenylation there are additional mechanisms that lead to translational 
inhibition. This is supported by the finding that mRNAs lacking a poly(A)-tail are still 
repressed by miRNAs and by tethered GW182 protein (Eulalio et al., 2008b; Eulalio 
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et al., 2009b; Pillai et al., 2005; Wu et al., 2006). miRNAs were also observed to 
repress mRNA reporters the deadenylation of which was blocked by a non-poly(A) 
sequence following the poly(A)-tail (Fukaya and Tomari, 2011; Mishima et al., 2012). 
Furthermore, miRNAs and tethered GW182 protein still silenced reporter mRNAs in 
cells depleted of the deadenylase complex component NOT1 (Behm-Ansmant et al., 
2006; Eulalio et al., 2008b). And finally, in cell free extracts from mouse Krebs 
ascites cells it was found that miRNA-mediated inhibition of translation preceded 
deadenylation (Fabian et al., 2009). 
Based on these observations the following model of miRNA-mediated silencing 
was suggested: miRNA-mediated silencing begins with repression of translation 
initiation that may be enhanced by deadenylation (Djuranovic et al., 2011). The 
ensuing deadenylation would contribute to silencing and ultimately lead to mRNA 
decay to consolidate the more transient translational repression (Djuranovic et al., 
2011; Fabian et al., 2009; Fabian et al., 2010; Huntzinger and Izaurralde, 2011).  
 
1.7 Aim of this study 
 
The aim of this study was to understand the mechanism of miRNA-mediated gene 
silencing. Despite an extensive research effort, the molecular events leading to 
miRNA-mediated repression are not entirely understood. Studies aiming to shed light 
on this process came to different and sometimes even contradictory conclusions. As 
a consequence of these discrepant results, a plethora of different models for the 
mechanism of miRNA-mediated repression has been proposed.  
Our idea was to study the protein factors that are responsible for executing the 
miRNA-mediated repression in order to get a clearer picture of the mode of silencing. 
As the proteins of the GW182 family emerged as key factors of the silencing 
mechanism, we decided to focus on these proteins. Deletion and mutational analysis 
should reveal what parts of the protein and more specifically what sequence 
elements mediate the repression. Further, we aimed to identify the proteins 
interacting with GW182 to learn about the molecular events leading to repression. 
Finally, because the relation and relative contribution of translational inhibition and 
mRNA deadenylation/decay to silencing were matters of intensive debate, we planed 
to investigate the role of the poly(A) tail in GW182-mediated repression. 
Results 
2. Results 
The aim of this study was to uncover the mechanism of miRNA-mediated gene 
silencing. Work performed by others demonstrated that the family of GW182 proteins 
plays a crucial role in this process. GW182 proteins are recruited to miRNA targets 
via direct interaction with AGO proteins (Eulalio et al., 2009a; Till et al., 2007). The 
crucial role of GW182 proteins in miRNA-mediated silencing is evidenced by the 
facts that interference with the AGO-GW182 interaction and depletion of the GW182 
protein alleviates miRNA mediated repression (Behm-Ansmant et al., 2006; Eulalio et 
al., 2008b; Rehwinkel et al., 2005; Till et al., 2007). Furthermore, direct tethering of 
GW182 proteins to an mRNA represses the mRNA even in the absence of AGO 
protein, suggesting that GW182 is the effector protein acting downstream of AGO 
(Behm-Ansmant et al., 2006). Therefore we reasoned that understanding the function 
of GW182 proteins would give us insight about the mechanism of miRNA-mediated 
silencing. 
Consequently, we decided to study the role of GW182 in miRNA-mediated gene 
silencing. The results obtained in the course of this study are described in three 
published papers that are attached in this thesis. Appendices A and B contain the 
papers “Importance of the C-terminal domain of the human GW182 protein TNRC6C 
for translational repression” and “Mammalian miRNA RISC Recruits CAF1 and PABP 
to affect PABP-Dependent Deadenylation” to which I contributed as a co-author. 
Here in the results section I briefly summarize the results of these two papers and 
describe the experiments that were performed by myself in more detail. The third 
paper “miRNA repression involves GW182-mediated recruitment of CCR4-NOT 
through conserved W-containing motifs” to which I contributed as a co-first author, is 
attached in the results section. Finally, in the last section of Results I describe 
preliminary results about the analysis of the CNOT1 protein that were obtained as 
part of a follow up study of the third paper. 
 
2.1 Importance of the C-terminal domain of the 
human GW182 protein TNRC6C for translational 
repression 
Jakob T. Zipprich, Sankar Bhattacharyya, Hansruedi Mathys, and Witold Filipowicz 
(The full paper is attached in Appendix A) 
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Mammalian genomes encode three GW182 paralogs, TNRC6A, TNRC6B and 
TNRC6C. A role for TNRC6A and TNRC6B in miRNA-mediated repression had 
already been demonstrated but it was not known whether this is also the case for 
TNRC6C. Sankar Bhattacharyya found that RNAi-mediated knockdown of each 
individual TNRC6 protein partially alleviates repression of a reporter RNA that is 
repressed by miRNA let-7b, thus demonstrating that all three TNRC6 proteins are 
important for efficient miRNA-mediated repression (Appendix A, Figure 2c). Sankar 
Bhattacharyya also tested the function of individual TNRC6 proteins using a tethering 
assay. In this assay the protein of interest is expressed as a fusion with the phage N 
peptide that specifically binds to box B RNA hairpins inserted into the 3`UTR of a 
Renilla Luciferase (RL) reporter RNA (RL-5BoxB). Artificial tethering of each TNRC6 
protein to the 3`UTR of a reporter RNA strongly repressed the expression of the 
reporter RNA as a result of a combination of effects on the mRNA level and mRNA 
translation (Appendix A, Figure 3a and 3b). 
To gain insight into the mechanism of repression exerted by TNRC6 proteins, 
Jakob Zipprich generated a collection of deletion mutants of TNRC6C and tested 
their repressive function in the tethering assay. This analysis revealed the C-terminal 
part of TNRC6C (CED, also referred to as N1370), encompassing a conserved 
domain of unknown function (DUF/PAM2) and a RNA recognition motif (RRM), as a 
key effector domain mediating repression (Appendix A, Figure 4). Sankar 
Bhattacharyya found that similarly as observed for the full length TNRC6C protein, 
tethering of the CED fragment (NHA-N1370) affects both mRNA translation and 
stability (Appendix A, Figure 6a). 
 
2.1.1 The inhibitory effect of tethering TNRC6C or CED 
on translation is not due to deadenylation 
To learn whether translational repression induced by tethering TNRC6C or the CED 
fragment could be explained by the deadenylation of the reporter mRNA, we 
investigated the poly(A)-tail status of reporter mRNAs using an RNase H assay. 
RNase H cleaves DNA-RNA hybrids and therefore in the presence of oligo(dT) 
removes the poly(A)-tail of reporter mRNAs. Thus, reporter mRNAs bearing a 
poly(A)-tail are expected to be shortened by the treatment with RNaseH in the 
presence of oligo(dT), whereas reporter mRNAs that had already been deadenylated 
in the cell, cannot be shortened any further by the RNase H treatment. We found that 
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RL-5BoxB reporter mRNAs isolated from cells expressing TNRC6C or the CED 
fragment fused to the phage N peptide (NHA-TNRC6C or NHA-N1370) showed an 
increased mobility in an agarose gel when treated with RNaseH in the presence of 
oligo(dT) (Figure 2.2, for a schematic representation of TNRC6C and CED see 
Figure 2.1). These data indicate that the inhibitory effect on translation induced by 
tethering TNRC6C or the CED fragment is not due to deadenylation of the reporter 
mRNA. 
Binding of RNA by RRM domains of RNA-binding proteins commonly involves 
stacking interactions between aromatic amino acid side-chains and nucleotides 
(Clery et al., 2008). Interestingly, the RRM domain of GW182 proteins contains 
several conserved aromatic amino acids and Jakob Zipprich found that some of 
these residues are required for maximal silencing activity of the CED in a tethering 
assay (Appendix A, Figure 5c). Furthermore, Sankar Bhattacharyya analyzed the 
effect of tethering the CED or its RRM domain mutants on reporter mRNA translation 
and stability. He found that compared to the wild-type CED, the RRM domain 
mutants F1543A and H1537A/Y1556A were specifically impaired in repressing 
translation (Appendix A, Figure 6a). As we considered the possibility, that the 
repressive effect on translation seen upon tethering of the CED could be due to 
mRNA deadenylation, we asked whether the RRM domain mutants were also 
impaired in inducing mRNA deadenylation compared to the wild-type CED. We found 
that the mRNA that escaped degradation by tethered CED or its RRM domain mutant 
(H1537A/Y1556A) was not detectably deadenylated (Figure 2.2). Thus, as mentioned 
above, the inhibitory effect on translation induced by tethering the CED seems not to 
be due to deadenylation of the reporter mRNA. Consequently, impaired translational 
repression activity of the RRM domain mutants compared to the wild-type CED is 
unlikely due to an impaired ability to induce deadenylation.  
 
Figure 2.1: Schematic representation of human TNRC6C and its deletion mutants used 
in the experiments shown in figures 2.2 and 2.3. Positions of N-GW-rich, Q-rich, UBA, 
31 
Results 
DUF/PAM2, and RRM domains are indicated. Numbers correspond to amino acid positions. 
The positions of aromatic amino acids mutated to alanines are indicated by asterisks. 
 
Figure 2.2: Treatment with RNase H in the presence of oligo(dT) results in faster 
mobility of both control mRNAs and mRNAs repressed by tethering TNRC6C or the C-
terminal effector domain of TNRC6C. RL-Con and RL-5BoxB mRNAs were coexpressed in 
HEK293 cells with proteins indicated above the panels. RNA isolated from transfected cells 
was incubated with RNase H in the absence or presence of oligo(dT) and analyzed by 
Northern blotting. The same blot was consecutively hybridized with probes specific for RL and 
actin mRNAs. Figure 6b from Zipprich et al., (2009), see Appendix A. 
 
2.1.2 The CED fragment does not interact with 
endogenous AGO or TNRC6C proteins 
We considered the possibility that the CED fragment (Figure 2.1) induces repression 
by recruiting the endogenous miRNP complex via interaction with endogenous AGO 
or TNRC6 proteins. Using immunoprecipitation assays we tested whether the CED 
fragment (as a fusion with an HA tag and the N peptide, NHA-CED (NHA-N1370)) 
interacts with endogenous AGO proteins or TNRC6C. NHA-CED did co-
immunoprecipitate detectable amounts of neither AGO proteins nor TNRC6C, 
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Figure 2.3: The CED (N1370 fragment) of TNRC6C does not interact with endogenous 
Ago and TNRC6C proteins. (A) Cell extracts of HEK293 cells transiently expressing the 
indicated fusion proteins were incubated with anti-HA Affinity Matrix (Roche), and 
immunoprecipitated proteins (45% of the total immunoprecipitate) were analyzed by Western 
blotting using the indicated antibodies. Note that anti-AGO mAb 2A8 recognizes all human 
AGO proteins (Nelson et al., 2007). Inputs represent 1% (detection of Ago) and 5% (detection 
of TNRC6C) of the cell extract used for IP. Nontransfected cells served as a control. (B) 
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Results 
N1370 does not interact with TNRC6A and TNRC6B proteins. Cell extracts of HEK293 cells 
transiently expressing indicated epitope-tagged proteins were incubated with anti-Flag M2-
Agarose Affinity Gel (Sigma), and immunoprecipitated proteins (45% of the total 
immunoprecipitate) were analyzed by Western blotting using anti-HA 3F10 mAb. Inputs 
represent 2% of the cell extract used for IP. Note that HA-TNRC6B unspecifically binds to -
Flag beads and traces of it are present in IPs from both N1370-expressing and control cells. 
(*) The band most probably represents the IgG heavy chain. Figure 7 from Zipprich et al., 
(2009), see Appendix A. 
 
whereas full length TNRC6C (NHA-TNRC6C) and an N-terminal fragment of 
TNRC6C (NHA-1-1034) efficiently co-immunoprecipitated endogenous AGO proteins 
(Figure 2.3, panel A). Since no antibody detecting TNRC6A and TNRC6B was 
available, we co-expressed HA-tagged TNRC6A (HA-TNRC6A) or TNRC6B (HA-
TNRC6B) together with FLAG-HA-tagged CED (FLAG-NHA-CED (FLAG-NHA-
N1370)) or AGO2 (FLAG/HA-Ago2) in HEK293 cells and performed co-
immunoprecipitation experiments. FLAG-NHA-CED co-immunoprecipitated neither 
HA-TNRC6A nor HA-TNRC6B, whereas both proteins were co-immunoprecipitated 
with FLAG/HA-Ago2 (Figure 2.3, panel B). These data indicate that the repression 
induced by the CED fragment is not due to its interaction with AGO or TNRC6 
proteins and suggest that the CED functions as an autonomous repressive domain. 
 
2.1.3 Cross species repressive activity of GW182 
proteins and their mutants 
Chekulaeva et al., (2009) found that the Drosophila GW182 protein contains three 
distinct regions that induce repression when artificially tethered to a reporter RNA in 
Drosophila S2 cells: the N-terminal GW-rich domain, the Q-rich domain and a C-
terminal fragment encompassing the DUF and RRM regions (Figure 2.4, panel A). 
We tested whether tethering the Drosophila GW182 protein and its subfragments can 
induce repression when tethered to the RL-5BoxB reporter in human HEK293 cells. 
Tethering the full length Drosophila GW182 protein induced repression of the RL-
5BoxB reporter in HEK293 cells to a similar extent as tethering of human TNRC6C 
did (Figure 2.4, panel B). The N-terminal GW-rich region (1-605) of the Drosophila 
GW182 protein also strongly repressed the RL-5BoxB reporter upon tethering 
whereas the Q-rich domain (605-830) and two C-terminal fragments (940-1385 and 
940-1215) of the Drosophila GW182 protein induced only mild repression of the RL-
5BoxB reporter in HEK293 cells (Figure 2.4, panel B). Hence, whereas the full length  
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A 
 
B 
 
Figure 2.4: Effect of tethering of DmGW182 and its deletion mutants on activity of RL-
5BoxB reporter in human cells. (A) Schematic representation of TNRC6C, TNRC6C CED, 
and Drosophila GW182 and its deletion mutants used for the experiment shown in B. 
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Positions of N-GW-rich, Q-rich, UBA, DUF/PAM2, and RRM domains are indicated. Numbers 
correspond to amino acid positions. (B) (Upper panel) Tethering of DmGW182 and its 
deletion mutants represses activity of RL-5boxB reporter in HEK293 cells. Indicated plasmids 
expressing human TNRC6C or Drosophila DmGW182, or their mutants, were transfected to 
cells together with RL-5boxB and FL-Con. Normalized RL activity is indicated as the 
percentage of activity in cells expressing HA-TNRC6C set as 100%. (Lower panel) 
Expression of fusion proteins analyzed by Western blotting using anti-HA antibody. (Inset at 
the bottom) Shows stronger exposure of the two lanes at far right, indicating that the Q-rich 
domain (mutant 605-830) is expressed at a much lower level than the remaining proteins. The 
data represent means from three independent experiments. Figure 8 from Zipprich et al., 
(2009), see Appendix A. 
 
Drosophila GW182 protein is active in repression in HEK293 cells, not all of its 
subfragments that are active repressors in S2 cells function efficiently in HEK293 
cells. 
 
2.2 Mammalian miRNA RISC Recruits CAF1 and 
PABP to Affect PABP-Dependent Deadenylation 
Marc R. Fabian, Géraldine Mathonnet, Thomas Sundermeier, Hansruedi Mathys, 
Jakob T. Zipprich, Yuri V. Svitkin, Fabiola Rivas, Martin Jinek, James Wohlschlegel, 
Jennifer A. Doudna, Chyi-Ying A. Chen, Ann-Bin Shyu, John R. Yates III, Gregory J. 
Hannon, Witold Filipowicz, Thomas F. Duchaine, and Nahum Sonenberg 
(The full paper is attached in Appendix B) 
 
Marc Fabian in the laboratory of Nahum Sonenberg found that a let-7 miRNA loaded 
RNA-induced silencing complex interacts with the poly(A)-binding protein (PABP) 
and the CAF1 and CCR4 deadenylases (Appendix B, Figure 2). Furthermore Marc 
Fabian demonstrated that miRNA-mediated deadenylation depends on CAF1 activity 
and PABP in mouse Krebs-2 ascites extracts (Appendix B, Figure 3f and 4b). 
 
Having identified the CED of TNRC6C as an autonomous repressive domain, we 
aimed to elucidate the mechanism by which the CED represses its targets. We 
hypothesized that the CED may function as a repressive domain by interacting with 
other proteins. To identify those proteins, we expressed the CED as a fusion with 
GST in HEK293 cells and pulled it down from cell extracts via Glutathione Sepharose 
beads. Pulled-down proteins were resolved by SDS-PAGE and analyzed by mass  
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Figure 2.5: The C-terminal effector domain of TNRC6C interacts with PABP. (A) Cell 
extracts of HEK293 cells, transiently expressing the indicated fusion proteins, were incubated 
with Anti-HA Affinity Matrix (Roche), and immunoprecipitated proteins were analyzed by 
western blotting using the indicated antibodies. Inputs represent 1% of the cell extract used 
for IP. Nontransfected cells served as a control. (B) Cell extracts of HEK293 cells transiently 
expressing GST-CED (GST-N1370) were pulled down using glutathione Sepharose resin in 
the presence or absence of micrococcal nuclease. GST pulldowns were analyzed by western 
blotting using anti-PABP, anti-eIF4G, and anti-GST antibodies. Nontransfected cells served 
as a control. Figure 6 B and C modified from Fabian et al., (2009), see Appendix B. 
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38 
spectrometry. This analysis identified the poly(A)-binding protein (PABP) as a factor 
interacting with the CED. To test whether other regions of TNRC6C also interact with 
PABP, we expressed HA-tagged fragments spanning different regions of TNRC6C in 
HEK293 cells and performed immunoprecipitation experiments. Only the CED (NHA-
N1370) but not other fragments of TNRC6C co-immunoprecipiated endogenous 
PABP (Figure 2.5, panel A). GST-CED (GST-N1370) also pulled down endogenous 
PABP from HEK293 cell extracts that were treated with micrococcal nuclease, 
indicating that the CED interacts with PABP in an RNA-independent manner (Figure 
2.5, panel B). Notably, in the absence of micrococcal nuclease GST-CED pulled 
down both PABP and eIF4G. In contrast, after micrococcal nuclease treatment GST-
CED pulled down only PABP, providing evidence for the effectiveness of the 
micrococcal nuclease treatment. 
 
Marc Fabian could then demonstrate that GW182 directly interacts with PABP 
and that this interaction is required for maximal miRNA-mediated deadenylation 
(Appendix B, Figures 6a and 7d). 
 
2.3 miRNA repression involves GW182-mediated 
recruitment of CCR4-NOT through conserved W-
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The CED of both human and fly GW182s interacts with PABP, and 
this interaction, possibly by interfering with the PABP-eIF4G associa-
tion, promotes target mRNA deadenylation by recruiting, through PABP, 
the components of the CCR4–NOT deadenylation complex7,8,12,13. In 
addition, others14–16 have demonstrated the role of CCR4–NOT and 
PAN2–PAN3 deadenylation complexes in the deadenylation of miRNA 
targets. It is unclear how GW182 proteins recruit these deadenylase com-
plexes and how translation repression is modulated. One possible model 
is that the interaction of CED with PABP interferes with the PABP-
eIF4G association and reduces translation7,12,13. However, interfering 
with eIF4G-PABP interaction and binding of the CCR4–NOT complex 
through PABP cannot explain the repression of mRNAs bearing no 
poly(A) tails (reviewed in refs. 2,3), nor can it explain the repression by 
GW182 domains other than CED.
Previous work on the fly GW182 and human NED indicated a role 
for glycine-tryptophan (GW) repeats as effector motifs contributing 
to miRNA-mediated silencing17,18. Here we set out to investigate how 
the GW182 CED and NED regions bring about mRNA repression. We 
found that motifs bearing tryptophan residues also in contexts other 
than GW or WG function as important repressive sequences in the 
CED, both in human and D. melanogaster cells. The effector G/S/TW 
and WG/S/T motifs in the NED and CED recruit the components of 
CCR4–NOT and PAN2–PAN3 complexes in a PABP-independent 
manner to repress function of both poly(A)+ and poly(A)– mRNAs. 
These results identify the recruitment of the CCR4–NOT complex 
MicroRNAs (miRNAs) are small, ~21-nt–long RNAs that post-
transcriptionally regulate gene expression in eukaryotes. In animals, 
miRNAs bind to partially complementary sites in mRNAs, leading to 
translational repression and mRNA deadenylation and degradation1–4. 
miRNAs function as part of ribonucleoprotein complexes, miRNPs, 
with Argonaute (AGO) and GW182 family proteins being the crucial 
components. GW182s interact directly with AGO proteins and function 
downstream as effectors mediating mRNA repression. Hence, under-
standing the function of GW182 proteins is critical for understanding 
miRNA-mediated repression.
GW182 functional regions have been mapped in D. melanogaster 
and mammalian proteins. In D. melanogaster, three regions were found 
to repress tethered mRNA to a similar extent5: the N-terminal effec-
tor domain (NED) having multiple GW-repeats, the middle Q-rich 
region, and the C-terminal effector domain (CED) containing the 
poly(A) binding protein (PABP)-interacting motif 2 (PAM2) and the 
RNA-recognition motif (RRM). The role of the CED in repression was 
also previously established by others6–8. In mammals, tethering of the 
three regions mentioned above also represses reporter mRNA, with 
the major contribution being provided by the CED9–11. The mecha-
nism by which GW182 domains repress mRNA function appears to 
be evolutionarily conserved, as dGW182 can repress mRNA function 
in mammalian cells, and human TNRC6 proteins (mammals express 
three counterparts of dGW182: TNRC6A, B and C) act as repressors in 
D. melanogaster cells5,8,9.
miRNA repression involves GW182-mediated recruitment 
of CCR4–NOT through conserved W-containing motifs
Marina Chekulaeva1,4, Hansruedi Mathys1,2,4, Jakob T Zipprich1,2, Jan Attig1, Marija Colic1, Roy Parker3  
& Witold Filipowicz1,2
mirna-mediated repression in animals is dependent on the gW182 protein family. gW182 proteins are recruited to 
the mirna repression complex through direct interaction with argonaute proteins, and they function downstream to 
repress target mrna. Here we demonstrate that in human and Drosophila melanogaster cells, the critical repressive 
features of both the n-terminal and c-terminal effector domains of gW182 proteins are gly/ser/thr-trp (g/s/tW) or 
trp-gly/ser/thr (Wg/s/t) motifs. these motifs, which are dispersed across both domains and act in an additive manner, 
function by recruiting components of the ccr4–not deadenylation complex. a heterologous yeast polypeptide with 
engineered Wg/s/t motifs acquired the ability to repress tethered mrna and to interact with the ccr4–not complex. 
these results identify previously unknown effector motifs functioning as important mediators of mirna-induced 
silencing in both species, and they reveal that recruitment of the ccr4–not complex by tryptophan-containing motifs 
acts downstream of gW182 to repress mrnas, including inhibiting translation independently of deadenylation.
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in human cells8,13. Deletion of PAM2 (CEDDPAM2) abrogated the 
 association with PABP without affecting the interaction with CNOT1 
and CAF1, suggesting that the CED interaction with CCR4–NOT is 
PABP-independent (Fig. 1d). Moreover, the observed interactions were 
not mediated by RNA, as they were resistant to micrococcal nuclease 
treatment (Fig. 1d and Online Methods).
To identify sequences in CED∆PAM2 responsible for the CCR4–NOT 
interaction, we did pull-down assays with CED∆PAM2 subfragments (see 
Fig. 1a). Deleting either M2 or C-terminal (Cterm) regions reduced the 
interaction with CNOT1 and CAF1. The RRM alone did not pull down 
CNOT1 or CAF1, whereas a fusion of M2 and Cterm regions pulled 
them down with an efficiency similar to that of CEDDPAM2 (Fig. 1d).
repression by the ceD correlates with ccr4–not interaction
The CED domain and its subfragments were tested for activity in repress-
ing protein synthesis in an mRNA-tethering assay (Supplementary 
Fig. 2a). Tethering of the CED or CED∆PAM2 repressed Renilla luciferase 
expression by approximately ten times, when compared to proteins lacking 
the N-peptide (Fig. 1f). Constructs lacking either M2 or Cterm regions 
showed reduced repression, whereas the M2-Cterm fusion repressed 
almost as well as CED∆PAM2 (Fig. 1f). Hence, similarly to their require-
ment for the interaction with the CCR4–NOT complex, the combined M2 
and Cterm regions are sufficient for effective mRNA repression8.
as a critical event for miRNA-mediated mRNA degradation and 
 translation repression.
results
the ceD of tnrc6c interacts with the ccr4–not complex
The CED of human TNRC6C (DN1370 fragment; Fig. 1a) functions 
as an autonomous repressive domain, inducing both translational 
inhibition and mRNA degradation9. To elucidate how the CED 
induces the repression of target mRNAs, it was expressed as a gluta-
thione S-transferase (GST) fusion in HEK293T cells and used for pull-
down experiments. Among the pulled-down proteins, MS identified 
several components of the CCR4–NOT complex, including CNOT1, 
its scaffolding component and CNOT8, a paralog of the deadenylase 
CNOT7/CAF1 (Fig. 1b). PABP was also among the interacting pro-
teins, consistent with previous findings8,12,13. The interaction of the 
CED with different components of CCR4–NOT, either endogenous or 
ectopically expressed, was confirmed by western blotting (Fig. 1c,d). 
Notably, endogenous TNRC6A could also co-immunoprecipitate 
CNOT1 (Fig. 1e).
CAF1 was reported to interact with PABP through the TOB1 pro-
tein19, raising the possibility that the CED recruits CCR4–NOT through 
PABP. The PAM2 motif (Fig. 1a and Supplementary Fig. 1) represents 
the main region in the CED responsible for its interaction with PABP 
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Figure 1 The TNRC6C CED interacts with components of the CCR4–NOT complex. (a) Schematic 
representation of human TNRC6C and fragments analyzed in the study. Individual domains and 
regions of TNRC6C are indicated: N-GW, GW-repeat–rich region; UBA, ubiquitin associated–like 
domain; RRM, RNA-recognition motif; M2 and Cterm2, regions flanking RRM, constituting—together 
with PAM2 and RRM—the CED region. (b) MS analysis of proteins interacting with the CED. Relevant 
proteins are listed along with peptide coverage and amount of assigned spectra. For full list of 
proteins, see Supplementary Table 1. (c) Validation of the CED interaction with selected CCR4–NOT 
components by GST pull-down assays and western blotting. GST-RRM was used as a control.  
(d) M2 and Cterm regions of the CED interact with components of the CCR4–NOT complex but not with PABP. TNRC6C CED and its subfragments were 
used for GST pull-down assays. Inputs (7%) and pull-down assays were analyzed by western blotting. Extracts from nontransfected cells were used as 
controls. (e) CNOT1 co-immunoprecipitates with endogenous TNRC6A. (f) M2 and Cterm regions of TNRC6C mediate repression of tethered mRNA. 
HEK293T cells were co-transfected with plasmids encoding NHA-CED or indicated fragments, and RL-5BoxB and firefly luciferase–transfection control 
(FL-Con) reporters. As negative controls, untethered hemagglutinin-CED (HA-CED) and tethered NHA-RRM (where ‘N’ stands for tethering λ peptide; see 
Supplementary Fig. 2a) were expressed. Values represent percentage of Renilla luciferase activity (normalized to firefly luciferase activity) in the presence 
of nontethered HA-CED or HA-CEDDPAM2. In all luciferase assays presented in this work, values represent means ± s.e.m. from three to six experiments. 
Expression levels of HA- or NHA-fusion proteins were estimated by western blotting.
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to as W-motifs), rather than only GW or WG repeats, must have a role 
in repression. The TNRC6C CED contains eight W-motifs (Fig. 2a and 
Supplementary Fig. 1). We analyzed the effect of Trp→Ala mutations 
in W-motifs on expression of the tethered mRNA (Fig. 2a). Notably, 
although single Trp→Ala mutations had no marked effect on repres-
sion by the CED, their combinations had a progressive additive effect. 
Notably, when all eight tryptophans were mutated (W8), repression by 
the CED was fully alleviated. We observed no alleviation when other con-
served amino acid stretches were mutated in either PAM2 or M2 regions. 
Western blot analysis showed that the differences in repressive poten-
tial could not be explained by differences in expression levels (Fig. 2a). 
The most conserved tryptophan residue, Trp1515, did not contribute to 
repression (8W and 7W mutants differ only in the Trp1515 mutation). 
Trp1515 participates in the RRM structure6, whereas other W-motifs 
reside in regions predicted as disordered (http://dis.embl.de). Otherwise, 
W-motifs seem to contribute to repression independently of the degree 
of conservation and the context; that is, whether they are located next to 
glycine, serine or threonine residues (Fig. 2a).
Because the CED Trp→Ala mutants relieve repression activity, we 
determined, by MS, how these mutations affect the interaction of pro-
teins with the CED (Supplementary Fig. 4a). As expected, the wild-type 
CED associated with different components of the CCR4–NOT complex. 
However, none of them associated with the 7W mutant, indicating that 
the CED interacts with CCR4–NOT in a W-dependent manner. As both 
wild-type and 7W mutant CEDs contain the PAM2 region, each associ-
ated with PABP. We also observed that the PAN2–PAN3 deadenylase 
complex components were present among proteins bound by wild-type 
but not 7W mutant fusions, though PAN2 and PAN3 were found in 
smaller amounts than CCR4–NOT proteins.
When analyzed in the context of full-length TNRC6C, deletion of 
M2 and Cterm regions alleviated mRNA repression to a level com-
parable to that seen when the entire CED is deleted (Supplementary 
Fig. 2b). Similarly, both TNRC6C deletion mutants interacted less 
strongly with CAF1 and CNOT1 (Supplementary Fig. 2c). The ability 
of both mutants to still partially repress mRNA function and associate 
with CCR4–NOT is readily explained by observations that, in addition 
to the CED, N-proximal regions of GW182s have the potential to repress 
mRNAs5,9,17,18 and associate with CCR4–NOT components (see below).
To determine the features of M2 and Cterm regions that repress 
mRNA function, we identified conserved regions of two to six amino 
acids by alignment of different GW182 proteins (Supplementary 
Fig. 1). Because their mutagenesis in the context of CEDDPAM2 had 
a very limited effect (data not shown), we tested the mutations in the 
context of CEDDPAM2 subfragments, M2-RRM or RRM-Cterm (Fig. 1a 
and Supplementary Fig. 2d–h). This analysis revealed considerable 
redundancy of the CED sequences responsible for mediating both 
the interaction with CCR4–NOT and repression of mRNA function. 
Unexpectedly, our results also showed that all mutations appreciably 
affecting both activities were in elements containing tryptophan resi-
dues, and those tryptophan residues were important for the repres-
sive activity, in a manner that involved recruitment of CCR4–NOT 
(Supplementary Figs. 2d–h and 3a,b and Supplementary Results).
W-motifs represent signals recruiting deadenylase complexes
When inspecting the alignment of the CED across different species, we 
noted that GW or WG repeats in one GW182 homolog often align with 
the S/TW or WS/T repeats in other homologs (Supplementary Fig. 1). 
We hypothesized that reiterated G/S/TW or WG/S/T repeats (referred 
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Figure 2  W-motifs in GW182 proteins mediate mRNA repression by recruiting CCR4–NOT and PAN2–PAN3 deadenylation complexes. (a) Mutations of 
tryptophan residues in W-motifs alleviate repression by the TNRC6C CED. Schematic representation of the TNRC6C CED with positions of W-motifs marked 
with asterisks is shown above the graph. Plasmids encoding either wild-type NHA-CED or its mutants (mutations always to alanine; when several consecutive 
amino acids are mutated, the number corresponds to the first residue in the mutated stretch) were co-transfected to HEK293T cells, together with RL-5BoxB 
and FL-Con. As negative controls, plasmids encoding untethered HA-TNRC6C or HA-CED were used. Mutants 2W through 8W contain Trp→Ala mutations in 
W-motifs (for details, see Online Methods). All GW, W1487 W1494 W1648 W1659; most conserved tryptophan, W1504 W1515; less conserved tryptophan, 
W1487 W1605 W1648 W1659. Values represent percentages of Renilla luciferase produced in the presence of untethered HA-CED control. Expression  
of HA- or NHA- fusion proteins was estimated by western blotting (lower panel). (b) Proteins identified as interacting with the CED in a tryptophan-dependent 
manner by MS (Supplementary Fig. 4a) were validated by GST pull-down assays and western blotting. Positions of protein size markers are indicated.  
(c) W-motifs are required for repression by the D. melanogaster GW182 CED. NHA-dGW182 CED, either wild-type or with mutations, were co-transfected 
with FL-5BoxB and RL-Con in S2 cells. As negative controls, plasmids encoding HA-dGW182 and HA-dGW182 CED were used. Mutants 2W through 8W 
contain mutations in W-motifs, with some (5Wa and 7Wa) having different combinations of mutated tryptophans (positions of W-motifs are marked with 
asterisks in the scheme above; for details, see Online Methods). Expression of firefly luciferase was normalized to Renilla luciferase. Values represent 
percentages of firefly luciferase produced in the presence of HA-CED. Expression of HA-fusions was estimated by western blotting.
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also weakly interact with the CED through PABP, which is consistent 
with the direct PAN3-PABP interaction previously described20.
To investigate whether the role of W-motifs in repression is conserved 
across the species, we also introduced Trp→Ala mutations into the eight 
W-motifs in the dGW182 CED (Fig. 2c and Supplementary Fig. 1). 
The mutant proteins were tethered to the firefly luciferase reporter 
FL-5BoxB, expressed in fly S2 cells. As in the case of the TNRC6C CED, 
mutations alleviated repression in an additive manner, leading to almost 
no repression when all tryptophans were mutated. In contrast, mutation 
of other conserved sequences had no appreciable effect (Fig. 2c).
Taken together, our data indicate that the role of W-motifs in mRNA 
repression is evolutionarily conserved and that W-motifs function by 
recruiting CCR4–NOT and PAN2–PAN3 complexes independently 
of PABP.
repression by neD and ceD follows a similar mechanism
To test if the recruitment of the CCR4–NOT complex represents a 
mechanism conserved across different effector domains and across spe-
cies, we analyzed the function of the dGW182 NED in human HEK293T 
cells. Our previous work demonstrated that the dGW182 NED is able 
to repress the tethered mRNA in human cells9, and we investigated 
whether mutations in W-motifs in that region would affect its repres-
sive potential. Because the 205–490 dGW182 fragment, studied previ-
ously in S2 cells, was less effective in human cells (data not shown), 
We also analyzed the pull-down assays by western blotting (Fig. 2b). 
Both CNOT1 and CAF1 interacted with wild-type CED but not with its 
7W mutant. Mutations of W-motifs also strongly affected association 
with PAN2 and PAN3 but had no major effect on interaction with PABP. 
In two out of four experiments, however, PABP binding was slightly 
affected in the 7W mutant (1.5-fold to two-fold; not shown). This could 
be explained by the secondary weak PABP binding site located in the M2 
or Cterm regions7,13. Interactions with PABP through this site seemed 
to be indirect8, suggesting that they occur through components of the 
CCR4–NOT or PAN2–PAN3 complexes.
We have mapped regions in the CED required for PABP and CCR4–
NOT interactions, so we were able to determine the interdependence of 
these interactions. Mutations in PAM2 that disrupted the CED-PABP 
interaction (mutant EF1388; mutations are always to alanine; when 
several consecutive amino acids are mutated, the number corresponds 
to the first residue in the mutated stretch) did not affect the associa-
tion of CED with CCR4–NOT, whereas the 7W mutant that did not 
interact with CCR4–NOT still interacted with PABP (Fig. 2b). Hence, 
the CED interactions with CCR4–NOT and PABP are independent. 
The PAN2–PAN3 interactions were more complex: mutation of PAM2 
somewhat reduced binding of PAN2 and PAN3, though not as strongly 
as mutations of W-motifs, and the double EF1388 7W mutant showed no 
PAN2–PAN3 binding (Fig. 2b). These results suggest that PAN2–PAN3 
is primarily recruited through the function of W-motifs but that it can 
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Figure 3  W-motifs present in the dGW182 NED and the engineered yeast protein fragment repress 
tethered mRNA and recruit components of CCR4–NOT. (a) The dGW182 NED W-motifs function in 
mRNA repression. HEK293T cells were transfected with RL-5BoxB, FL-Con and plasmids expressing 
either full-length NHA-dGW182 or its NED (1–490) (WT or 6W mutant; for description of the  
mutant, see ref. 17). As negative controls, HA-dGW182 and HA-dGW182(1–490) were used. As 
positive controls, TNRC6C NHA-CED and full-length NHA-dGW182 were tethered. Values represent 
percentages of Renilla luciferase produced in the presence of HA-dGW182(1–490). Western blot 
analysis of HA- or NHA-fusion proteins is presented below. (b) GST fusions of the dGW182(1–490), 
WT and 6W mutant, expressed in HEK293T cells, were used for GST pull-down assays. Inputs (7% for 
anti-CNOT1, anti-CAF1, anti-tubulin and anti-GST; 15% for anti-PABP, anti-PAN2 and anti-PAN3) and 
the pulled-down material were analyzed by western blotting, using indicated antibodies. Additional western blots (on the right) for PABP, PAN2 and PAN3 
represent pull-down assays done with the TNRC6C GST-CED analyzed in parallel on the same gel. Anti-PAN3 antibody cross-reacts with GST (asterisk).  
(c) W-motifs are sufficient to induce repression of tethered mRNA. HEK293T cells were transfected with RL-5BoxB, FL-Con and plasmids encoding 
engineered N-Sic-GST protein fusions having either four (N-Sic4xW-GST) or seven (N-Sic7xW-GST) W-motifs. N-Sic-GST containing no tryptophan residues, 
and NHA-GST, served as controls; plasmids encoding TNRC6C N-CED-GST, WT and 7W mutant were transfected for comparison. (d) GST pull-down assays 
with GST-Sic7xW, GST-CED (positive control), and GST-CED 7W and GST-Sic (negative controls), were done as in Figure 1d. The pulled-down material was 
analyzed by western blotting, using indicated antibodies.
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GST polypeptides and their activity tested in the tethering assay. 
Notably, the proteins containing W-motifs were able to repress Renilla 
 luciferase-5BoxB (RL-5BoxB) mRNA, with the degree of repression 
being dependent on the number of motifs (Fig. 3c). Moreover, GST pull-
down experiments revealed that both CAF1 and CNOT1, but not PABP, 
were bound by Sic7xW but not the control tryptophan-free fragment 
(Fig. 3d). Hence, W-motifs are not only necessary but also sufficient to 
induce mRNA repression by recruiting CCR4–NOT.
W-motifs function in a genuine mirna-mediated repression
We next investigated whether W-motifs also function in the context 
of full-length GW182 proteins. Mutation of tryptophan residues in 
W-motifs of the CED strongly compromised the repressive potential of 
TNRC6C in HEK293T cells (Fig. 4a, mutants 7W and 8W, ~four-fold 
effect; for clarity, the data are also shown as fold derepression in the right 
panels of Fig. 4a,b). A more marked effect (~ten-fold) of tryptophan 
mutations on activity of the CED alone (Fig. 4a; see also Fig. 2a) is read-
ily explained by the potential of the TNRC6 N-proximal sequences to 
partially repress the tethered mRNA9,18. In the context of the full-length 
TNRC6C, the PAM2 mutation EF1388 led to moderate alleviation of 
repression, consistent with previous data8.
a longer 1–490 fragment was used instead. We observed that six 
Trp→Ala mutations in GW repeats in the 205–490 region (mutant 
NHA-dGW182(1–490)6W) led to a marked alleviation of repression 
(Fig. 3a), similar to that observed in D. melanogaster S2 cells17.
Analysis of interaction partners of the dGW182 NED(1–490) in 
HEK293T cells revealed that it interacts with CNOT1 and CAF1 in 
a W-dependent manner (Fig. 3b), suggesting that the mechanism of 
mRNA repression by different GW182 domains is similar and involves 
the recruitment of CCR4–NOT through W-motifs. Neither PABP nor 
PAN2–PAN3 was detected in the NED GST pull-down assays, whereas 
they were pulled down with the TNRC6C CED (Fig. 3b, lower panels). 
Thus, interaction with PABP and PAN2–PAN3 may not be required 
for repression by the NED.
engineered W-motifs are sufficient to induce repression
We investigated whether W-motifs are not only required but also  sufficient 
to induce mRNA repression. We introduced X→Trp mutations (with X 
corresponding to any amino acid) to the unstructured fragment of the 
yeast protein Sic1p21. The resulting engineered proteins, having either four 
(Sic4xW) or seven (Sic7xW, Supplementary Fig. 4b and Supplementary 
Methods) sequences resembling the W-motifs, were fused to N- and 
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Figure 4  W-motifs are necessary for 
repression by full-length GW182 and 
function in bona fide miRNA repression. 
(a) W-motifs are required for repression 
by tethered full-length TNRC6C. The 
experiment was done as in Figure 2a 
but included the full-length TNRC6C. 
The right panel shows fold derepression 
relative to repression induced by WT 
NHA-TNRC6C or NHA-CED taken to 
be a value of 1 (broken line). Western 
analysis of expression levels of relevant 
mutants in a and other panels, with 
anti-HA antibody, is shown below the 
graphs. (b) Mutations in W-motifs lead to partial derepression of tethered mRNAs in D. melanogaster S2 cells. The assay was done as in Figure 2c but with 
the full-length dGW182 and TNRC6C. 6W, 7W and EF1388 mutations were described in Figures 2 and 3a but are here introduced into the full-length 
proteins. 13W mutant combines 6W and 7W; PAM2mut has EF960 WK967 Thr982 mutated. NHA-Q–rich (1080–1245) and NHA-CED represent TNRC6C 
fragments. In the right panel, data are presented as in a. (c) W-motifs are required to rescue depletion of endogenous dGW182. Endogenous dGW182 was 
depleted in D. melanogaster S2 cells with dsRNA (open bars); a batch of cells was treated with GFP-specific dsRNA as a control (black bars). Cells were 
transfected with RL-Con, FL-nerfin, and plasmids encoding miR-9b or miR-12, or the empty vector. To rescue depletion of dGW182, increasing amounts 
of plasmids encoding NHA-dGW182, NHA-TNRC6C or their mutants were co-transfected. In panels c and d, extracts from cells transfected with highest 
plasmid concentrations were used for western blotting. (d) W-motifs are necessary to complement the knockdown of endogenous TNRC6 proteins. HeLa cells 
were transfected with siRNAs targeting three endogenous TNRC6 proteins (open bars) or AllStars siRNA (negative control, black bars), RL-hmga2 reporter 
containing let-7 sites or its mutant version (RL-hmga2 mut), and increasing amounts of plasmids expressing NHA-TNRC6A or its mutants: 8W has Trp→Ala 
mutations in W-motifs within the CED region (Supplementary Fig. 1 and Online Methods); EF1358 has PAM2 mutated.
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role of W-motifs and ccr4–not in poly(a)– mrna repression
Recruitment of the CCR4–NOT deadenylase explains how miRNAs 
and tethered GW182 silencing domains induce deadenylation and 
mRNA decay2,3. Indeed, we observed that tethering of the dGW182 
CED induces deadenylation of the FL-5BoxB reporter and that this 
effect is dependent on W-motifs (Supplementary Fig. 5). Do the CED 
and CCR4–NOT also mediate the translational repression known to 
be induced by miRNA machinery2–4? To address this question we first 
tested whether the dGW182 CED can repress, in a W-motif– dependent 
manner, tethered mRNAs in which the polyadenylation signal is sub-
stituted by either a histone stem loop (HSL) or a hammerhead ribo-
zyme (HhR). These mRNAs, FL-5BoxB-HSL and FL-5BoxB-HhR, 
were previously shown to have no poly(A) and to undergo transla-
tional repression in S2 cells in response to tethered dGW182, without 
changes in mRNA levels25. Tethering of dGW182 to FL-5BoxB-HSL 
and FL-5BoxB-HhR repressed their activity by four and two times, 
respectively (Fig. 5a), as reported25. Tethering of the dGW182 CED 
or its longer version extending to the dGW182 C terminus (CED*) 
was slightly less inhibitory, but, notably, the inhibition was nearly fully 
relieved by mutating W-motifs. Similarly to the effect of CED domains, 
direct tethering of the fly Caf1 (dCAF1) and human CNOT1 (the 
D. melanogaster clone is not available) reduced, by 55% to 75%, activity 
of both poly(A)+ and poly(A)– reporters in S2 cells (Fig. 5b). Although 
the inhibition of poly(A)+ RNA by either the dGW182 CED domain or 
CCR4–NOT components was associated with a decrease of approxi-
mately two times in mRNA levels, repression of poly(A)– mRNAs was 
not accompanied by pronounced mRNA degradation (Fig. 5b).
We also investigated whether human TNRC6C CED and human 
CCR4–NOT proteins can repress tethered mRNA independently of 
poly(A) in HEK293T cells. We found that both classes of proteins repress 
activity of the poly(A)– reporter that was either expressed from plasmids 
or transfected as in vitro transcribed mRNA, the latter bearing the cordy-
cepin residue at the 3ʹ end to prevent its potential adenylation in the cell. 
Inhibition of the poly(A)– mRNAs was not accompanied by their degrada-
tion (Supplementary Figs. 6a–e and 7a–d and Supplementary Results).
Collectively, these results show that recruitment of the GW182 CED 
or components of CCR4–NOT also induces silencing of poly(A)– 
mRNAs, without any accompanying RNA degradation, suggesting that 
the CCR4–NOT complex mediates not only mRNA deadenylation but 
also translational repression.
repression of poly(a)– rna by gW182 depends on ccr4–not
If the CCR4–NOT complex functions downstream of GW182 during 
repression of poly(A)– mRNAs, the inhibitory effect of GW182 should 
be dependent on CCR4–NOT. To address this assumption, dGW182 and 
its fragments were tested for their ability to repress the poly(A)– mRNA 
in S2 cells depleted of NOT1, a large CCR4–NOT complex scaffolding 
protein26. Depletion of NOT1 resulted in a marked alleviation of repres-
sion, more pronounced for the fragments of dGW182 (2.5-fold to three-
fold) than the full-length dGW182 (two-fold) (Fig. 6a). This is probably 
due to dGW182 also containing domains (for example, Q-rich5) that 
may repress mRNA by a CCR4–NOT–independent mechanism.
The observation that repression of poly(A)– RNA by tethering 
dGW182 and its fragments depends on NOT1 suggested that the CCR4–
NOT complex also acts downstream of GW182 in translational repres-
sion. Consistently, repression caused by tethering of the CCR4–NOT 
proteins dCAF1 and CNOT1 to FL-5BoxB-HSL RNA was not affected 
by depletion of endogenous dGW182 (Fig. 6b). Of note, the dGW182 
depletion resulted in partial (30–40%) alleviation of the repression of the 
poly(A)+ FL-5BoxB reporter (Fig. 6b). This is consistent with results indi-
cating that GW182 affects repression not only through the  recruitment 
In D. melanogaster S2 cells, mutating W-motifs also led to allevia-
tion of repression induced by either dGW182 or TNRC6C, though the 
effects were less pronounced than in human cells (Fig. 4b). This can be 
explained by a marked contribution of the Q-rich domains of these pro-
teins to the repression in S2 cells (Fig. 4b, NHA-Q-rich and ref. 5). For 
dGW182, mutating W-motifs in either NED (mutant 6W) or CED (7W) 
alone had only a mild effect (~two-fold), but combining these mutations 
(13W) led to more than four-fold alleviation of repression. Mutating 
seven tryptophans within the CED of TNRC6C alleviated repression 
~three-fold, with mutations in PAM2 having no effect (Fig. 4b).
Having demonstrated that W-motifs function in the context of 
full-length GW182 proteins, we analyzed their importance in a bona 
fide miRNA repression assay. We depleted S2 cells of the endogenous 
dGW182 and tested tryptophan mutants of dGW182 for activity to 
rescue miRNA repression. To assess miRNA-mediated silencing, cells 
were co-transfected with the firefly luciferase–nerfin (FL-nerfin) 
reporter and the plasmid expressing miR-9b, which targets the 
FL-nerfin 3ʹ UTR. miR-9b efficiently repressed FL-nerfin mRNA in 
control cells (Fig. 4c, black bars), and depletion of dGW182 (open 
bars) partially alleviated miR-9b–induced repression; as expected, 
transfection of a plasmid encoding wild-type dGW182 resistant to 
RNAi rescued the repression. Mutations of tryptophans in either NED 
(6W) or CED (7W) had only a minor effect on the functionality of 
dGW182 in the rescue, consistent with independent repression by 
NED and CED domains5. However, combining the tryptophan muta-
tions in both regions led to a strong alleviation of repression, demon-
strating the role of W-motifs in miRNA-mediated silencing. Mutation 
of the PAM2 motif had no appreciable effect.
Because GW repeats present in the N-terminal part of dGW182 
contribute to dAGO1 binding22, we tested if mutations of tryptophans 
introduced into dGW182 affect its interaction with dAGO1. We found 
that whereas the 7W mutant interacted with dAGO1 as efficiently as 
wild-type dGW182, the 6W and 13W mutants showed lower levels 
of binding (Supplementary Fig. 4c). Consequently, it is possible that 
tryptophan residues in the NED contribute to the rescue not only by 
enhancing the CCR4–NOT interaction (Fig. 3b) but also by increasing 
the affinity of dGW182 for dAGO1. However, as 6W and 13W mutants 
have similar dAGO1-binding properties (Supplementary Fig. 4c), we 
can conclude that W-motifs in the CED are required for the dGW182 
function in miRNA repression (Fig. 4c).
Because human TNRC6C is able to complement the knockdown of 
dGW182 in S2 cells8 (Fig. 4c), we tested the effect of tryptophan muta-
tions on its function in rescue experiments. Notably, mutations of the 
W-motifs within the CED region (7W) strongly alleviated repression 
by TNRC6C. This is consistent with findings that the CED represents 
the major repressive region of human GW182 proteins6,9,11. To test the 
requirement of W-motifs for miRNA repression in human cells, we used 
a reporter having the 3ʹ UTR of the HMGA2 gene (RL-hmga2), which is 
targeted by let-7 miRNA23,24. This miRNA is expressed endogenously 
in HeLa cells, and it represses RL-hmga2 by about three times when 
compared with its mutant version that has disabled let-7 sites (Fig. 4d, 
black bars). Depletion of all three TNRC6 proteins by RNAi led to almost 
full alleviation of the repression (Fig. 4d, open bars), which could be 
rescued with the wild-type TNRC6A (we used a TNRC6A paralog, as it 
functions most efficiently in the complementation assay8). Mutation of 
PAM2 (EF1358) partially interfered with the rescue, consistent with the 
previous report8. Notably, mutations of W-motifs either alone (8W) or 
in combination with PAM2 mutation (EF1358 8W) led to a nearly com-
plete loss of TNRC6A function in miRNA repression. We conclude that 
W-motifs of both D. melanogaster and human GW182s are important 
for bona fide miRNA-mediated silencing.
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dGW182, TNRC6C and TNRC6A to rescue miRNA-mediated silenc-
ing in GW182-depleted cells was strongly compromised upon mutation 
of W-motifs. (v) Finally, fragments of the yeast protein Sic1p having 
engineered W-motifs acquired the ability to repress mRNA and to inter-
act with the CCR4–NOT components. Hence, W-motifs are not only 
required but also sufficient to induce repression by recruitment of the 
CCR4–NOT complex. Notably, two motifs in TNRC6C, identified in 
an accompanying paper27 as important for mediating deadenylation 
and CCR4–NOT interaction in vitro, also contain tryptophan residues.
It is unlikely that alleviation of mRNA repression by Trp→Ala 
substitutions is due to perturbation by the higher-order structure of 
the polypeptides or by their folding upon binding to target proteins. 
First, the mutated W-motifs are located in the NED and CED regions 
that are predicted to be disordered (http://dis.embl.de). Indeed, NMR 
analysis of the TNRC6C NED confirmed its disordered character 
(F. Laughlin, M. Chekulaeva, W.F. and F. Allain, unpublished data). 
Second, in the case of the CED ‘half ’ regions—that is, the M2-RRM 
and RRM-Cterm regions—mutating even one or two tryptophan 
residues had an  appreciable effect on repression. Third, the Sic1p pro-
tein fragment used for the gain-of-repression experiments is known 
to be unstructured21 and, apart from engineered W-motifs, shows no 
sequence similarity to repressive GW182 fragments.
We also observed that the CED domain interacts with the PAN2–PAN3 
complex in a manner dependent on W-motifs. Others15 have previously 
shown that PAN2 contributes to miRNA-mediated deadenylation, most 
probably at its initial stage. Our data indicate that PAN2–PAN3 is primar-
ily recruited through the function of the W-motifs in the CED, but it can 
also weakly interact with the CED through PABP (Fig. 2c), consistent with 
the previously described direct PAN3-PABP interaction20.
of CCR4–NOT but also through the association with PABP, and the 
latter interaction has been shown to be important for miRNA-induced 
de adenylation7,12,13. We conclude that the CCR4–NOT complex also 
functions downstream of GW182 during repression of poly(A)– mRNAs, 
consistent with its role in mediating inhibition of translation.
Discussion
We here provide evidence that human and D. melanogaster GW182 
proteins repress mRNAs by recruiting the CCR4–NOT complex to 
the mRNA, in a PABP-independent manner. This recruitment speci-
ficity comes from W-motifs that are dispersed throughout the N- and 
C-terminal regions of the proteins and that act in an additive manner. 
Moreover, we found that recruitment of CCR4–NOT represses both 
poly(A)+ and poly(A)– mRNAs, arguing that this complex, in addition 
to catalyzing mRNA deadenylation, also mediates miRNA-induced 
translational repression.
The following evidence supports the conclusion that W-motifs rep-
resent critical signals for recruiting CCR4–NOT and inducing mRNA 
repression. (i) Exhaustive mutagenesis of the CED identified redundant 
W-containing elements in the CED M2 and Cterm regions and dem-
onstrated a strong correlation between repression and interaction with 
CCR4–NOT. (ii) Introduction of an increasing number of Trp→Ala 
mutations, in both GW (or WG) and S/TW (or WS/T) contexts, across 
the CED regions of either TNRC6C or dGW182, had an additive effect 
on alleviating repression, regardless of whether these substitutions were 
tested in the CED or full-length proteins. (iii) W-motifs present in the 
NED and CED regions functioned in an additive manner and by similar 
mechanisms that involved the recruitment of the CCR4–NOT complex. 
(iv) In the assay measuring bona fide miRNA repression, the activity of 
0
20
40
60
80
100
120
FL-5BoxB
FL-5BoxB-HSL
FL-5BoxB-HhR
0
20
40
60
80
100
120
140
NHA-
CED
N
H
A
-la
cZ
N
H
A
-d
G
W
18
2
 7
W
NHA-
CED*
W
T
W
T
 P
P
P
G
LT
10
63
 P
P
P
G
LT
10
63
 7
W 7W
 8
W
a
N
H
A
-la
cZ
N
H
A
-d
G
W
18
2
 7
W
W
T
W
T
 P
P
P
G
LT
10
63
 P
P
P
G
LT
10
63
 7
W 7W
 8
W
a
N
H
A
-la
cZ
N
H
A
-d
G
W
18
2
 7
W
W
T
W
T
 P
P
P
G
LT
10
63
P
P
P
G
LT
10
63
 7
W 7W
 8
W
a
FL-5BoxB FL-5BoxB-HSL FL-5BoxB-HhR b
HA
-d
CA
F1
NH
A-
dC
AF
1
NH
A-
CN
OT
1
HA
-C
NO
T1
35 kDa-
25-
-250 kDa
a
NHA-
CED
NHA-
CED*
NHA-
CED
NHA-
CED*
NHA-
CED
N
H
A
-la
cZ
N
H
A
-d
G
W
18
2
 7
W
NHA-
CED*
 P
P
P
G
LT
10
63
 P
P
P
G
LT
10
63
 7
W 7W
 8
W
a
W
T
W
T
-250
-130
-100
-70
-55
-35
FL-5BoxB
FL-5BoxB-HSL
FL-5BoxB-HhR
RL
RL
RL
HA
-d
CA
F1
NH
A-
dC
AF
1
NH
A-
CN
OT
1
HA
-C
NO
T1
N
or
m
al
iz
ed
 F
L 
ac
tiv
ity
 (
%
)
N
or
m
al
iz
ed
 F
L 
ac
tiv
ity
 (
%
)
Figure 5  The CED W-motifs and CCR4–NOT complex contribute to repression of poly(A)– mRNAs 
in fly cells. (a) The CED W-motifs contribute to repression of poly(A)– mRNA in fly cells. S2 cells 
were co-transfected with plasmids encoding NHA fusions of the WT dGW182 CEDs (NHA-CED 
or NHA-CED*) or its indicated mutants, together with plasmids encoding the indicated reporters 
(FL-5BoxB, FL-5BoxB-HSL or FL-5BoxB-HhR) and RL-Con. Normalized firefly luciferase activity 
is indicated as the percentage of activity in cells expressing NHA-lacZ set as 100%. Expression 
of relevant HA- and NHA-fusion proteins was estimated by western blotting and is shown in the 
panel on the right. (b) Tethering dCAF1 or human CNOT1 represses poly(A)+ and poly(A)– mRNAs 
in fly cells. Cells were co-transfected with plasmids expressing HA or NHA fusions of dCAF1 or 
human CNOT1 and plasmids encoding indicated reporters. Normalized firefly luciferase activity is indicated as the percentage of activity in cells expressing 
HA fusions of dCAF1 or human CNOT1 set as 100%. Expression levels of HA- and NHA-fusion proteins were estimated by western blotting (shown above the 
graph). HA- and NHA-CNOT1 were only detectable after enrichment by anti-HA antibody immunoprecipitation. Lower signal of the NHA-tagged, compared to 
HA-tagged protein, may be partially due to the lower reactivity of anti-HA antibody with the internally located epitope. Analysis of mRNA levels by northern 
blotting is shown below the graph. Identity of analyzed reporters (including Renilla luciferase mRNA as a reference) is shown on the left, and the co-
transfected CCR4–NOT complex components are indicated at the bottom.
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the TNRC6C CED and CCR4–NOT most probably occurs through 
the CNOT1 subunit of the complex, because human CNOT1, but not 
CNOT6 or CNOT7/CAF1, interacted with the CED in the yeast two-
hybrid system (Supplementary Fig. 8). CNOT1 was also by far the most 
effectively pulled down CCR4–NOT complex component identified by 
MS (Fig. 1b and Supplementary Fig. 4a).
One of the most important findings of our work is that components 
of the CCR4–NOT complex are able to repress not only polyadenyl-
ated but also poly(A)-free mRNAs. The observation that repression of 
poly(A)– RNA by dGW182 and its fragments depends on CCR4–NOT, 
whereas repression by tethering of CCR4–NOT proteins is dGW182-
independent, indicates that the CCR4–NOT complex acts downstream 
of GW182 proteins also during repression of poly(A)– mRNAs. Together 
with the finding that the CCR4–NOT repression of poly(A)– RNAs is not 
associated with a decrease in mRNA levels, these data strongly implicate 
the CCR4–NOT proteins in mediating translational repression induced 
by miRNAs. These results are consistent with recent work29 showing that 
tethering of CAF1 to the microinjected reporter mRNA can repress trans-
lation at the initiation step in Xenopus laevis oocytes. Our experiments 
extend these results by demonstrating that the CCR4–NOT complex may 
be responsible for translational repression induced by miRNAs. We also 
found that in HEK293T and S2 cells, the tethering of CAF1 and, notably, 
other subunits of the CCR4–NOT complex, repressed mRNA activity 
(Supplementary Fig. 7c), without affecting the levels of poly(A)– mRNA 
(Fig. 5b and Supplementary Fig. 7b). Jointly, these observations indi-
cate that W-motif–mediated recruitment of the CCR4–NOT complex 
causes both translational repression and  deadenylation of target mRNAs 
The additive contribution of W-motifs, distributed in disordered pro-
tein regions, raises the question of how these motifs promote the interac-
tion of GW182 and CCR4–NOT. Does the sheer quantity of the motifs 
just increase the probability of initial productive interactions? Do the 
 tryptophan-containing regions recruit more than one CCR4–NOT com-
plex at a time? One model of GW182 function is reminiscent of protein-
protein interactions reported for the U2AF homology motif (UHM) of 
the U2 snRNP factor U2AF65 (ref. 28). In that case, the spliceosome com-
ponent SF3b155 binds to the U2AF65 UHM through motifs having an 
essential tryptophan and consensus RWD/E. Similarly to GW182 proteins, 
SF3b155 contains an unstructured region with seven RWD/E repeats28.
The CCR4–NOT components CAF1 and CNOT1 were previously 
identified as important for miRNA-mediated deadenylation in both 
flies and mammals, and it has been suggested that the interaction of 
GW182 with PABP might lead to the recruitment of CCR4–NOT to 
mRNA7,12,14–16. Our data indicate that recruitment of CCR4–NOT by 
W-motifs present in CED and NED regions is independent of PABP and 
represents either a complementary or alternative mechanism for repres-
sion. The critical observation in our study was that deletion of PAM2 
or its mutation that disrupts CED-PABP interaction did not affect the 
CED association with CCR4–NOT and mRNA repression, whereas the 
CED 7W mutant, which still interacted with PABP but not with CCR4–
NOT, was inactive in repression (Fig. 2). Moreover, the dGW182 NED 
region, which is repressive in both S2 and HEK293T cells, interacted 
with the CCR4–NOT complex components but not with PABP (Fig. 3b). 
Similarly, the repressive yeast Sic1p fragment associated with the 
CCR4–NOT proteins but not PABP (Fig. 3d). The association between 
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Figure 6  Repression of poly(A)– RNA by tethering 
dGW182 or its fragments depends on NOT1, but 
repression by tethered CCR4–NOT components 
is dGW182-independent. (a) Repression of FL-
5BoxB-HSL reporter by tethering dGW182 or 
its fragments is alleviated in S2 cells depleted 
of NOT1. S2 cells treated with dsRNA targeting 
GFP or NOT1 were co-transfected with plasmids 
expressing either NHA fusions of dGW182 and 
its fragments or the PIN domain (either WT or 
a catalytic mutant thereof) of the endonuclease 
SMG6, and also reporter plasmids FL-5BoxB-
HSL and RL-Con. Normalized firefly luciferase 
activity is indicated as percentage of the activity 
in cells expressing NHA-lacZ or SMG6-PINmut, 
set as 100%. The NOT1 depletion affected the 
repression by dGW182 and its fragments but 
had no effect on repression by SMG6-PIN that 
targets mRNA for endonucleolytic degradation35, 
supporting the specificity of the effect.  
(b) Repression of FL-5BoxB and FL-5BoxB- 
HSL reporters by tethered dCAF1 and human 
CNOT1 is unaffected in S2 cells depleted of 
dGW182. Normalized firefly luciferase activity 
is indicated as the percentage of activity in cells 
expressing HA-dCAF1 or HA-CNOT1, or cells 
transfected with pAC5.1 (empty vector), each  
set as 100%. The efficiency of GW182 depletion 
was analyzed by western blotting (lower panel). 
Lanes 1–5, dilutions of the extract from S2 cells 
treated with GFP-specific (control) dsRNA.  
(c) Scheme illustrating a possible mode of 
action of GW182 proteins in miRNA-mediated 
repression. GW182 proteins are recruited to mRNA through direct interaction with the miRNA–AGO complex. The GW182 NED and CED regions both recruit, 
through the W-motifs, the CCR4–NOT complex that represses translation and leads to mRNA deadenylation. Interaction of the GW182 PAM2 motif with 
PABP may interfere with the PABP-eIF4G association, thus contributing to translational inhibition and mRNA deadenylation. The PABP interaction with the 
CED M2/C-term regions (broken line) may be mediated by the CCR4–NOT complex (see text).
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(see model in Fig. 6c). We find it interesting that in yeast and in fly, the 
CCR4–NOT complex is known to interact with the translational repres-
sor Dhh1/Me31b30,31, whose orthologs in other organisms are known to 
be required for miRNA-mediated repression32–34, suggesting a possible 
mechanism by which the CCR4–NOT complex could repress translation.
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Methods and any associated references are available in the online version 
of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular 
Biology website.
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Cell culture, transfections, RNAi and luciferase assays. Human HEK293T cells 
were grown in DMEM (GIBCO BRL) supplemented with 2 mM l-glutamine and 
10% (v/v) FCS buffer. Transfections were done in 6-, 12-, 24- and 96-well plates with 
nanofectin (PAA Laboratories), according to manufacturer’s instructions. In tether-
ing experiments, cells were transfected with 1 ng RL-5BoxB, 20 ng FL-Con and 20– 
30 ng HA- or NHA-fusion constructs per well in a 96-well plate. For other formats, the 
amount of plasmids was adjusted proportionally. Cells were lysed 24 h after transfec-
tion. For TNRC6 rescue experiments, HeLa cells stably expressing Tet-On machin-
ery36 were transfected using attractene reagent (Qiagen). Per well of the 96-well 
plate, transfection mixtures contained 10 ng of the let-7 reporter plasmid, increasing 
amounts of NHA-TNRC6A or its point mutants (20, 60 and 180 ng), and either 
siRNAs specific to TNRC6A, B and C (5ʹ-GCCUAAUCUCCGUGCUCAATT-3ʹ, 
5ʹ-GGCCUUGUAUUGCCAGCAATT-3ʹ and 5ʹ-GCAUUAAGUGCUAAACAA-
ATT-3ʹ (Microsynth; sequences represent sense strands), 0.53 pmol each; or 
1.6 pmol AllStars siRNA negative control (Qiagen). TNRC6A plasmids were made 
resistant to siRNA by introducing silent point mutations. Let-7 reporter plasmids 
(kindly provided by J. Béthune) encoded Renilla luciferase fused to the human 
HMGA2 3ʹ UTR, either WT with sites recognized by let-7 (RL-hmga2), or mutant 
in which let-7 sites were mutated (RL-hmga2 mut)37,38, as well as FL-Con, both 
under control of the tetracycline-responsive element. Expression of reporters was 
induced with 1 mg ml–1 doxycycline 2 d after transfection and cells were lysed 
4 h after induction. D. melanogaster S2 cells were transfected in 96-well plates with 
Cellfectin II and PLUS reagents (Invitrogen). In tethering experiments, we trans-
fected 5 ng FL-5BoxB plasmid, 30 ng RL-Con, and 20–30 ng plasmid encoding HA- 
or NHA-fusion protein per well. Cells were lysed 3 d after transfection. In rescue 
experiments, transfection mixtures contained 5 ng FL-nerfin reporter plasmid, 
30 ng RL-Con and 5 ng of either an empty vector or a plasmid encoding miR-9b 
or miR-12 per well of a 96-well plate; plasmids encoding dGW182, TNRC6C and 
their mutants were added in increasing amounts from 3–30 ng. RNAi experiments 
were conducted as described39 using dsRNA targeting the dGW182 3ʹ UTR or the 
coding region of NOT1. S2 cells were treated with dsRNA twice, on days 1 and 4, 
transfected on day 6 and lysed on day 9.
Luciferase activities were measured with the Dual-Luciferase Reporter Assay 
System (Promega). In all luciferase assays, values represent means ± s.e.m. from 
three to six independent experiments.
CED mutants containing mutations in W-motifs. Positions of single tryptophan 
mutations are as indicated in Figure 2a,c. Other mutants in the TNRC6C CED 
are designated as follows: 2W stands for W1445 W1487; 3W, W1445 W1487 
W1494; 4W, W1445 W1487 W1494 W1659; 5W, W1445 W1487 W1494 W1648 
W1659; 6W, W1445 W1487 W1494 W1605 W1648 W1659; 7W, W1445 W1487 
W1494 W1504 W1605 W1648 W1659; 8W, W1445 W1487 W1494 W1504 
W1515 W1605 W1648 W1659; all GW, W1487 W1494 W1648 W1659; most 
conserved, W1504 W1515; and less conserved, W1487 W1605 W1648 W1659.
For selecting most conserved and less conserved W-motifs mutated in the last 
two mutants, the protein alignment included sequences of more GW182 proteins 
than the one shown in Supplementary Figure 1 (data not shown).
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Supplementary Figure 1. Alignment of CED regions of GW182 proteins 
from different species. Alignment was performed using the T-Coffee tool. The 
CED regions used throughout the work are delineated with bent arrows. Note 
that in the case of D. melanogaster GW182, two different variant of the region, 
CED and CED*, were used. PAM2 and RRM motifs are highlighted in blue and 
pink, respectively. Mutated tryptophan residues are shown in red, other 
mutations are highlighted in grey. Amino acids were always mutated to alanines. 
G residue in the sequence LGSP has not been mutated what is indicated by 
putting it in brackets in Supplementary Figure 2d. Starts and ends of deletion 
mutants analyzed in Supplementary Figure 3b are marked with vertical and bent 
lines. The numbers correspond to amino acid positions in full-length GW182 
proteins. Numbers of TNRC6A correspond to the protein described in3. Asterisks 
mark residues identical in all sequences, colons mark conservative substitutions, 
and dots mark semi-conservative substitutions. 
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Supplementary Figure 2. Repressive potential of the TNRC6C CED 
correlates with its association with the CCR4–NOT complex. (a) Schematic 
representation of the RL-5BoxB reporter construct used in mRNA tethering 
assays. In this assay, protein fusions with the phage λ N-peptide are co-
expressed in HEK293T cells, together with Renilla luciferase (RL) mRNA reporter 
containing BoxB hairpins in the 3’ UTR (RL-5BoxB). (b) Repression of RNA 
function by NHA-TNRC6C and its deletion mutants (schematically shown in 
Figure 1a). Tethering constructs were co-transfected with RL-5BoxB and FL-Con. 
Values represent percentages of RL activity measured in the presence HA-
TNRC6C. (c) TNRC6C and its mutants tested in panel (b) were analyzed for their 
ability to bind the CCR4–NOT complex and PABP, using GST pull-downs 
followed by western blotting analysis with the antibodies indicated. (d) NHA-M2-
RRM and NHA-RRM-Cterm-encoding constructs or indicated mutants were co-
transfected with RL-5BoxB and FL-Con in HEK293T cells. Values represent 
percentages of RL produced in the presence of non-tethered HA-CED control. 
Expression levels of HA- or NHA-fusion proteins were analyzed by western 
blotting. (e) Mutations of W residues in Cterm lead to alleviation of repression by 
RRM-Cterm. Tethering assay with indicated RRM-Cterm mutants was performed 
as in (d). (f) Point mutants of RRM-Cterm that showed alleviation of repression in 
(e) were tested by GST pull-downs and western blotting for interaction with 
components of the CCR4–NOT complex. (g) Mutations of W residues in M2-
RRM lead to alleviation of repression induced by its tethering to mRNA. 
Tethering assay with the indicated M2-RRM mutants was performed as in panel 
(d). Values represent percentages of RL activity seen in the presence of HA-
CED. (h) M2-RRM mutants that showed alleviation of repression in panel (g) 
were analyzed for interaction with CAF1 protein using GST pull-downs and 
western blotting. The assay was done as described in Figure 1d. 
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Supplementary Figure 3. Redundancy of the CED sequences 
responsible for mediating repression of mRNA function. (a) Duplicated 
M2 or Cterm regions retain the full repressive potential of the M2-Cterm 
fusion. Analyzed constructs are indicated at the top. Values are normalized to 
activity of HACEDΔPAM2 which is taken as 100%. (b) Activity of M2-RRM and 
RRM-Cterm fragments bearing step-wise deletions of M2 and Cterm regions. 
Deletion mutants of NHA-M2-RRM and NHA-RRM-Cterm fragments are 
schematically shown on the top. Numbers correspond to amino acid positions 
(for more details, see Supplementary Fig. 1). Activity of mutants was analyzed 
in the mRNA tethering assay (shown in the middle). The tethering assay was
performed as described in Figure 1f. Values represent percentages of RL 
activity seen in the presence of NHA-RRM, which is known not to repress the 
tethered mRNA (ref. 3; Fig. 1f). Expression of HA- and NHA-fusions was 
estimated by western blotting with anti-HA antibody (bottom). 
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Supplementary Figure 4. MS analysis of proteins associating with the 
TNRC6C CED in a W-dependent manner and estimation of the role of W-
motifs in mRNA repression. (a) MS analysis of proteins associating with the 
TNRC6C CED in a W-dependent manner. The GST-TNRC6C CED, either wild-
type or 7W mutant, was expressed in HEK293T cells and protein content of GST 
pull-downs was analyzed by MS. Relevant identified proteins are listed, along 
with numbers of detected spectra. The PAN2–PAN3 complex was selected as a 
specific CED interactor since it was not pulled down by the 7W mutant. PAN2 
(but not PAN3) was also identified in MS analysis shown in Figure 1b (1 assigned 
spectrum) but its role was originally not pursued since the 7W mutant providing 
specificity control was not available at that time. Of note, MS analysis presented 
in Figure 1b was performed with the less sensitive MS equipment (see 
Supplementary Methods) than the one shown in this figure. (b) Sequences of 
engineered Sic, Sic4xW, and Sic7xW protein fragments tested in the tethering 
assay in Figure 3c. An N-terminal fragment of the S. cerevisiae Sic1p protein 
(positions 1-90), in which several phosphorylation sites are mutated 
(Ser/Thr->Ala; shown in italics) served as a control (Sic). Introducing either four 
or seven X->W amino acid mutations (see the alignment, mutations are in red), 
always next to G, S, or T residues, resulted in Sic4xW and Sic7xW constructs. 
(c) Contribution of W-motifs within NED and CED to the dGW182-dAGO1 
interaction. D. melanogaster S2 cells were transfected with plasmids encoding 
NHA-dGW182 or its mutants described in Figure 4b and c: 6W has six 
tryptophanes mutated in W-motifs in the NED1, 7W contains mutations of W-
motifs within the CED (Fig. 2c), and 13W represents a combination of both. The 
dGW182 (490-1384) fragment was analyzed as a negative control. Cell lysates 
were used for immunoprecipitations with an anti-AGO1 antibody, according to1. 
Inputs and immunoprecipitates were analyzed by western blotting using anti-HA 
or anti-AGO1 antibodies, as indicated on the left. Expression of anti-tubulin was 
estimated as a loading control. Positions of protein size markers are indicated.  
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Supplementary Figure 5. W-motifs of dGW182 are involved in mRNA
deadenylation. S2 cells were transfected with FL-5BoxB and either NHACED,
NHA-CED 7W or NHA-lacZ expressing plasmids. Poly(A) tails of FL-5BoxB
reporter were estimated using G-tailing/PAT [poly(A) test] assay19. To prevent 
decapping and degradation of deadenylated mRNAs, S2 cells were depleted of 
decapping activators Ge1 and Me31b22. Lanes 1, 3, and 5 show PCR products 
corresponding to the fragment of the reporter 3’UTR including poly(A) tails (A). 
PCR products in lanes 2, 4, and 6 correspond to the 263 base-pairs product 
originating from the 3’-UTR region starting ~30-nt upstream of the
polyadenylation site. These products (S) do not include poly(A) tails. Position 
corresponding to fully deadenylated mRNA (A0) is indicated. DNA size markers 
are shown on the left. 
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Supplementary Figure 6. Tethering of the TNRC6C CED represses function 
of both poly(A)+ and poly(A)– mRNAs. (a) Schematic representation of the RL-
5BoxB-HSL+HhR reporter construct. (b) The poly(A) status of mRNA expressed 
from the transfected RL-5BoxB-HSL+HhR reporter was assessed by fractionation 
of total cellular RNA on oligo(dT)25 beads. HEK293T cells were co-transfected with 
plasmids expressing HA-CED and plasmids encoding either RL-5BoxB or RL-
5BoxB-HSL+HhR, and also with FL-Con. Total cellular RNA was isolated and 
fractionated on oligo(dT)25 beads. The reporter RNA levels in the total cellular 
RNA and in the fraction retained on oligo(dT)25 beads [corresponding to poly(A)+ 
RNA] were determined by quantitative real-time PCR. Average RNA levels of 
Renilla luciferase and firefly luciferase reporters from two independent 
experiments are shown as percentage of the levels in cells expressing RL-5BoxB 
reporter, which are set as 100%. (c) Effect of tethering the CED or CEDΔPAM2 on 
activity of RL-5BoxB and RL-5BoxB-HSL+HhR reporters. HEK293T cells were co-
transfected with plasmids expressing NHA-CED or NHA-CEDΔPAM2, and plasmids 
encoding either RL-5BoxB or RL-5BoxB-HSL+HhR, and also with FL-Con. HA-CED 
served as a negative control. Normalized RL activity is indicated as the percentage 
of activity in cells expressing HA-CED set as 100%. (d) Analysis of RL-5BoxB and 
RL-5BoxB-HSL+HhR RNA levels by Northern blotting in an experiment performed as 
described in panel (c). Total RNA isolated from cells transfected with indicated 
plasmids was analyzed using RL- or FL-specific probes. Control, cells transfected 
only with RL and FL reporters. Positions of RL and FL mRNAs are indicated. 
Quantification of Northern blots, shown in the lower panel, was performed using 
a PhosphorImager and the Image-Quant software. Normalized values represent 
means ± SE (n = 3). (e) Effect of tethering CED or CEDΔPAM2 on activity of the in 
vitro transcribed RL-5BoxB mRNAs, either poly(A)+ or poly(A)–, and either 
containing or not the cordycepin residue at the 3’ end, which were transfected 
into cells. HEK293T cells were also co-transfected with the in vitro transcribed RNAs 
encoding HA or NHA fusions of CED or CEDΔPAM2 (as indicated), as well as with 
the in vitro transcribed RNA encoding FL. Normalized RL activity is indicated as the 
percentage of activity in cells expressing HA-CED or HA-CEDΔPAM2 set as 100%. 
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Supplementary Figure 7. Tethering of the CCR4–NOT complex components 
represses activity of both poly(A)+ and poly(A)– mRNAs in HEK293 cells. (a) 
Effect of tethering CNOT1 or CAF1 (or its catalytic mutant, CAF1mut) on activity of 
RL-5BoxB and RL-5BoxB-HSL+HhR reporters. HEK293T cells were co-transfected 
with plasmids expressing HA or NHA fusions of the indicated proteins and plasmids 
encoding RL-5BoxB or RL 5boxB HSL+HhR, and FL-Con. Normalized Renilla 
luciferase activity is indicated as percentages of activity in cells expressing indicated 
HA-fusion protein, which are set as 100%. The expression of fusion proteins was 
analyzed by Western blotting using αHA antibody (shown in the lower panel). (b) 
Northern blot analysis of the mRNA levels of the RL-5BoxB and RL-5boxB-
HSL+HhR reporters in an experiment performed as described in Supplementary 
Figure 7a. RNA isolated from transfected cells was subjected to Northern blotting 
analysis to estimate changes in the reporter mRNA levels upon tethering of indicated 
proteins. Quantification of Northern blots, shown in the lower panel, was 
performed using a PhosphorImager and the Image-Quant software. The 
normalized RL mRNA levels are indicated as percentages of the levels in cells 
expressing indicated HA-fusion proteins, which are set as 100%. Values represent 
means ± SE (n = 3). (c) Repression of RL-5BoxB reporter by tethering the indicated 
CCR4–NOT complex components. HEK293T cells were co-transfected with 
plasmids expressing HA and NHA fusions of the indicated CCR4–NOT complex 
components and plasmids encoding RL-5BoxB and FL-Con reporters. As a control, 
the effect of plasmids expressing either HA-CEDΔPAM2 or NHA-CEDΔPAM2 was 
measured. Normalized RL activity is indicated as the percentage of activity in cells 
expressing HA-CEDΔPAM2 set as 100%. (d) Effect of tethering CAF1 or CAF1mut 
on activity of the in vitro transcribed poly(A)+ or poly(A)– RL-5BoxB reporter RNAs 
transfected into cells. HEK293T cells were co-transfected with the in vitro transcribed 
RNAs encoding HA or NHA fusions of CAF1 or CAF1mut and the in vitro transcribed 
RNA reporters, both RL-5BoxB and FL-Con. The poly(A)– RL-5BoxB RNA contained 
cordycepin residue at the 3’ end. Normalized RL activity is indicated as the 
percentage of activities in cells expressing HA-CAF1 or HA-CAF1mut, which are set 
to 100%. Bars represent means ± SE (n=4) for CAF1 and averages from two 
independent experiments for CAF1mut. 
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Supplementary Figure 8. The TNRC6C CED interacts with CNOT1 in yeast 
two-hybrid system. Yeast strain W303-1B was transformed with the indicated 
LexA- and B42-fusion expression plasmids (or an empty pJG4-5 vector) 
together with a LacZ reporter gene containing eight LexA operator sites. 
CNOT1, CNOT6 and CNOT7 were also transformed together with empty 
pJG4-5 vector as control for lack of self-activation. The CNOT1-CNOT6 combi-
nation served as another negative control. The graph shows a representative 
experiment (of four experiments performed). Bars show -Gal activity [nmol 
min  mg ]. Values represent mean +/- SEM.-1 -1
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Supplementary Table 1. Mass spectrometry analysis of GST-CED pull-down. 
 
Accession Description Number of 
  
Assigned 
Spectra 
GST26_SCHJA  Glutathione S-transferase class-mu 26 kDa isozyme   382 
CLH1_HUMAN   Clathrin heavy chain 1  283 
TNR6C_HUMAN  Trinucleotide repeat-containing gene 6C protein  257 
CNOT1_HUMAN   CCR4-NOT transcription complex subunit 1  66 
GSTP1_HUMAN Glutathione S-transferase P  50 
GRP78_HUMAN   78 kDa glucose-regulated protein  42 
PABP1_HUMAN   Polyadenylate-binding protein 1  35 
AP2A1_HUMAN AP-2 complex subunit alpha-1  31 
RENT1_HUMAN Regulator of nonsense transcripts 1  28 
A8K916_HUMAN   cDNA FLJ78481, highly similar to Homo sapiens  27 
 adaptor-related protein complex 2  
SND1_HUMAN Staphylococcal nuclease domain-containing protein 1  25 
PK1L2_HUMAN   Polycystic kidney disease protein 1-like 2  23 
CBR1_HUMAN   Carbonyl reductase [NADPH] 1  21 
HSP7C_HUMAN   Heat shock cognate 71 kDa protein  19 
AP2A2_HUMAN AP-2 complex subunit alpha-2  19 
A4D1U3_HUMAN  Single-stranded DNA binding protein 1  18 
GSTM3_HUMAN   Glutathione S-transferase Mu 3  17 
PABP4_HUMAN   Polyadenylate-binding protein 4  16 
A8K795_HUMAN   
cDNA FLJ75751, highly similar to Homo sapiens 
eukaryotic  13 
 translation elongation factor 1 b  
A8K5I0_HUMAN   cDNA FLJ75127, highly similar to Homo sapiens heat  13 
 shock 70kDa protein 1A  
OGT1_HUMAN   UDP-N-acetylglucosamine--peptide  13 
 N-acetylglucosaminyltransferase 110 kDa subunit   
DHX30_HUMAN   Putative ATP-dependent RNA helicase DHX30  12 
P3H1_HUMAN Prolyl 3-hydroxylase 1  11 
GSTM2_HUMAN   Glutathione S-transferase Mu 2  11 
A6NNH4_HUMAN  Fragile X mental retardation 1, isoform CRA_e  10 
TR150_HUMAN Thyroid hormone receptor-associated protein 3  10 
ROA2_HUMAN   Heterogeneous nuclear ribonucleoproteins A2/B1  9 
DHX9_HUMAN   ATP-dependent RNA helicase A  9 
KIF7_HUMAN Kinesin-like protein KIF7  9 
AP1B1_HUMAN   AP-1 complex subunit beta-1  8 
DESP_HUMAN   Desmoplakin  8 
TIM13_HUMAN Mitochondrial import inner membrane translocase  8 
 subunit Tim13   
ADT2_HUMAN   ADP/ATP translocase 2  7 
FXR1_HUMAN Fragile X mental retardation syndrome-related protein 1  7 
HNRPU_HUMAN   Heterogeneous nuclear ribonucleoprotein U  7 
UHMK1_HUMAN   Serine/threonine-protein kinase Kist  6 
MATR3_HUMAN   Matrin-3  6 
PPIB_HUMAN   Peptidyl-prolyl cis-trans isomerase B  6 
DDX1_HUMAN   ATP-dependent RNA helicase DDX1  6 
HNRPC_HUMAN   Heterogeneous nuclear ribonucleoproteins C1/C2  6 
B2R7N5_HUMAN  cDNA, FLJ93526, Homo sapiens ribosomal protein  6 
 S3 (RPS3)  
Q5SUJ3_HUMAN  Ribosomal protein S18  6 
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MCM7_HUMAN   DNA replication licensing factor MCM7  5 
SFPQ_HUMAN   Splicing factor, proline- and glutamine-rich  5 
DDX21_HUMAN Nucleolar RNA helicase 2  5 
CNOT3_HUMAN CCR4-NOT transcription complex subunit 3  5 
BCLF1_HUMAN   Bcl-2-associated transcription factor 1  5 
DJC10_HUMAN   DnaJ homolog subfamily C member 10  5 
ROA3_HUMAN   Heterogeneous nuclear ribonucleoprotein A3  5 
ZBT37_HUMAN   Zinc finger and BTB domain-containing protein 37  4 
AP2S1_HUMAN   AP-2 complex subunit sigma  4 
F120A_HUMAN Constitutive coactivator of PPAR-gamma-like protein 1  4 
A8K4Z8_HUMAN   cDNA FLJ75550, highly similar to Homo sapiens  4 
 heterogeneous nuclear ribonucleoprotein A1  
A8K7H3_HUMAN  
cDNA FLJ77670, highly similar to Homo sapiens 
ribosomal  4 
 protein S15a (RPS15A)  
Q0IIN1_HUMAN Q0IIN1_HUMAN 4 
RCD1_HUMAN   Cell differentiation protein RCD1 homolog  4 
B2R6F3_HUMAN  cDNA, FLJ92926, Homo sapiens splicing factor,  4 
 arginine/serine-rich 3 (SFRS3)  
B4DPV7_HUMAN  cDNA FLJ54534, highly similar to Homo sapiens  4 
 cysteinyl-tRNA synthetase (CARS)  
A2A3R6_HUMAN  A2A3R6_HUMAN 4 
HSP74_HUMAN   Heat shock 70 kDa protein 4  4 
USP9X_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-X  4 
B2R549_HUMAN   cDNA, FLJ92341, Homo sapiens ribosomal protein  4 
 S13 (RPS13)  
HNRPM_HUMAN  Heterogeneous nuclear ribonucleoprotein M  4 
WDR68_HUMAN   WD repeat-containing protein 68  4 
A8MUS3_HUMAN  Putative uncharacterized protein RPL23A  4 
HS90B_HUMAN   Heat shock protein HSP 90-beta  3 
LARP1_HUMAN La-related protein 1  3 
NUCL_HUMAN   Nucleolin  3 
B0ZBD0_HUMAN  40S ribosomal protein S19  3 
B4DTG2_HUMAN  cDNA FLJ56389, highly similar to Elongation 3 
 factor 1-gamma   
RL22_HUMAN    60S ribosomal protein L22  3 
B2RDD5_HUMAN  cDNA, FLJ96562, Homo sapiens ribosomal protein  3 
 S16 (RPS16)  
B3KMN4_HUMAN  cDNA FLJ11706 fis, clone HEMBA1005101, highly similar  3 
 to RNA-binding protein 14   
ELAV1_HUMAN   ELAV-like protein 1  3 
B2RMP5_HUMAN  EEF2 protein (Eukaryotic translation elongation factor 2,  3 
 isoform CRA_a)   
SC23B_HUMAN   Protein transport protein Sec23B  3 
Q5JVH5_HUMAN  Ribosomal protein 26 (RPS26) pseudogene  3 
FXR2_HUMAN   Fragile X mental retardation syndrome-related protein 2  2 
CNOTA_HUMAN CCR4-NOT transcription complex subunit 10  2 
RS14_HUMAN   40S ribosomal protein S14  2 
F136A_HUMAN Protein FAM136A  2 
PERQ2_HUMAN 
PERQ amino acid-rich with GYF domain-containing 
protein 2  2 
PPIA_HUMAN   Peptidyl-prolyl cis-trans isomerase A  2 
IF2B3_HUMAN   Insulin-like growth factor 2 mRNA-binding protein 3  2 
Q05D43_HUMAN  YBX1 protein (Fragment)  2 
CLCB_HUMAN   Clathrin light chain B  2 
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A9X7H1_HUMAN 
Eukaryotic translation elongation factor 1 alpha 
(Fragment)  2 
B2R4T2_HUMAN  cDNA, FLJ92205, Homo sapiens ribosomal protein S5  2 
 (RPS5)  
A8K4W3_HUMAN  cDNA FLJ77116, highly similar to Homo sapiens clathrin,  2 
 light polypeptide   
CBR3_HUMAN   Carbonyl reductase [NADPH] 3  2 
B4E3B6_HUMAN cDNA FLJ54408, highly similar to Heat shock 70 kDa  2 
 protein 1   
A3R0T7_HUMAN  Liver histone H1e  2 
B0YJA5_HUMAN   Mitochondrial import inner membrane translocase subunit  2 
 Tim8 B   
B2R4M7_HUMAN  cDNA, FLJ92149, Homo sapiens ribosomal protein S25  2 
H2A1B_HUMAN Histone H2A type 1-B/E  2 
P5CR3_HUMAN   Pyrroline-5-carboxylate reductase 3  2 
TIM8A_HUMAN   Mitochondrial import inner membrane translocase subunit  2 
 Tim8 A   
TTC19_HUMAN   Tetratricopeptide repeat protein 19, mitochondrial  2 
HNRPR_HUMAN   Heterogeneous nuclear ribonucleoprotein R  2 
B2R4C1_HUMAN  
cDNA, FLJ92036, highly similar to Homo sapiens 
ribosomal  2 
 protein L31 (RPL31)  
Q5T0P7_HUMAN  40S ribosomal protein S24  2 
CA163_HUMAN Hcp beta-lactamase-like protein C1orf163  2 
A4D1Q6_HUMAN  Similar to dJ753D5.2 (Novel protein similar to RPS17  2 
 (40S ribosomal protein S17))   
Q76M58_HUMAN  40S ribosomal protein S12  2 
PAN2_HUMAN PAB-dependent poly(A)-specific ribonuclease subunit 2  1 
B2R4H3_HUMAN  cDNA, FLJ92089, Homo sapiens ribosomal protein L17  1 
DHX36_HUMAN   Probable ATP-dependent RNA helicase DHX36  1 
NUP93_HUMAN   Nuclear pore complex protein Nup93  1 
WDR47_HUMAN WD repeat-containing protein 47  1 
A9C4C1_HUMAN  Ribosomal protein S9 (Ribosomal protein S9)  1 
TPC10_HUMAN Trafficking protein particle complex subunit 10  1 
Q5HY50_HUMAN  Ribosomal protein L10 (Fragment)  1 
A8K674_HUMAN  cDNA FLJ75516, highly similar to Xenopus tropicalis  1 
 ubiquitin C  
A6ND19_HUMAN  Putative uncharacterized protein ENSP00000352315  1 
B2R4E3_HUMAN  cDNA, FLJ92058, Homo sapiens ribosomal protein S10  1 
RL26L_HUMAN   60S ribosomal protein L26-like 1  1 
B2REA7_HUMAN  Ribosomal protein L36a  1 
A6NEC0_HUMAN  Putative uncharacterized protein MAGOHB  1 
A8K517_HUMAN   
cDNA FLJ77921, highly similar to Homo sapiens 
ribosomal  1 
 protein S23 (RPS23)  
AP1S1_HUMAN   AP-1 complex subunit sigma-1A  1 
RL35_HUMAN   60S ribosomal protein L35  1 
YOT5_CAEEL Uncharacterized protein ZK632.5  1 
HNRPG_HUMAN   Heterogeneous nuclear ribonucleoprotein G  1 
HNRH3_HUMAN   Heterogeneous nuclear ribonucleoprotein H3  1 
B2RD15_HUMAN  B2RD15_HUMAN 1 
SYTL2_HUMAN  Synaptotagmin-like protein 2  1 
RL21_HUMAN    60S ribosomal protein L21  1 
A4D1G5_HUMAN  Ribosomal protein S27  1 
B2R5H2_HUMAN  cDNA, FLJ92473, Homo sapiens enhancer of rudimentary  1 
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4 
 
 homolog (Drosophila) (ERH)  
RS30_HUMAN   40S ribosomal protein S30  1 
ZN184_HUMAN   Zinc finger protein 184  1 
B3KSK8_HUMAN 
cDNA FLJ36521 fis, clone TRACH2002138, highly similar 
to  1 
 Adenylate cyclase type 5   
DCR2_YEAST   Phosphatase DCR2  1 
PCBP1_HUMAN   Poly(rC)-binding protein 1  1 
A8K094_HUMAN   
cDNA FLJ76205, highly similar to Homo sapiens 
ribosomal  1 
 protein L8 (RPL8)  
B2RE88_HUMAN  cDNA, FLJ96465, highly similar to Homo sapiens solute  1 
 carrier family 25   
CNOT8_HUMAN   CCR4-NOT transcription complex subunit 8  1 
 
Mass spectrometry analysis of GST-CED pull-down. Identified proteins are 
listed with a short protein description and the number of assigned spectra.  
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SUPPLEMENTARY RESULTS 
 
Mutational analysis of the TNRC6C CED identifies functional elements 
containing W residues  
To determine the features of M2 and Cterm that repress mRNA function, we 
identified conserved regions of 2–4 amino acids by alignment of vertebrate 
and insect GW182 proteins (Supplementary Fig. 1). Mutagenesis of the 
selected sequences in the context of full-length CED or CEDΔPAM2 had a 
very limited effect on their ability to repress mRNA function (data not shown). 
Hence, the effect of mutations was tested in a context of fragments containing 
only the M2 or Cterm region adjacent to RRM, referred to as M2-RRM or 
RRM-Cterm, respectively (see Fig. 1a).  
Two of the three mutations in RRM-Cterm, LW1647 and SLW1657 (all 
mutations throughout the paper are to alanines; if several consecuitive amino 
acids are mutated, numbers always correspond to the first mutated residue) 
reduced repression by approximately two times (Supplementary Fig. 2d). We 
noted that amino acids mutated in LW1647 and SLW1657 include W residues 
in a context of GW or WG dipeptides (see Supplementary Fig. 1), shown 
previously to be important not only for the interaction of GW182 proteins with 
Argonautes but also for the AGO-independent repression of protein synthesis 
by the N-terminal domain of both D. melanogaster and human GW182s1,2. 
Hence, we generated mutants in which only W residues of LW1647 and 
SLW1657 amino acids are mutated, either singly or both. We found that 
mutation of W residues alone (mutants W1648 and W1659) had an effect 
similar to that of mutants LW1647 and SLW1657. Mutation of both W residues 
(mutant W1648 W1659) resulted in a stronger reduction in repression than for 
the single W mutants (Supplementary Fig. 2e). We also observed that the 
mutants LW1647, SLW1657, W1648, W1659, and W1648 W1659, which were 
all less inhibitory than the wild-type RRM-Cterm, were also strongly affected in 
their activity to pull down CNOT1 and CAF1, with the strongest effect seen 
with W1659 and the W1648 W1659 double mutant (Supplementary Fig. 2f). 
These results indicated that the Ws in Cterm are important both for mRNA 
repression and interaction with the CCR4–NOT complex.  
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 A similar conclusion emerged from the analysis of the M2 domain. This 
analysis revealed that mutations of sequences bearing W residues, or of W 
residues alone (mutants STW1485, W1487, W1495) generally reduced 
repression more than mutations of amino acids not including tryptophanes 
(mutants PPP1474 and GLT1477) or individual non-W amino acids or 
combinations thereof (mutants N1467, K1482, and N1467 K1482) 
(Supplementary Fig. 2d and 2g). Notably, simultaneous mutation of two W 
residues, both present in the GW (or WG) context, produced the strongest 
effect among the M2-RRM mutants tested (Supplementary Fig. 2g). We also 
observed that the ability of these mutants to interact with CAF1 correlated with 
their repressive activity. For example, mutant GLT1477 interacted with CAF1 
as much as wild-type M2-RRM did. In contrast, the interaction was partially 
affected in mutants STW1485 and W1495, and was nearly eliminated for the 
mutant W1487 W1495 (Supplementary Fig. 2h). 
 The data presented above pointed towards a considerable redundancy 
of sequences in the CED responsible for mediating both its interaction with 
CCR4–NOT and its repressive function in protein synthesis. Such redundancy 
is additionally indicated by step-wise deletion of the M2 and Cterm regions in 
a context of M2-RRM and RRM-Cterm fragments (Supplementary Fig. 3b). 
Moreover, we found that fragments containing duplications of either M2 
(mutant M2-M2) or Cterm (mutant Cterm-Cterm) induced the repression to the 
level similar of that of the M2-Cterm fusion (Supplementary Fig. 3a). Hence, 
the M2 region does not seem to carry any unique functional elements which 
differ from those present in Cterm, and vice versa. 
Together, the data presented above suggested redundancy in the 
features of the CED domain that repress mRNA function, and indicated that W 
residues may be important for that repression activity in a manner that 
involves recruitment of the CCR4–NOT complex.  
 
Tethering of the TRNC6C CED represses protein synthesis from both 
poly(A)+ and poly(A)– mRNAs in HEK293 cells   
We investigated whether the TNRC6C CED can repress tethered mRNA 
independently of poly(A) tail. To generate a poly(A) tail-free reporter, we 
initially replaced the cleavage and polyadenylation signal in the RL-5BoxB 
 6
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reporter with sequences comprising a histone stem-loop and a downstream 
element (referred to as HSL) responsible for formation of the 3’ end of histone 
mRNAs, which do not undergo polyadenylation. Since in transfected HEK293 
cells only about 50% of the transcript was cleaved at the HSL element (data 
not shown), we additionally introduced a hammerhead ribozyme (HhR) in a 
region downstream of HSL to produce RL-5BoxB-HSL+HhR reporter 
(Supplementary Fig. 6a). We have verified, by fractionating the total cellular 
RNA on oligo(dT)25 beads and performing quantitative real-time PCR (RT-
qPCR), that more than 99% of transcripts generated from transfected RL-
5BoxB-HSL+HhR is poly(A)-free (Supplementary Fig. 6b). 
Tethering of CED or CEDΔPAM2 repressed expression of the RL-
5BoxB poly(A)+ reporter by approximately ten times when compared to the 
CED lacking the N-peptide (Supplementary Fig. 6c; see also Zipprich et al.3). 
Interestingly, expression being driven by RL-5BoxB-HSL+HhR, yielding 
poly(A)– RNA, was also strongly repressed (approximately five times; 
Supplementary Fig. 6c). Northern analysis showed that whereas tethering of 
TNRC6C fragments induced marked degradation of the polyadenylated RNA, 
the level of RNA transcribed from RL-5BoxB-HSL+HhR plasmid remained 
unaffected (Supplementary Fig. 6d; quantification of multiple notherns is 
shown in a lower panel).  
Northern analysis revealed that, in addition to RNA of the size expected 
for RL-5BoxB HSL+HhR RNA, larger RNA species cross-reacting with the RL 
probe also accumulated in transfected cells (Supplementary Fig. 6d). This 
raised a possibility that RL activity measured in cells expressing RL-5BoxB-
HSL+HhR reporter might originate, at least partially, from transcripts other 
than those processed at HSL and HhR sites. We therefore sought for 
additional evidence that the TNRC6C CED and CEDΔPAM2 fragments can 
induce repression independently of a poly(A) tail. Towards this end, we 
transfected HEK293 cells with in vitro transcribed poly(A)-tail free RL-5BoxB 
RNA. To minimize a possibility that the poly(A)– in vitro transcript gets 
polyadenylated upon its accumulation inside the cell, we also used a form of 
poly(A)– transcript which contains a residue of cordycepin, an AMP analog, 
incorporated at the 3’ end of RNA; cordycepin lacks the ribose 3’-OH group 
which would be required for extension of RNA with additional As or other 
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nucleotide residues4. Tethering of either CED or CEDΔPAM2 repressed 
expression of RL from the in vitro synthesized poly(A)+ RL-5BoxB RNA by 70 
to 80%. Importantly, it also repressed, by approximately 30 to 40%, the 
expression from transfected non-polyadenylated RL-5BoxB RNA, irrespective 
whether it bore the cordycepin end or not (Supplementary Fig. 6e). Of note, 
expression of RL from cordycepin-bearing RL-5BoxB RNA was approximately 
three times higher then that from non-modified poly(A)– 5boxB RNA (data not 
shown), consistent with a reported protective effect of cordycepin against 
3’?5 exonucleolytic degradation5. In further experiments, cordycepin-modified 
transcripts were used as a poly(A)– RNA.  
 
Tethering of CCR4–NOT complex components represses protein 
synthesis from both poly(A)+ and poly(A)– mRNAs in HEK293 cells 
We tested whether direct tethering of the CCR4–NOT complex components to 
mRNA is sufficient to induce its silencing in HEK293 cells. Cooke et al.6 
reported previously that tethering of CAF1 or its catalytically inactive mutant to 
the microinjected reporter mRNA, either poly(A)+ or poly(A)–, can repress 
translation at the initiation step in Xenopus leavis oocytes. We found that also 
in HEK293 cells, tethering of CAF1 or its catalytic mutant represses RL 
expression from the RL-5BoxB reporter (Supplementary Fig. 7a). Interestingly, 
tethering of CNOT1, CNOT2, CNOT6 and, to lesser extend, CNOT3 (all 
expressed as NHA fusions), also repressed the RL-5BoxB reporter function 
(Supplementary Fig. 7a,c). Comparison of the effect on activity of RL-5BoxB 
and RL-5BoxB-HSL+HhR reporters, expressing poly(A)+ or poly(A)– RNAs 
respectively, revealed that also poly(A)– RNA was repressed by three to four 
times by tethering of CNOT1, CAF1 or CAF1 catalytic mutant (Supplementary 
Fig. 7a). Notably, similarly as observed with tethering of the TNRC6C CED 
and CEDΔPAM2 fragments (see Supplementary Fig. 6), tethering of CAF1 or 
CNOT1 proteins resulted in a marked (two to three times) decrease of the 
level of polyadenylated RL-5BoxB RNA but not RNA transcribed from the RL-
5BoxB-HSL+HhR reporter, which should be poly(A)-free (Supplementary Fig. 
7b). 
We also tested if tethering of CAF1 or its catalytic mutant will repress 
function of the in vitro transcribed RL-5BoxB RNA, either polyadenylated or 
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poly(A)-free, transfected to HEK293 cells. We found that tethering of either 
CAF1 protein repressed expression of RL from the poly(A)+ RL-5BoxB RNA 
by 80–90%. Importantly, it also repressed, by approximately 60%, the 
expression from transfected poly(A)-free (cordycepin-modified) RL-5BoxB 
RNA (Supplementary Fig. 7d).   
Taken together, the results presented in the last two sections indicate 
that recruitment of the TNRC6C CED or different components of the 
deadenylase CCR4–NOT complex to the 3’ UTR of mRNAs induces their 
silencing even if the transcripts have no poly(A) tail. Since the repression of 
poly(A)– RNA was not associated with deacrease of mRNA levels, the data 
also suggest that the CCR4–NOT complex not only mediates deadenylation 
but also translational repression of mRNA. These findings extend recent 
observations of Cooke et al.6 showing that tethering of CAF1 can induce 
translational repression in microinjected X. laevis oocytes. They also indicate 
that the repression may not result from a direct effect of CAF1 but rather is 
due to the recruitment of a whole CCR4–NOT complex to mRNA. 
 
 
SUPPLEMENTARY METHODS 
 
DNA constructs and protein mutants 
Reporter plasmids RL-5BoxB and FL-Con7, and FL-5BoxB, RL-Con and FL-
nerfin8, as well as FL-5BoxB-HSL and FL-5BoxB-HhR9 have been described 
previously. Plasmids encoding NHA, NHA-lacZ, dGW182 and its deletion 
fragments10, as well as miR-9b and miR-128 have also been described. 
Plasmids encoding TNRC6A, TNRC6C and its deletion fragments3, the pEBG-
Δ1370 plasmid encoding TNRC6C GST-CED11, and pSR-HA-CCR412 have 
been reported. Point mutations in TNRC6C, TNRC6A and dGW182 constructs 
were introduced by site-directed mutagenesis according to13. The TNRC6A 
clone lack the first 312 amino acids14. Plasmids encoding the dGW182 N-
terminal effector domain (1-490) and its point mutants used for tethering 
assays in human cells, as well as sub-fragments of TNRC6C, were generated 
by PCR-amplification of the corresponding fragments of the NHA- or HA-
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dGW182 regions (wild-type or its indicated mutants1) or TNRC6C, and cloning 
into either pCI-neo vector (Promega) or pCI-neo bearing an HA- or NHA-tag7. 
To construct the plasmid expressing the M2-Cterm fusion, the M2 and Cterm 
encoding regions were separately amplified by PCR and consecutively cloned 
into pCI-NHA vector7. A plasmid expressing TNRC6C lacking the M2 and 
Cterm regions was generated by cloning a PCR amplified fragment encoding 
the RRM into a construct encoding amino acids 1-1413 of TNRC6C in pCI-
NHA vector7.  
To generate N-Sic-GST and its W-containing versions, the Sic-, Sic4xW-, and 
Sic7xW-encoding fragments were chemically synthesized (Genscript; for 
protein sequence information, see Supplementary Figure 4B) and cloned into 
a pCI-neo vector containing NHA-GST, by removing the HA-tag and inserting 
Sic sequences between the N and GST regions. The TNRC6C N-CED-GST 
construct and its 7W mutant were generated similarly, by replacing the HA-tag 
in pCI-NHA-GST with PCR-amplified CED fragments. Plasmids expressing 
GST-tagged dGW182 (1-490), TNRC6C, and their deletions and point 
mutants, all used for GST pull-downs, were generated by cloning the 
corresponding PCR-amplified fragments into the pEBG vector (Addgene). 
Plasmids encoding GST-tagged Sic and Sic7xW, used for GST pull-downs, 
were obtained by cloning the chemically synthesized fragments mentioned 
above into the pEBG vector.  
To obtain plasmids expressing HA-CNOT1 and NHA-CNOT1, the 
CNOT1 coding region from the plasmid pME-FLAG-CNOT115 (a kind gift of 
Dr. T. Yamamoto, University of Tokyo) was PCR amplified and cloned into 
pCI-HA or pCI-NHA vector7 using the In-Fusion 2.0 Dry-Down PCR Cloning 
Kit (Clontech) or cloned into a pAC5.1A vector containing NHA- or HA-tag. For 
generating plasmids expressing HA- or NHA-tagged CNOT2, CNOT3L or 
CNOT6, the corresponding coding sequences were amplified by PCR using 
B42 vectors described in Lau et al.16 (kindly provided by Dr. H.T.M. Timmers, 
University of Utrecht) as template and cloning the PCR product into pCI-HA or 
pCI-NHA vector7. Plasmids expressing HA-CAF1, NHA-CAF1, HA-CAF1 
D40A (CAF1 D40A is referred to as CAF1mut in the text), and NHA-CAF1mut 
were obtained by PCR amplification of the CAF1-encoding sequence from 
plasmids pSR-HA-Caf1 or pSR-HA-Caf1 D40A17 (kind gifts of Dr. A-B. Shyu, 
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The University of Texas Medical School, Houston) and cloning into pCI-HA or 
pCI-NHA vector7.  
The plasmid RL-5BoxB-poly(A) that was used for generating in vitro 
transcribed reporter RNA was obtained by cloning an Xba1-Stu1 fragment of 
the plasmid RL-5BoxB-pA18 (a kind gift of Dr. M. Fabian, McGill University, 
Montreal), which encodes 5BoxB sites and a 98-nt-long poly(A) tail, into the 
Xba1-Stu1 digested RL-5BoxB reporter plasmid. The sequence between the 
T7 promoter and ATG codon was modified in all plasmids (except FL-Con) 
used for the in vitro transcription to obtain transcripts bearing identical 5` UTR. 
Correctness of all plasmids was verified by sequencing.  
 
Immunoprecipitations and Western blotting 
For western blotting analysis, inputs and the pulled-down or 
immunoprecipitated material were separated by SDS-PAGE using 10% linear 
polyacrylamid gels or NuPAGE Novex 4–12% Bis-Tris Gels (Invitrogen). For 
estimating the expression level of HA-fusion proteins in tethering or rescue 
assays, aliquots of cell lysates in Passive Lysis Buffer (PLB, Promega) were 
analyzed by SDS-PAGE as described above. Proteins were detected using 
ECL (GE Healthcare) or SuperSignal West Femto Chemiluminescent 
ubstrate (Thermo Scientific). S
 
Mass spectrometry analysis 
Protein content from GST pull-downs shown in Supplementary Fig. 4b was 
analyzed by MS, using an LTQ/Orbitrap VELOS mass spectrometer (Thermo 
Fischer Scientific) equipped with Agilent 1100/1200 Series Nanoflow LC 
system (Agilent Technologies). For MS analysis shown in Figure 1b, a 4000 Q 
TRAP mass spectrometer (Applied Biosystems, Foster City, CA) was used. 
 
Northern blotting and poly(A) tail length measurement 
10–20 µg of total RNA isolated from HEK293T or S2 cells using Trizol 
Reagent (Invitrogen) was resolved in a denaturing 1% (w/v) agarose gel and 
transferred to Hybond-N+ membrane (GE Healthcare Life Sciences) using 10X 
SSC. RL- or FL-specific probes internally labelled with [α-32P]UTP were 
hybridized to the RNA on the membrane in ULTRAhyb Ultrasensitive 
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Hybridization Buffer (Ambion) at 68°C. After washing the membrane with 
0.2XSSC containing 0.1% (v/v) SDS at 68°C, the signal was detected using a 
PhosphorImager screen and a GE TyphoonTM 9400 scanner. 
For poly(A) tail length measurement, total RNA was isolated from S2 
cells expressing FL-5BoxB and either NHA-CED, NHA-CED 7W or NHA-lacZ 
with Trizol LS reagent (Invitrogen). Poly(A) tails of FL-5BoxB mRNA were 
estimated using the poly(A) tail length assay kit (Affymetrix) based on G-
tailing/PAT (poly(A) test) assay19. FL-5BoxB-specific primers were: 
TTATCTCGAGGTCACCCATT (forward); and GCAATAGCATCACAAATTTCA 
(reverse). The expected PCR amplification product is 263 base-pairs long and 
corresponds to the region starting at 30 nucleotides upstream of the 
polyadenylation site. The same forward primer was also used for estimation of 
poly(A) length. 
 
Fractionation of total cellular RNA and RT-qPCR 
Total cellular RNA, isolated from HEK293T cells 24 h post-transfection with 
Trizol, was used for poly(A)+ RNA selection using Dynabeads® Oligo (dT)25 
(Invitrogen). 7 μg of RNA dissolved in 100 μl of water was mixed with 100 μl of 
Binding Buffer (20 mM Tris-HCl, pH 7.5, 1M LiCl) and heated at 65°C for 2 
min. After cooling down on ice the RNA was mixed with 0.1 mg Dynabeads® 
Oligo (dT)25 in 100 μl of Binding Buffer. After incubation for 5 min at room 
temperature the beads were washed twice with 200 μl of Washing Buffer (10 
mM Tris-HCl, pH 7.5, 0.15 M LiCl) and the selected RNA was eluted with 100 
μl of 10 mM Tris-HCl, pH 7.5 at 75°C for 2 min. The fractionation procedure 
was repeated two more times, the input and selected RNA fractions were 
treated with RQ1 RNase-free DNase (Promega) according to the 
manufacturers protocol, and used for RT-qPCR.  
300 ng of each RNA was reverse-transcribed using SuperScript™ III 
First-Strand Synthesis SuperMix (Invitrogen) and the resulting cDNA was 
used as a template for qPCR with the ABI 7500 Real-Time PCR system and 
Platinum SYBR Green qPCR SuperMix, using reporter-specific primers 
amplifying the RL or FL coding regions. 
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In vitro transcription and transfection of RNA 
Plasmids used as templates for the in vitro transcription were linearized using 
the following restriction enzymes: plasmids encoding HA- or NHA-fusion 
proteins with Mfe1, FL-Con with Hpa1, and plasmids encoding RL-5BoxB 
reporters with Not1 [5’ of the plasmid-encoded poly(A) stretch] to yield a 
template for poly(A)– RNA synthesis or with Age1 [3` of the poly(A) stretch]. 
Before in vitro transcription, the Age1-linearized plasmid was treated with 
mung bean nuclease to remove the overhang produced by Age1 to ensure the 
DNA template ends with a stretch of 98 A residues. The in vitro transcription 
was performed using the MEGAscript T7 kit (Ambion), following the 
manufacturers instructions, and RNA was purified using the RNeasy mini kit 
(Qiagen). 3` ends of some of the in vitro transcribed RNAs were modified by 
incorporating a cordycepin nucleotide (3’-deoxyadenosine 5’-triphosphate) 
using yeast poly(A) polymerase4. Briefly, purified in vitro transcripts (0.2 μM) 
were incubated for 10 min at 37°C with 20 μM cordycepin triphosphate (Jena 
Bioscience) and yeast poly(A) polymerase (Affymetrix). Transcripts were then 
repurified as described above.  
RNA transfections were performed in six-well plates with ~90% 
confluent HEK293T cells, using Lipofectamine 2000 transfection reagent 
(Invitrogen). 50 ng of the RL reporter RNA, 150 ng of the FL-Con RNA and 
600 ng of RNA encoding HA- or NHA-fusion protein were transfected per well. 
Cells were harvested 16 h post-transfection in Passive Lysis Buffer (PLB; 
Promega) and activity of RL and FL was analyzed as described above.  
 
Yeast two-hybrid assays 
For all experiments, the strain W303-1B [MATα leu2-3,112 trp1-1 can1-100 
ura3-1 ade2-1 his3-11,15] was used. LexA-CNOT1L (amino acids 648-2376), 
CNOT6 and CNOT7 constructs (in pEG202 backbone) were a kind gift from 
H.T.M. Timmers (University of Utrecht) as was B42-CNOT2 (all described 
in16). B42-CED was cloned by amplifying the CED ORF by PCR with 
oligonucleotides ATGATGCCCGGGCTCGTGCCAAATCTGACAGTGAT  and 
GTCTGCTCGAAGCATTAACCC used as forward and reverse primers, 
respectively.The PCR product was cloned into the pJG4-5, also provided by 
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H.T.M. Timmers. The reporter plasmid pSH18-34 was used to measure β-Gal 
activity20. Transformations with different plasmids were carried out according 
to the protocol described in21.  
For measurements of β-Gal activity, 100 μl SC [-Trp -His –URA, 
containing 2% (w/v) lactate, 3% (v/v) glycerol and 2% (w/v) glucose] was 
inoculated with a single colony and grown for 6-7 h. The preculture was 
diluted 1:100 in 5 ml SC without glucose and grown overnight. Galactose was 
added to a final concentration of 2% (w/v) and culture was grown for 5 more 
hours. Cells were pelleted and stored at -80°C. The β-Gal-activity was 
analyzed according to the protocol described in21.  
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Results 
2.4 Deletion analysis of the human CNOT1 
protein 
As our experiments suggested that GW182 interacts directly with CNOT1, we were 
interested in characterizing the molecular interaction between these two proteins. 
Furthermore, we were interested to identify the parts of CNOT1 that mediate 
repression. To answer these questions, we generated a collection of deletion 
mutants of CNOT1 (Figure 2.6, panel A) and tested their repressive potential in the 
tethering assay in HEK293 cells and also probed their interaction with the C-terminal 
region of TNRC6C in GST pull-down assays.  
Tethering NHA-tagged CNOT1 strongly repressed (7-fold) activity of the RL-
5BoxB reporter when compared to HA-tagged CNOT1 protein lacking the N peptide. 
Progressive deletion from the N-terminus revealed that a central part of the CNOT1 
protein is required for inducing maximal repression of reporter mRNA in the tethering 
assay. Whereas deletion of the N-terminal 243 amino acids did not affect repression, 
deleting the N-terminal 1068- and 1602 amino acids reduced repression from 7-fold 
to 3.5-fold and 1.5-fold, respectively (Figure 2.6, panel B and Figure 2.11). 
Conversely, progressive deletions carried out from the C-terminus revealed that 
amino acids 1827-2376 are required for maximal repression but a fragment lacking 
this part was still efficiently repressing (5-fold repression) the reporter mRNA (Figure 
2.6, panel B and Figure 2.11). Whereas a CNOT1 fragment containing amino acids 
1-1601 efficiently repressed (5.5-fold) mRNA function, a fragment containing amino 
acids 1-1069 was almost inactive, suggesting that the region between amino acids 
1069 and 1601 is particularly important for inducing repression (Figure 2.6, panel B 
and Figure 2.11).  
As the aforementioned results indicated that a central region of CNOT1 is 
important for inducing repression, we tested whether a central fragment 
encompassing amino acids 727-1601 would be active in repression. Indeed, 
tethering this fragment reduced activity of the RL-5BoxB reporter 5-fold, which is 
comparable to the extent of repression induced by the fragments 1-1601 and 840-
2376 (Figure 2.6, panel B and Figure 2.11). Further deletion analysis of the central 
region did not reveal a shorter fragment with the same repressive activity as the 
fragment 727-1601, suggesting that maximal repressive activity is only achieved 
when this region of the protein is intact (Figure 2.6, panels B and C and Figure 2.11). 
Interestingly, the central region of CNOT1 that seems to be important for repression 
also encompasses the minimal fragment able to interact with CAF1 as identified by 
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Sandler et al., (2011), suggesting that CAF1 may play a role in the repression 
induced by tethered CNOT1 (Figure 2.11). 
 
Figure 2.6: Tethering a central fragment of CNOT1 efficiently represses the expression 
of Renilla Luciferase (RL) reporter mRNA. (A) Schematic representation of CNOT1 and its 
deletion mutants. Conserved domains according to the NCBI Protein Database are indicated 
(blue: DUF3819 super family, green: Not1 super family). (B and C) Plasmids encoding 
indicated HA- or NHA-tagged CNOT1 or fragments thereof were co-transfected into HEK293T 
cells with RL-5BoxB and FL-Con plasmids. RL expression was normalized to the activity of FL 
and is shown as percentage of activity in cells expressing HA-CNOT1. The values are means 
(±standard error of the mean (SEM)) from three experiments. (Lower panels) Expression 
78 
Results 
levels of HA- or NHA-tagged proteins was assessed by Western blotting using anti-HA 
antibody. 
 
To test which regions of CNOT1 interact with the CED, we expressed the CED as 
a glutathione S-transferase (GST) fusion together with NHA-tagged CNOT1 and 
fragments thereof in HEK293 cells and performed pull-down experiments. All the N-
terminal deletion fragments of CNOT1 were efficiently pulled down by the CED, 
suggesting that the NHA tagged C-terminal region 1827-2376 of CNOT1 is sufficient 
to interact with the CED (Figure 2.7, panel A). Deletions from the C-terminus of 
CNOT1 revealed however that the C-terminus is not the only fragment that 
contributes to the interaction with the CED, as the NHA-tagged CNOT1 fragment 1-
1826 was still efficiently pulled down by the CED (Figure 2.7, panel B). Whereas the 
fragment NHA-CNOT1 1-1601 was efficiently pulled down by the CED, a fragment 
encompassing amino acids 1-1068 interacted very poorly with the CED, suggesting 
that the region 1069-1601 is important for the interaction with the CED (Figure 2.7, 
panel B). Indeed, further pull-down experiments revealed that the NHA-tagged 
CNOT1 fragments encompassing amino acids 727-1601, 1069-1601 and 1354-1578 
all interacted with the CED or CEDPAM2 indicating that the region 1354-1578 is 
sufficient for the interaction (Figure 2.8 and Figure 2.9). Importantly, interaction of 
these fragments with the CED depended on the tryptophan residues present in the 
CED (Figure 2.10).  
In summary, the analysis of CNOT1 fragments revealed that at least two different 
regions of CNOT1 are capable of interacting with the CED of TNRC6C in HEK293 
cell extracts. Hence, the CED is able to contact both the middle- and the C-terminal 
part of CNOT1. The identification of CNOT1 fragments interacting with the CED in 
HEK293 cell extract should serve as a basis for further biophysical and structural 
characterization of the interaction between GW182 and CNOT1 proteins. It will be 
interesting to learn how multiple W-motifs of the CED contribute to the interaction 
with the two regions of CNOT1.  
79 
Results 
 
Figure 2.7: A C-terminal fragment of CNOT1 is sufficient to interact with the TNRC6C 
CED in HEK293 cell extracts. (A) GST pull-down assay with GST-tagged CED and HA-
tagged human CNOT1 and fragments thereof. HEK293T cells were co-transfected with 
plasmids encoding NHA-CNOT1 or indicated fragments and GST-tagged CED. Inputs (7%) 
and pull-down assays were analyzed by western blotting. Extracts from cells not transfected 
with GST-CED were used as a control. (B) GST pull-down assay was performed as described 
in A but with different fragments of CNOT1. 
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Figure 2.8: A central NHA-tagged fragment of CNOT1 is sufficient to interact with the 
TNRC6C CEDPAM2 in HEK293 cell extracts. GST pull-down assay was performed as 
described in Figure 2.7A using GST-tagged CEDPAM2 instead of GST-tagged CED. 
 
 
Figure 2.9: The NHA-tagged fragments of CNOT1 encompassing amino acids 1069-
1601 and 1354-1578 interact with GST-CEDPAM2 in HEK293 cell extracts. GST pull-
down assay was performed as described in Figure 2.8. 
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Figure 2.10: The interaction between the CED and NHA-tagged fragments of CNOT1 
depends on the tryptophan residues in the CED. GST pull-down assay was performed as 
described in Figure 2.7A using GST-tagged CEDor a mutant version thereof containing 
seven tryptophan to alanine mutations (GST-CED 7W). 
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Figure 2.11: Summary of the results from tethering assays and GST pull-down assays. 
The collection of deletion mutants of CNOT1 analyzed is represented schematically. 
Conserved domains according to the NCBI Protein Database are indicated (blue: DUF3819 
super family, green: Not1 super family). The region of CNOT1 that was found by Sandler et 
al., (2011) to be sufficient for the interaction with CAF1 is marked with a red bar. Other 
regions of CNOT1 found to interact with the indicated proteins in yeast two-hybrid assays by 
Lau et al., (2009) and Albert et al., (2000) are also marked with a red bar. The strength of 
repression induced by each fragment in the tethering assay is indicated as fold repression. 
We estimated the enrichment of each of the fragments in the GST-CED pull-down assay and 
indicate our estimations on the right using the following scale: +++, ++, +/-, - (+++ meaning 
strongest enrichment, - meaning weakest enrichment). The fragment 1069-1315 is labeled 
with “-?” because it did not interact with CEDPAM2 in two experiments but interacted with 
the full CED in one performed experiment. The fragments labeled with NT were not tested in 
GST pull-down assays. 
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3. Discussion 
 
Owing to the important role of miRNAs as post-transcriptional regulators of gene 
expression, the molecular mechanism of miRNA-mediated gene silencing has been 
subject to intensive studies by many research groups worldwide. However, as 
studies aiming to shed light on this process came to different and sometimes even 
contradictory conclusions, it has been difficult to draw a comprehensive picture of the 
molecular events leading to miRNA-mediated repression. In order to extend our 
understanding of the mechanism of miRNA-mediated gene silencing, we studied the 
function of GW182 proteins that have emerged as key components executing 
miRNA-mediated repression. 
In this work we identify the C-terminal fragment of TNRC6C (CED) as a key 
region mediating miRNA-induced repression by interacting with PABP via its PAM2 
motif and by recruiting the PAN2-PAN3 and CCR4-CAF1-NOT deadenylase 
complexes via conserved tryptophan-containing motifs. 
 
In the following part of the discussion I do not indicate references for our own 
results presented in this thesis. These results are described in chapter two (2. 
Results) and appendices A and B of the thesis. The results obtained by others are 
however specifically referenced in the text. 
 
3.1 The role of different regions of GW182 
proteins in miRNA-mediated silencing 
 
The following evidence supports the conclusion that the C-terminal region of TNRC6 
proteins represents a key region mediating miRNA-induced repression. First, in the 
tethering assay the CED represses a reporter mRNA to the same extent as full length 
TNRC6C and it appears to do so in an autonomous manner as we do not detect it to 
interact with AGO or TNRC6 family proteins. In contrast to the CED which reduces 
the reporter protein level 10 times, the GW-rich and Q-rich domains of TNRC6C only 
repress reporter protein levels 2-3 times. Second, whereas the expression of wild-
type TNRC6A rescues miRNA mediated repression in HeLa cells depleted of 
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Figure 3.1: Domains and important regions of selected GW182 proteins. Schematic 
representation of human (Hs) TNRC6C and Drosophila (Dm) GW182 proteins. Positions of 
GW-rich, Q-rich, UBA, DUF (PAM2), and RRM domains are indicated. Important regions of 
the proteins discussed in the text are marked with red. The regions indicated are based on 
the following references: (Chekulaeva et al., 2009; Chekulaeva et al., 2011; Chekulaeva et al., 
2010; Eulalio et al., 2009a; Eulalio et al., 2009d; Fabian, 2011; Fabian et al., 2009; Zipprich et 
al., 2009). Figure modified from Zipprich et al., (2009). 
 
TNRC6 proteins, a version of TNRC6A containing mutations in residues critical for 
CED function, fails to do so completely. Third, in contrast to wild-type TNRC6C, 
TNRC6C containing mutations critical for CED function fails to rescue miRNA-
mediated repression in Drosophila S2 cells depleted of DmGW182. 
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These observations are in agreement with findings by Lazzaretti et al., (2009) 
showing that the N-terminal parts of TNRC6A, TNRC6B and TNRC6C proteins 
containing the sequence upstream of the UBA domain were inactive in the tethering 
assay in HEK293 cells whereas the C-terminal fragments of the proteins strongly 
reduced reporter RNA activity. Furthermore, Huntzinger et al., (2010) found that in 
contrast to wild-type TNRC6A, a mutant TNRC6A lacking the silencing domain was 
unable to rescue miRNA-mediated silencing in HeLa cells depleted of TNRC6A and 
TNRC6B. Similarly, the silencing activity of zebrafish TNRC6A in a tethering assay in 
zebrafish embryos was found to depend largely on a C-terminal part encompassing 
amino acids 1310-1567 and this part of the protein was also sufficient to induce 
silencing to the same extent as the full length protein (Mishima et al., 2012).  
A key role in miRNA-mediated silencing was also demonstrated for the C-terminal 
region of Drosophila GW182. Deleting the middle (M-GW) and the Cterm regions of 
Drosophila GW182 completely abolished its silencing activity in a complementation 
assay in Drosophila S2 cells (Eulalio et al., 2009a) and in a tethering assay a C-
terminal region of DmGW182 was sufficient to silence bound reporter transcripts 
(Chekulaeva et al., 2009). 
 
What do we know about the contribution to miRNA-mediated silencing of regions 
of GW182 other than its C-terminal part? It is well established, and our data confirm it, 
that the N-terminal part of GW182 mediates the interaction with AGO proteins 
(Behm-Ansmant et al., 2006; Lazzaretti et al., 2009; Till et al., 2007) - but does it 
have additional (more direct) functions in silencing? The following evidence indicates 
a contribution of the N-terminal region of GW182 proteins to silencing. First, we 
observed mild repression of transcripts bound to fragments containing the N-terminal 
GW-rich region or the Q-rich region of TNRC6C in a tethering assay. Similarly, a 
fragment of the N-terminal part of TNRC6A (amino acids 896-1045) induced 
repression of bound mRNA in HEK293 cells (Yao et al., 2011). Second, N-terminal 
fragments of DmGW182 strongly repressed bound transcripts in Drosophila S2 cells 
(Chekulaeva et al., 2009) as well as in HEK293 cells in a cross-species experiment 
and induced their deadenylation in a tethering assay in S2 cell lysates (Fukaya and 
Tomari, 2011). Third, N-terminal fragments of DmGW182 encompassing the N-
terminal GW-rich region or both the N-terminal GW-rich region and the Q-rich region, 
partially rescued miRNA-mediated silencing in S2 cells depleted of endogenous 
GW182 (Chekulaeva et al., 2009). 
It is not clear why the N-terminal part of human TNRC6C can induce silencing in 
the tethering assay whereas in a complementation assay its paralog, TNRC6A, with 
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mutations only in the C-terminal region is inactive in silencing. Also, it needs to be 
explained why the N-terminal region of DmGW182 can rescue miRNA-mediated 
silencing of one (Chekulaeva et al., 2009) but not other (Eulalio et al., 2009a) 
reporters.  
 
More detailed analysis of the C-terminal region of the human TNRC6C protein 
revealed that the M2 and Cterm regions are required and sufficient for inducing 
efficient repression in a tethering assay and for the interaction with the CCR4-CAF1-
NOT complex components.  
In support of these data, the M2 and Cterm regions of DmGW182 and human 
TNRC6B were found to contribute to miRNA-mediated silencing in complementation 
assays in S2 cells (Huntzinger et al., 2010) and a function in miRNA-mediated 
silencing was also demonstrated for the M2 and Cterm regions of TNRC6A in a 
complementation assay in HeLa cells (Braun et al., 2011). Further, in a mammalian 
cell-free extract from mouse Krebs-2 ascites cells, deadenylation induced by a 
tethered C-terminal fragment of TNRC6C was severely reduced when the tethered 
fragment was lacking the Cterm region (Fabian, 2011). Also, the M2 and Cterm 
regions of the silencing domain of TNRC6B were shown to contribute to the 
interaction with in vitro translated CNOT1 (Braun et al., 2011) and the interaction 
between recombinant TNRC6C silencing domain and CCR4-CAF1-NOT complex 
components from HeLa cell extracts largely depended on the Cterm region (Fabian, 
2011). 
 
What is the role of the RNA recognition motif (RRM) which represents the most 
conserved part of vertebrate and insect GW182 proteins? Tethering the RRM of 
TNRC6C did not induce repression of bound RNA which is in line with the 
observation that the RRM also was not observed to interact with the CCR4-CAF1-
NOT complex. However, introducing point mutations into the RRM of the CED 
fragment and deleting the RRM from the CEDPAM2 fragment modestly but 
significantly reduced silencing, indicating that the RRM is required for maximal 
silencing efficiency. A modest contribution of the RRM domain of DmGW182 to 
miRNA-mediated silencing was also observed by (Eulalio et al., 2009c). Taken 
together these data indicate a modest contribution of the RRM domain to GW182-
mediated silencing but the mode of this contribution is not clear. 
 
Our findings together with data of others indicate that GW182 proteins act as 
poly(A)-binding protein (PABP)-interacting proteins. Mass spectrometry analysis 
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identified PABP as an interaction partner of the C-terminal domain of TNRC6C and 
subsequent deletion and mutational analysis of the CED revealed that the PAM2 
region is essential for the interaction between the CED and PABP. The PAM2 region 
(previously termed domain of unknown function (DUF)) shows sequence similarity 
with the PABP-interacting motif 2 (PAM2) which is present in PAIP1 and PAIP2 and 
other proteins involved in translation and mRNA degradation. The PAM2 motif of 
PAIP1 and PAIP2 binds to the C-terminal MLLE domain of PABP (Kozlov et al., 
2001). Indeed, structural and biochemical analyses demonstrated that the PAM2 
motif of TNRC6C binds to the MLLE domain of PABP in a similar way as the PAM2 
of PAIP1 and PAIP2 (Fabian et al., 2009; Jinek et al., 2010; Kozlov et al., 2010). 
Several lines of evidence indicate that the interaction between GW182 proteins 
and PABP has a functional role in miRNA-mediated silencing. First, we observed that 
mutating residues of the PAM2 region characterized to be critical for PABP 
interaction, interfered with the activity of TNRC6A in miRNA-mediated silencing in a 
complementation assay. The PAM2 region of TNRC6A was also found to contribute 
to miRNA-mediated silencing by Huntzinger et al., (2010) and Braun et al., (2011). 
Second, an excess of PAIP2-derived PAM2 peptide that competes with the 
TNRC6C-PABP interaction, interfered with miRNA-mediated deadenylation in mouse 
Krebs-2 ascites cell extract (Fabian et al., 2009). In the same in vitro system, 
mutation of residues of the PAM2 region critical for the interaction with PABP 
reduced the rate of deadenylation by the C-terminal domain of TNRC6C in a 
tethering assay (Fabian, 2011; Jinek et al., 2010). Finally, a mutation introduced into 
the PAM2 motif of a fragment of zebrafish TNRC6A that completely abolished 
interaction with PABP, slightly reduced repression activity of the fragment in a 
tethering assay in zebrafish embryos (Mishima et al., 2012).  
It is not clear why we did not observe any significant influence of deleting or 
mutating the PAM2 region on the silencing activity of tethered CED in HEK293 cells. 
Possibly, a modestly reduced rate of deadenylation would not influence the protein 
steady state level. Further, the function mediated by the PAM2 region may be 
dispensable when the CED is tethered to a target mRNA, consistent with the 
observation that PABP promotes association of miRISC with miRNA-regulated 
mRNAs (Moretti et al., 2012). 
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3.2 The role of tryptophan-containing motifs in 
GW182 proteins 
 
In this work we provide evidence that the human and Drosophila GW182 proteins 
recruit the CCR4-CAF1-NOT deadenylase complex in a PABP-independent manner 
via tryptophan-containing motifs (W-motifs). The following evidence supports the idea 
that W-containing motifs in GW182 proteins are crucial elements for recruiting the 
deadenylase complex and inducing repression. First, mutational analysis of sub-
fragments of the TNRC6C CED identified W-containing motifs in the M2 and Cterm 
regions required for silencing activity and interaction with the CCR4-CAF1-NOT 
deadenylase complex. The analysis demonstrated a strong correlation between 
repression and interaction with the CCR4-CAF1-NOT complex. Second, introducing 
an increasing number of tryptophan to alanine mutations in the CEDs of TNRC6C 
and DmGW182 caused a gradual alleviation of repression mediated by these 
domains in tethering assays. Third, tryptophan-containing motifs in the N-terminal 
effector domain (NED) of DmGW182 that were shown to be essential for the 
silencing activity of this domain (Chekulaeva et al., 2010), are also crucial for the 
interaction with the deadenylase complex. Fourth, tryptophan-containing motifs 
proved to be essential for maximal miRNA-mediated silencing activity of DmGW182, 
TNRC6C and TNRC6A in complementation assays. Fifth, introducing tryptophan 
residues into an unstructured fragment of the yeast Sic1p enabled the engineered 
protein to mediate repression in tethering assays and to interact with the CCR4-
CAF1-NOT complex.  
The crucial role of W-motifs in miRNA-mediated silencing is further supported by 
the finding of Fabian et al., (2011) who demonstrated that the interaction between 
TNRC6C and the CCR4-CAF1-NOT complex is mediated via two conserved 
tryptophan-containing motifs that were also found to be important for promoting 
deadenylation of targeted mRNA. Furthermore, substitution of all tryptophan residues 
in the C. elegans GW182 protein AIN-1 abrogated its interaction with CeALG-1, 
CeNOT1, CeNOT2, and CePAN3 (Kuzuoglu-Ozturk et al., 2012).  
 
How do the W-motifs promote the interaction with the CCR4-CAF1-NOT complex? 
The involvement of multiple hydrophobic tryptophan residues is reminiscent of 
previously reported examples of protein-protein interactions. For example, the 
interaction between the spliceosomal component SF3b155 with the large subunit of 
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the U2 small nuclear RNA auxiliary factor (U2AF65) is mediated via multiple motifs 
containing an essential tryptophan. Similarly to GW182 proteins, the tryptophan 
containing motifs are located in an unstructured region of SF3b155 (Thickman et al., 
2006). Another example are the (FG)-nucleoporines which are characterized by 
unfolded domains with extensive repeats of phenylalanine-glycine (FG) repeats and 
act as a selectively permeable barrier in nuclear pore complexes (Walde and 
Kehlenbach, 2010). Importantly, structural studies revealed that the FG repeats 
directly can bind to multiple hydrophobic FG-binding sites formed by -helices of 
HEAT repeats in nuclear transport receptors (Bayliss et al., 2000; Terry and Wente, 
2009). It will be interesting to determine whether a similar structural principle applies 
to the interaction between GW182 and deadenylase complexes. 
 
Based on the observations that first, GW182 proteins interact with the poly(A)-
binding protein (Fabian et al., 2009; Zekri et al., 2009) and second, that CCR4-CAF1-
NOT complex components are co-precipitated with the poly(A)-binding protein (Zekri 
et al., 2009), it has been suggested that PABP might act as an adaptor protein 
allowing GW182 to recruit the CCR4-CAF1-NOT deadenylase complex to the mRNA 
to induce miRNA-mediated deadenylation (Zekri et al., 2009). Our data indicate that 
GW182 proteins can recruit the CCR4-CAF1-NOT deadenylase complex in a PABP-
independent manner. First, deletion or mutation of the PAM2 motif which abrogates 
the interaction of the C-terminal domain of human TNRC6C with PABP, did not affect 
the interaction of the CED with the deadenylase complex components. Second, the 
CED containing 7 tryptophan to alanine mutations still interacted with PABP but not 
with the CCR4-CAF1-NOT complex components. Similarly, the interaction between 
TNRC6C and PABP was unaffected by the deletion of the M2 and Cterm regions of 
TNRC6C, whereas these deletions significantly reduced the interaction between 
TNRC6C and the CCR4-CAF1-NOT complex components. Third, an N-terminal 
fragment of DmGW182 (amino acids 1-490) and the Sic1p fragment containing 
tryptophan residues interacted with CCR4-CAF1-NOT complex components but not 
with PABP.  
It is likely that the interaction between GW182 proteins and the CCR4-CAF1-NOT 
complex is mediated via the CNOT1 protein, as a fragment of human CNOT1 but not 
CNOT7/CAF1 or CNOT6/CCR4 interacted with the CED in a yeast two-hybrid assay. 
Furthermore, depletion of CNOT1 in HEK293 cells strongly reduced the interaction 
between TNRC6C and CNOT2, CNOT6/CCR4, or CNOT7/CAF1 (Braun et al., 2011). 
In addition, in HeLa cells depleted of CNOT1, the C-terminal region of TNRC6C 
failed to interact with components of the CCR4-CAF1-NOT complex (Fabian, 2011). 
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Finally, in a pull-down assay with recombinant proteins expressed in E. coli, a GST 
fusion of the C-terminal domain of TNRC6B interacted with CNOT1 in vitro (Braun et 
al., 2011) and the recombinant silencing domain of TNRC6C expressed in E. coli 
interacted with human CNOT1 produced in insect SF9 cells (Fabian, 2011).  
 
3.3 The role of the poly(A) tail in silencing 
mediated by the CED and components of the 
CCR4-CAF1-NOT complex 
 
MiRNAs regulate gene expression through translational repression and mRNA 
deadenylation and degradation. However, the relative contribution of these effects is 
unclear. Whereas some studies reported mRNA decay as a predominant effect 
(Baek et al., 2008; Bagga et al., 2005; Guo et al., 2010; Lim et al., 2005) other 
studies show translational repression without accompanying mRNA decay (Lee et al., 
1993; Mathonnet et al., 2007; Olsen and Ambros, 1999; Pillai et al., 2005; Thermann 
and Hentze, 2007). 
Our data suggest, that the C-terminal region of TNRC6C can mediate all the 
effects attributed to miRNAs: translational repression, deadenylation, and mRNA 
decay. In tethering assays the CED reduced the reporter mRNA level maximally five 
times but reduced the reporter protein level 10 times, indicating that part of the 
repression is due to inhibition of translation. Examination of the poly(A) tail status 
revealed that the reporter mRNA that escaped degradation by tethered TNRC6C or 
tethered CED was not deadenylated, indicating that translational repression of the 
reporter is not due to removal of the poly(A) tail but rather results from a more direct 
interference with the translation process. In line with this idea, the following evidence 
indicates that the C-terminal regions of GW182 proteins are able to repress not only 
polyadenylated but also poly(A)-free mRNAs. First, the CEDs of human TNRC6C 
and DmGW182 were able to repress mRNAs in which the polyadenylation signal is 
substituted by a histone stem-loop (HSL) or a hammerhead ribozyme (HhR). Second, 
the CED of human TNRC6C repressed in vitro transcribed poly(A) tail-free mRNAs 
that were transfected into HEK293 cells. It is unlikely that these in vitro transcripts 
were repressed only upon their polyadenylation in cells, as incorporation of a 
cordycepin residue at the 3` end of the in vitro transcripts (cordycepin lacks the 
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ribose 3` OH group that would be required for the extension of the RNA with 
additional nucleotides) did not reduce repression induced by the tethered CED. 
Further, our data indicate that the repression of poly(A)-free mRNAs by GW182 
proteins is mediated via the CCR4-CAF1-NOT deadenylase complex. First, we 
observed that the W-motifs, which are essential for the CED - CCR4-CAF1-NOT 
complex interaction, are also required for the repression of poly(A)-free mRNAs by 
the tethered CEDs of human TNRC6C and DmGW182 (data for human TNRC6C are 
not shown). Second, tethering of CCR4-CAF1-NOT complex components in HEK293 
or S2 cells repressed not only polyadenylated but also poly(A)-free mRNAs and the 
RNA levels of poly(A)-free mRNAs were either not affected at all or only slightly 
reduced, indicating that the major part of the repression was due to inhibition of 
translation. Third, repression of poly(A)-free mRNAs in Drosophila S2 cells by 
tethered DmGW182 or its CED depended on NOT1 but repression by tethered CAF1 
or CNOT1 was not affected by the depletion of GW182, indicating that NOT1 acts 
downstream of GW182 in the repression of poly(A)-free mRNAs. 
The ability of the CCR4-CAF1-NOT deadenylase complex to mediate 
translational repression is corroborated by the findings of Cooke et al., (2010) who 
demonstrated that tethered CAF1 can repress translation of microinjected mRNAs at 
the step of initiation in Xenopus laevis oocytes. Confirming our observations, an 
involvement of NOT1 in DmGW182-mediated repression of a poly(A)-free reporter 
mRNA, was also observed by Braun et al., (2011). 
Collectively, these data indicate that recruitment of the CCR4-CAF1-NOT 
complex via tryptophan-containing motifs in GW182 proteins can induce both 
translational repression and deadenylation of mRNAs targeted by miRNAs.  
 
3.4 Discussion of our data and the current 
literature addressing the mechanism of miRNA-
mediated gene silencing 
 
Our findings revealing the GW182-mediated recruitment of PABP and deadenylase 
complexes are in accordance with previous studies indicating that mRNA 
degradation is a widespread effect of miRNA regulation as well as studies 
demonstrating a role of mRNA decay factors in miRNA-mediated repression 
(reviewed in Fabian et al., (2010) and Huntzinger and Izaurralde, (2011)). Importantly, 
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our findings indicate that miRNA-mediated deadenylation may be at least partially a 
direct effect of miRNA regulation (due to the recruitment of deadenylase complexes 
by GW182) and not merely a consequence of a translational block. This idea is 
consistent with data showing that even mRNAs with an artificial Appp-cap structure 
that impairs translation undergo miRNA-mediated deadenylation (Fabian et al., 2009; 
Mishima et al., 2006; Wakiyama et al., 2007). Collectively, these data support the 
notion that mRNA deadenylation and decay are an important component of miRNA-
mediated gene silencing (Djuranovic et al., 2011; Huntzinger and Izaurralde, 2011). 
The evidence that deadenylation is a widespread effect of miRNA regulation raises 
the question whether deadenylation alone could account for translational repression 
of target mRNAs. This scenario is unlikely as we observed that tethering GW182 or 
its C-terminal domain as well as tethering of the deadenylase complex components 
can also repress reporter mRNAs lacking a poly(A) tail. Our observations are 
consistent with data of others demonstrating the ability of GW182 and miRNAs to 
repress poly(A) tail-free mRNAs (Braun et al., 2011; Eulalio et al., 2008b; Eulalio et 
al., 2007c; Wu et al., 2006). Furthermore, reporter mRNAs refractory to 
deadenylation were still found to be repressed by miRNAs (Fukaya and Tomari, 2011; 
Mishima et al., 2012) and kinetic analyses of miRNA-mediated silencing revealed 
that translational repression preceds detectable deadenylation (Bazzini et al., 2012; 
Djuranovic et al., 2012; Fabian et al., 2009; Zdanowicz et al., 2009)(Béthune et al., 
2012). Collectively, these data indicate that besides deadenylation an additional 
mechanism of translational repression is operating during miRNA-mediated 
repression and that the CCR4-CAF1-NOT complex is involved in this process. 
What do we know about this mechanism of translational repression? Although we 
have not performed more detailed experiments addressing this question ourselves, 
Cooke et al., (2010) reported that CAF1, a component of the CCR4-CAF1-NOT 
complex, represses translation in a m7G cap dependent manner in Xenopus laevis 
oocytes. This finding is reminiscent of studies suggesting that miRNAs inhibit 
translation initiation and studies that reported a importance of the m7G cap structure 
in repression (Bhattacharyya et al., 2006; Ding and Grosshans, 2009; Mathonnet et 
al., 2007; Pillai et al., 2005; Thermann and Hentze, 2007; Zdanowicz et al., 2009). 
Therefore, it is intriguing to speculate that the CCR4-CAF1-NOT deadenylase 
complex contributes to the repression of translation initiation in a m7G cap dependent 
manner during miRNA-mediated gene silencing. Interestingly, the CCR4-CAF1-NOT 
complex is known to interact with the decapping activator and translational repressor 
Dhh1/Me31b in yeast and Drosophila (Coller et al., 2001; Temme et al., 2010) and 
indeed, orthologs of Dhh1 have been reported to be required for miRNA-mediated 
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repression in other organisms (Chu and Rana, 2006; Eulalio et al., 2007c). Thus, 
these data suggest a possible mechanism by which the CCR4-CAF1-NOT complex 
may repress translation. 
 
What could be the role of the interaction between GW182 and PABP in miRNA-
mediated gene silencing? Interestingly, in a tethering assay in zebrafish embryos it 
was observed that the PAM2 motif contributed to translational repression of a 
reporter that is refractory to deadenylation. Because the contribution was no longer 
observed in the presence of excess PAIP2, a protein that was shown to displace 
PABP from the poly(A) tail and eIF4G (Sonenberg and Dever, 2003), the authors 
concluded that the PAM2 motif contributes to translational repression by 
counteracting the function of PABP in translation (Mishima et al., 2012). PABP is 
thought to function in translation by binding to eIF4G and thereby promoting the 
formation of an mRNA closed loop. Indeed, one attractive model of miRNA action 
states that GW182 competes with eIF4G for binding to PABP and thereby GW182 
can interfere with the formation of an mRNA closed loop (which is thought to 
stimulate mRNA translation). Supporting this model, cell extract containing 
overexpressed GW182 silencing domain can compete away eIF4G from PABP (Zekri 
et al., 2009). Further evidence which may support this model is provided by the 
observations that adding a fragment of eIF4G that binds PABP blocks miRNA-
mediated deadenylation in vitro (Fabian et al., 2009) and that overexpression of 
PABP in HEK293T cells reduced miRNA-mediated repression (Walters et al., 2010). 
It is not known whether and how the binding of the PAM2 region to the C-terminal 
MLLE domain of PABP can influence the interaction of eIF4G with the N-terminal 
RRMs of PABP. An alternative but not mutually exclusive model states that, similarly 
as described for PAIP2 (Derry et al., 2006), the interaction between GW182 and 
PABP could reduce the affinity of PABP for the poly(A) tail which would expose the 
poly(A) tail to deadenylases and interfere with mRNA circularization (Huntzinger and 
Izaurralde, 2011). Indeed, a GW182 silencing domain fragment unable to bind PABP 
failed to induce processive deadenylation (Fabian, 2011). Rather, the deadenylation 
process was blocked along the poly(A) tail at increments of approximately 27 
nucleotides, which is the number of adenosines bound by a single PABP molecule, 
arguing that the GW182 silencing domain displaces PABP from the poly(A) tail to 
allow for processive deadenylation (Fabian, 2011). Another idea about the role of the 
GW182-PABP interaction states that this interaction may juxtapose the PABP-
associated poly(A) tail with the miRISC associated deadenylase complex to facilitate 
initiation of the deadenylation reaction (Fabian et al., 2009; Fabian et al., 2010). 
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In summary, our data and evidence published by others put forth the following 
model of miRNA-mediated gene silencing. GW182 acts as key repressor mediating 
miRNA-induced silencing by interacting with PABP via its PAM2 motif and by 
recruiting the PAN2-PAN3 and CCR4-CAF1-NOT deadenylase complexes via 
tryptophan-containing motifs. Both, the contact to PABP and the recruitment of the 
CCR4-CAF1-NOT complex mediate translational repression and facilitate 
deadenylation of target mRNAs.  
 
Although this model is in accordance with the majority of published data about the 
mechanism of miRNA-mediated gene silencing - not surprisingly - it cannot explain 
all reported observations. For example, this model does not predict any regulatory 
events of translation at post-initiation steps. 
It is important to note that our own data described in this thesis are the result of 
experiments with only two cell types: cultured mammalian HEK293 cells and 
Drosophila S2 cells. Similarly, the current view of miRNA regulation is based on 
studies in a limited set of cell types typically cultured in vitro (Fabian et al., 2010; 
Huntzinger and Izaurralde, 2011). Therefore, it will be interesting to investigate the 
mechanism of miRNA-mediated silencing in a more diverse set of cell types in their 
physiological context to learn whether miRNAs function in a cell- and/or 
development-dependent manner. For example, it has been suggested that in oocytes 
and embryonic or neuronal cells in which deadenylated mRNAs are often stable, 
miRNA targets may accumulate in a deadenylated, translationally silent form and 
eventually be translated again after being readenylated (Huntzinger and Izaurralde, 
2011).  
It will also be interesting to more comprehensively learn whether and how the 
mechanism of miRNA-mediated silencing is influenced in a target specific manner. It 
is well established, that the extent of miRNA-mediated repression can be influenced 
by miRISC- or mRNA-associating proteins (Bhattacharyya et al., 2006; Hammell et 
al., 2009; Kedde et al., 2007; Takeda et al., 2009). Moreover, evidence suggests that 
the mode of miRNA-mediated repression is influenced in a target specific manner 
(Eulalio et al., 2008a). Repression of some reporter miRNA targets in Drosophila S2 
cells could be entirely accounted for by mRNA degradation whereas others were 
mainly silenced by translational repression or by a more equal contribution of both 
processes (Behm-Ansmant et al., 2006; Eulalio et al., 2009b; Eulalio et al., 2007c). 
To explain these differences it has been suggested that the mode of miRNA-
mediated repression depends on specific features of the miRNA binding site and on 
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the specific complement of proteins associated with a given target mRNA (Eulalio et 
al., 2008a). 
Investigation of these and many more aspects will define a more comprehensive 
mechanistic picture of miRNA-mediated gene silencing. 
Materials and Methods 
4. Materials and Methods 
 
Most methodologies and materials used in this study have been described in the 
corresponding sections in the attached paper published in Nature Structural & 
Molecular Biology (Chekulaeva et al., 2011) and in the published papers attached as 
Appendices A (Zipprich et al., 2009) and B (Fabian et al., 2009). 
 
In the following section I describe materials and methods used in experiments that 
are part of this study but have not yet been published. 
 
4.1 DNA constructs 
 
Plasmids encoding the fragments of CNOT1 used for tethering and pull-down assays 
were generated by PCR-amplification of the corresponding fragments of the plasmid 
NHA-CNOT1 (Chekulaeva et al., 2011) and cloning into pCI-neo vector bearing a 
NHA-tag (Pillai et al., 2004). 
 
4.2 Tethering assays with NHA-tagged CNOT1 
and fragments thereof 
 
Transfection of human HEK293T cells were done in 6-well plates with Nanofectin 
(PAA Laboratories) according to the manufacturers instructions. In tethering 
experiments, cells were transfected with 50 ng RL-5BoxB (Pillai et al., 2004), 300 ng 
FL-Con (Pillai et al., 2004) and 400 ng HA- or NHA-fusion constructs per well. Cells 
were lysed 24 hours post-transfection and luciferase activities were measured with 
the Dual-Luciferase Reporter Assay System (Promega). 
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4.3 Pull-down assays 
 
Pull-down assays with GST-tagged CED or CEDPAM2 and NHA-tagged CNOT1 
and fragments thereof were performed as described previously (Chekulaeva et al., 
2011). 
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Importance of the C-terminal domain of the human
GW182 protein TNRC6C for translational repression
JAKOB T. ZIPPRICH, SANKAR BHATTACHARYYA, HANSRUEDI MATHYS, and WITOLD FILIPOWICZ
Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland
ABSTRACT
Proteins of the GW182 family play an important role in the execution of microRNA repression in metazoa. They interact
directly with Argonaute proteins, components of microRNPs, and also form part of P-bodies, structures implicated in
translational repression and mRNA degradation. Recent results demonstrated that Drosophila GW182 has the potential to both
repress translation and accelerate mRNA deadenylation and decay. In contrast to a single GW182 protein in Drosophila, the
three GW182 paralogs TNRC6A, TNRC6B, and TNRC6C are encoded in mammalian genomes. In this study, we provide
evidence that TNRC6C, like TNRC6A and TNRC6B, is important for efficient miRNA repression. We further demonstrate that
tethering of each of the human TNRC6 proteins to a reporter mRNA has a dramatic inhibitory effect on protein synthesis. The
repression is due to a combination of effects on the mRNA level and mRNA translation. Through deletion and mutagenesis, we
identified the C-terminal part of TNRC6C encompassing the RRM RNA-binding motif as a key effector domain mediating protein
synthesis repression by TNRC6C.
Keywords: GW182; miRNA; RNA stability; translation; polyadenylation
INTRODUCTION
MicroRNAs (miRNAs) are 20- to 22-nucleotide (nt)-long non-
coding RNAs regulating gene expression post-transcriptionally
by base-pairing to target mRNAs. In animals, most inves-
tigated miRNAs form imperfect hybrids with sequences in
the 39-untranslated region (39-UTR), with the miRNA 59-
proximal ‘‘seed’’ region (positions 2–8) providing most of
the pairing specificity (for review, see Bartel 2004; Bushati
and Cohen 2007; Filipowicz et al. 2008). Generally, the
miRNA association results in translational repression, fre-
quently accompanied by considerable degradation of mRNA
(Nilsen 2007; Standart and Jackson 2007; Eulalio et al. 2008a;
Filipowicz et al. 2008; Wu and Belasco 2008). More recently,
however, miRNAs were also found to have the potential to
activate translation (Vasudevan et al. 2007, 2008; Orom et al.
2008). For example, in nonproliferating cells or cells in the
G0 cell cycle phase, miRNAs were reported to stimulate
rather than inhibit protein synthesis (Vasudevan et al. 2007,
2008).
miRNAs function as components of ribonucleoprotein
(RNP) complexes, miRNPs. The best-characterized con-
stituents of miRNPs are proteins of the Argonaute (AGO)
family. Their function in miRNA-mediated repression is
well documented in many organisms (Peters and Meister
2007; Tolia and Joshua-Tor 2007). Mammals contain four
AGO proteins, AGO1-4, associating with similar sets of
miRNAs and participating in translational repression (Liu
et al. 2004; Meister et al. 2004). In Drosophila, Ago1 is
dedicated to the miRNA pathway while Ago2 mainly
functions in RNA interference (RNAi) (Peters and Meister
2007; Tolia and Joshua-Tor 2007). The Ago proteins
repress protein synthesis when artificially tethered to the
mRNA 39-UTR, indicating that they function as down-
stream effectors in the repression, with miRNAs mainly
acting as guides bringing the proteins to mRNA targets
(Pillai et al. 2004, 2005; Rehwinkel et al. 2005; Wu et al. 2008).
Argonautes are not the only proteins required for
the miRNA-mediated repression. Several components of
P-bodies (known also as GW-bodies), which are cytoplasmic
structures involved in the degradation and storage of trans-
lationally repressed mRNAs (Eulalio et al. 2007a; Parker and
Sheth 2007), also function in the miRNA pathway and,
consistently, repressed mRNAs, miRNAs, and Ago proteins
are enriched in P-bodies (Liu et al. 2005; Pillai et al. 2005; Sen
and Blau 2005; Huang et al. 2007; for review, see Jakymiw
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et al. 2007; Eulalio et al. 2008a; Filipowicz et al. 2008). Of the
P-body components, proteins of the GW182 family play a
particularly important role in the execution of miRNA
repression. GW182 proteins, characterized by the presence
of multiple Gly-Trp (GW) repeats (Eystathioy et al. 2002;
Ding et al. 2005; Rehwinkel et al. 2005; Schneider et al. 2006),
interact with Argonautes through their GW-rich domain
(Behm-Ansmant et al. 2006; Till et al. 2007; Eulalio et al.
2008b). Recent work carried out in the Drosophila system
demonstrated that this interaction is essential for the
repression (Till et al. 2007; Eulalio et al. 2008b). Importantly,
tethering of GW182 to the mRNA bypassed the Ago1
requirement for repression in Drosophila cells, demonstrat-
ing that GW182 functions in the same pathway but down-
stream from Ago1 (Behm-Ansmant et al. 2006).
Despite a considerable research effort, the mechanistic
details of miRNA function in repressing protein synthesis
are still poorly understood. Moreover, the results from
studies conducted in different systems and different labo-
ratories have often been contradictory, making it difficult
to obtain a lucid picture of the repression (Nilsen 2007;
Standart and Jackson 2007; Eulalio et al. 2008a; Filipowicz
et al. 2008; Wu and Belasco 2008). Although many experi-
ments investigating miRNA function in metazoan cells or
in vitro point to the initiation of translation as a target of
miRNA repression (Humphreys et al. 2005; Pillai et al.
2005; Bhattacharyya et al. 2006; Chendrimada et al. 2007;
Kiriakidou et al. 2007; Mathonnet et al. 2007; Wakiyama
et al. 2007), there is also considerable evidence that
miRNAs inhibit translation at post-initiation steps (Olsen
and Ambros 1999; Maroney et al. 2006; Nottrott et al. 2006;
Petersen et al. 2006; Lytle et al. 2007). Although reports
aimed at the reconciliation of some conflicting data have
appeared recently (Kong et al. 2008), the question of
whether the disparities represent artifacts of different
experimental approaches or whether miRNAs are indeed
able to repress protein synthesis by different mechanisms
remains one of the key problems to be resolved (Nilsen
2007; Eulalio et al. 2008a; Filipowicz et al. 2008).
Another important and unanswered issue is the relative
contribution of translational inhibition and mRNA degra-
dation to the final outcome of the repression. Most in-
vestigated mRNAs undergo moderate or substantial deg-
radation, which appears to be initiated by removal of the
poly(A) tail in response to miRNP association with the
mRNA 39-UTR (Bagga et al. 2005; Lim et al. 2005; Wu and
Belasco 2005; Behm-Ansmant et al. 2006; Giraldez et al.
2006; Rehwinkel et al. 2006; Schmitter et al. 2006; Eulalio
et al. 2007b). In Drosophila, the GW182 protein is impli-
cated in the recruitment of deadenylating enzymes to the
mRNA, although the protein also functions in translational
repression independently of its role in deadenylation (Behm-
Ansmant et al. 2006). However, many mRNAs repressed
by miRNAs are resistant to degradation (for a comprehensive
list, see Filipowicz et al. 2008). Which features of mRNA or of
the mRNA–miRNA interaction determine whether repres-
sion follows translational inhibition or mRNA decay? Is the
latter a consequence of translation being repressed, or does it
occur independently of the translational status of the mRNA?
In contrast to the single GW182 protein expressed in
Drosophila, three GW182 paralogs, TNRC6A, TNRC6B, and
TNRC6C,are encoded inmammaliangenomes (for review, see
Ding andHan 2007; Jakymiw et al. 2007). Evidence has already
been presented that the two human proteins TNRC6A and
TNRC6B function in the miRNA pathway and are important
for effective miRNA repression (Jakymiw et al. 2005; Liu et al.
2005; Meister et al. 2005; Till et al. 2007). However, mecha-
nistic details of the repression have not been investigated for
any of the mammalian proteins. In this study, we provide
evidence that TNRC6C, like TNRC6A and TNRC6B, is
essential for efficient miRNA repression and demonstrate that
tethering of each of the human GW182 proteins to reporter
mRNA has a dramatic effect on protein synthesis, with only a
moderate effect on mRNA stability. Finally, we identify the
C-terminal fragment of TNRC6C, encompassing the RNA-
bindingRRMmotif, as a regionmediating the repression. Two
other domains, GW-rich and Q-rich, also repress protein
synthesis upon tethering, but their effects are much less
pronounced than that of the C-terminal region.
RESULTS
Human GW182 protein TNRC6C is involved
in miRNA-mediated repression
The three GW182 protein paralogs encoded in mammalian
genomes, TNRC6A, TNRC6B, and TNRC6C, have a domain
organization similar to Drosophila GW182 (also known as
Gawky). At the N-proximal part, they contain a domain rich
in GW or WG repeats followed by a glutamine (Q)-rich
region of unknown function, hereafter referred to as DUF,
and an RNA-binding domain, RRM. TheDrosophilaGW182
and mammalian TNRC6C also contain a central ubiquitin-
associated (UBA) domain (Fig. 1A; for review, see Ding and
Han 2007). Two homologs of GW182 proteins, AIN-1 and
AIN-2, were characterized in Caenorhabditis elegans. While
AIN-1 and AIN-2 both contain GW- and Q-rich sequences,
they lack other domains present in mammalian proteins
(Ding et al. 2005; Zhang et al. 2007). Interestingly, through
database searches, we have identified a likely homolog of
TNRC6 and AIN proteins in the nematode Brugia malayi. In
addition to GW-containing and Q-rich sequences, this pro-
tein includes aDUFdomain (Fig. 1A,B). Hence, theB.malayi
protein likely represents an evolutionary link between
TNRC6 and AIN proteins.
The TNRC6A and TNRC6B proteins were demonstrated
previously to play a role in the miRNA pathway in
mammalian cells (Jakymiw et al. 2005; Liu et al. 2005;
Meister et al. 2005), but the expression and function of
TNRC6C have not been investigated. We raised polyclonal
Zipprich et al.
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antibodies (Abs) against peptides with sequence present in
TNRC6C but not two other mammalian GW182 proteins. In
Western analysis, the affinity-purified Ab recognized a pro-
tein of the expected size in lysates prepared from HEK293
and HeLa cells. The intensity of the recognized band was
weaker in lysates of cells in which TNRC6C was knocked
down by RNAi (Fig. 2A, lanes 7–10). Overexpression of the
HA-tagged version of the protein further confirmed that the
visualized band corresponds to TNRC6C (lane 6). The Ab
did not recognize overexpressed TNRC6A and TNRC6B
(Fig. 2A, lanes 4,5), consistent with it being specific for
TNRC6C. RT-PCR analysis with primers specific for indi-
vidual GW182 genes revealed that all three TNRC6 genes are
expressed in both HEK293 and HeLa cells (data not shown).
To find out whether TNRC6C, like TNRC6A and
TNRC6B (Jakymiw et al. 2005; Liu et al. 2005; Meister
et al. 2005), is required for miRNA-mediated repression, we
knocked it down using RNAi. As controls, TNRC6A and
TNRC6B were also individually depleted using gene-specific
siRNAs. The efficacy of the knockdowns was monitored by
following the levels of either ectopically expressed HA-
tagged TNRC6 proteins (Fig. 2B) or the endogenous
TNRC6C (Fig. 2A). For siRNAs directed
at TNRC6B and TNRC6C, we verified
that their effects were target-specific
(data not shown). As illustrated in Figure
2C, down-regulation of each TNRC6
protein partially rescued repression of
the Renilla luciferase (RL) reporter,
RL-3xBulgeB. RL-3xBulgeB harbors in
its 39-UTR three sites specific for let-7b
miRNA (Pillai et al. 2005; Schmitter et al.
2006), which is abundantly expressed in
HeLa cells. We conclude that TNRC6C
plays a role similar to those of TNRC6A
and TNRC6B, although the observation
that knockdown of each individual pro-
tein had a marked effect on miRNA
repression leaves open the possibility
that the functions of individual TNRC6
paralogs in mediating miRNA-mediated
inhibition do not entirely overlap.
Tethering of TNRC6 proteins
to mRNA causes repression
of protein synthesis
We used a tethering approach to inves-
tigate the effect of individual mamma-
lian TNRC6 paralogs on protein
synthesis. In this assay, which was used
successfully to study functions of AGO
proteins (Pillai et al. 2004; Rehwinkel
et al. 2005; Kiriakidou et al. 2007; Wu
et al. 2008) and the Drosophila GW182
(dGW182) (Behm-Ansmant et al. 2006), the proteins are
expressed as fusions with the HA-tag and the phage l N-
peptide, which specifically recognizes box B hairpins
inserted into the 39-UTR of RL-5BoxB reporter. The RL
expression was normalized to the activity of firefly lucifer-
ase (FL) expressed from the co-transfected plasmid bearing
no 5BoxB hairpins (FL-Con). As shown in Figure 3,
expression of the NHA version of each of the three TNRC6
proteins strongly repressed activity of the RL-5BoxB
reporter when compared to control TNRC6 proteins
containing the HA-tag but lacking the N peptide. Tethering
of NHA-LacZ, used as another control, yielded RL activity
similar to that measured in the presence of HA-TNRC6C
(see also Figs. 6A and 8, below; data not shown). Together
with Western analysis, which revealed similar expression
levels of NHA- and HA-tagged proteins (Fig. 3A), the data
demonstrate that the repression of protein synthesis is a
result of the TNRC6 proteins tethering to mRNA.
To find out whether the tethered TNRC6 proteins repress
RL activity by inhibiting translation or destabilizing the
mRNA, we quantified RL-5BoxB mRNA levels and, as a
reference, the levels of GFP mRNA coexpressed in transfected
FIGURE 1. Domain structure of selected GW-182-like proteins. (A) Schematic representation
of human (Hs) TNRC6A, TNRC6B, and TNRC6C proteins, the Drosophila (Dm) GW182
(dGW182), C. elegans (Ce) AIN-1 and AIN-2, and a candidate GW182 ortholog of Brugia
malayi (Bm). Positions of GW-rich, Q-rich, UBA (ubiquitin-associated), DUF (domain of
unknown function), and RRM domains are indicated. The percentage of amino acid identity
between highlighted regions of Drosophila, C. elegans, and B. malayi proteins is indicated. (B)
Amino acid alignments of DUF domains of selected GW proteins. Positions of amino acids
that have been mutated to alanines, either singly (T1410) or in the combination of two
(EF1388/1389 and WK1395/1396), are indicated. (Blue) Amino acids identical in more than
50% of proteins; (green) conservative substitutions by related amino acids.
Human GW182 proteins and translational repression
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cells. Comparison of RL activity (Fig. 3A) and Northern blot
data (Fig. 3B) revealed that tethering of TNRC6 proteins to
RL-5BoxB mRNA had a much stronger effect on protein
expression (10- to 20-fold) than on mRNA levels (approxi-
mately threefold), indicating that all three TNRC6 proteins
not only trigger marked mRNA destabilization but also
directly affect the translation process itself.
Identification of repressive domains of TNRC6C
by deletion analysis
To gain insight into the mechanism of TNRC6C-mediated
repression, we generated a collection of deletion mutants of
the protein and tested their effects on protein synthesis using
the tethering assay. Progressive deletions from the N
terminus of the protein (Fig. 4A) revealed that a fragment
bearing only the C-proximal domains DUF and RRM
(mutant DN1370) retained the potential to inhibit RL
activity upon tethering to mRNA (Fig. 4B). Quantification
of the data derived from many experiments in which effects
of NHA-TNRC6C and NHA-DN1370 were compared indi-
cated that repression by NHA-DN1370 was actually stronger
than that by a full-length NHA-TNRC6C (for significance of
the difference, see Fig. 5C and its legend), raising a possibility
that the N-terminal portion of TNRC6C may modulate
inhibitory activity of the C-terminal DN1370. Further
truncation of NHA-DN1370, leading to the removal of
DUF (mutant DN1471), decreased the repressive activity,
but this mutant still inhibited protein synthesis approxi-
mately fourfold compared with the more than 10-fold
repression seen with DN1370 (Fig. 4B). In the analysis of
mutants with progressive N-terminal deletions and of most
of the other mutants described below, care was taken to
assess mutant proteins expressed at similar levels (Fig. 4B).
This sometimes required the adjustment of amounts of
mutant-encoding plasmids transfected into cells (see Mate-
rials and Methods). However, within the range of plasmid
concentrations used for transfections, the extent of repres-
sion caused by individual mutants was generally indepen-
dent of the amount of transfected plasmid.
In a further set of mutants, progressive deletions were
carried out from the C terminus (Fig. 4A). As expected,
deletion of the C-terminal portion of TNRC6C containing
the DUF and RRM domains strongly affected the repressive
potential of the protein. Interestingly, analysis of other
mutants revealed that the N-terminal half of the GW-rich
domain (Fig. 4A, mutant 1–405) and a fragment encom-
passing the entire GW-rich domain and the UBA domain
(Fig. 4A, mutant 1–1034) each had some repressive activity:
their tethering inhibited protein synthesis z40% (Fig. 4C).
Tethering of the Q-rich domain alone (Fig. 4A, mutant
1080–1245) also caused an z65% repression of RL activity.
The repressive activity of a fragment encompassing both
the GW- and Q-rich domains (Fig. 4A, mutant 1–1368)
was not stronger than the individual domains alone.
The integrity of the DN1370 fragment is important
for effective repression
Since deletion analysis revealed that the C-terminal frag-
ment of TNRC6C (Fig. 5C, mutant DN1370) repressed
FIGURE 2. Expression of TNRC6C protein in HEK293 and HeLa cells
and its importance for effective miRNA-mediated repression. (A) Anti-
TNRC6C Abs specifically recognize endogenous TNRC6C in HEK293
and HeLa cell extracts and do not cross-react with overexpressed
TNRC6A and TNRC6B proteins. (Lanes 1–6) Extracts prepared from
HEK293 cells overexpressing indicated HA-TNRC6 proteins; (lanes 7–
10) extracts of HEK293 or HeLa cells transfected with either control or
anti-TNRC6 siRNAs. Abs used for Western analysis and positions of
protein size markers are indicated. (*) Non-specific proteins cross-
reacting with anti-TNRC6C Ab. Note that overexpression of TNRC6A
or TNRC6B proteins slightly decreases the level of endogenous
HTNRC6C (cf. lanes 4,5 and lane 7). (B) Knockdown of individual
TNRC6 proteins by specific siRNAs. Cells were cotransfected with
constructs expressing indicated NHA-tagged TNRC6 proteins and
either gene-specific or control siRNAs. One siRNA was used in the
case of TNRC6A, and mixtures of two in the case of TNRC6B and
TNRC6C (Materials and Methods). Anti-HA Ab was used for Western
blot analysis. (C) TNRC6C, similarly to TNRC6A and TNRC6B, is
required for efficient repression of RL-3xBulgeB reporter by endoge-
nous let-7 in HeLa cells. Down-regulation of each protein partially
rescues repression of RL-3xBulgeB. RL-3xBulgeBmut, containing
mutations in the seed sequence of the let-7 binding that prevent the
repression (Pillai et al. 2005; Schmitter et al. 2006), was used as a
control reporter. SiRNAs used for knockdowns are indicated. The data
represent means from three independent experiments.
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protein synthesis even more effectively than the full-length
protein, we focused our attention on this region. Repressive
activity of GW- and Q-rich domains was relatively small
and was not further investigated. The integrity of the
DN1370 fragment appeared to be important since deletion
of either the N-proximal DUF domain or 80 C-terminal
amino acids resulted in a significant decrease of the
repression. In addition, isolated RRM domain (Fig. 5C,
fragment NHA-1505–1610) was devoid of repressive poten-
tial (Fig. 5C, left part).
RNP1 and RNP2 motifs present in the RRM domains of
many characterized RNA-binding proteins contain aro-
matic residues involved in stacking interactions with RNA
ligands (Clery et al. 2008). Similarly, the RRM domains of
GW182 proteins contain several conserved aromatic amino
acids, both within and outside of RNP1 and RNP2 motifs
(Fig. 5B). Residues W1515, H1537, F1543, Y1556, and
F1583 were individually mutated to alanine in the context
of the DN1370 fragment. In another mutant, residues
H1537 and Y1556 were simultaneously replaced with
alanine. Several of the RRM mutants had a significantly
lower activity in repressing protein synthesis than the wild-
type DN1370 fragment (Fig. 5C, right part).
We also generated single or double amino acid muta-
tions in some conserved residues of the DUF domain (for
the identities of the mutated amino acids, see Fig. 1B).
However, these mutations had no appreciable effect on the
ability of the DN1370 fragment to
repress protein synthesis in the tether-
ing assay (data not shown).
The DN1370 fragment acts mainly
as a translational repressor
To find out whether the DN1370 frag-
ment acts similarly to the full-length
TNRC6C and affects both mRNA trans-
lation and stability, we examined the
level of RL-5BoxB reporter repressed by
tethering of the DN1370 fragment or its
RRM domain mutants. Comparison of
Northern blotting and RL activity data
originating from the same transfection
experiments indicated that tethering of
DN1370 results in an approximately two-
fold decrease in mRNA level under con-
ditions leading to an approximately 20-
fold drop in RL activity (Fig. 6A). Hence,
the inhibitory effect of DN1370 on RL
expression is due mainly to repression of
translation. After correction for differ-
ences inmRNA levels, the net effect of the
tethering of DN1370 on translation was
10-fold (Fig. 6A). Tethering of the two
tested DN1370 RRM domain mutants
also decreased the RL-5BoxBmRNA level twofold but did not
inhibit protein synthesis as much as the wild-type DN1370.
The net effect of the F1543A and H1537A/Y1556A mutants
on translation was only approximately 2.5-fold, compared
with the 10-fold effect ofDN1370 (Fig. 6A). This suggests that
the RRM domain functions in translational repression rather
than in mRNA destabilization.
We investigated whether the repressive effect on trans-
lation seen upon tethering of TNRC6C and its DN1370
deletion mutants could be due to mRNA deadenylation.
Total RNA isolated from cells transfected with vectors
expressing different proteins was subjected to RNase H
treatment in the presence or the absence of oligo(dT).
Incubation in the presence of oligo(dT) should result in
removal of poly(A) from mRNA and, consequently, in its
faster mobility in an agarose gel. Where the mRNA
has been deadenylated already in the cell, no major
difference in its mobility would be expected upon RNase
H digestion. As shown in Figure 6B, control RL-Con RNA
isolated from cells co-transfected with NHA-TNRC6C or
RL-5BoxB RNA isolated from cells co-transfected with HA-
TNRC6C contained poly(A) tracts since their mobility
increased upon oligo(dT) addition. Likewise, the mobility
of b-actin mRNA, analyzed as an additional control,
increased upon removal of poly(A) in vitro. Importantly,
RL-5BoxB RNA preparations isolated from cells transfected
with either NHA-TNRC6C or NHA-DN1370 deletion
FIGURE 3. Tethering of TNRC6 proteins to mRNA causes strong repression of protein
synthesis and partial mRNA degradation. (A) Indicated HA- or NHA-tagged TNRC6 proteins
were coexpressed into HEK293 cells with RL-5BoxB, FL-Con, and (in some transfections) GFP
reporters. (Upper panel) RL expression was normalized to the activity of FL and is shown as the
percentage of activity seen in the presence of HA-TNRC6C. Tethering of NHA-LacZ protein,
frequently used as an additional control (see Figs. 6 and 8), did not repress protein synthesis.
(Lower panel) Representative Western analysis of expressed proteins, performed with anti-HA
Ab. (B) Northern blot analysis of RL-5BoxB and GFP mRNAs levels. (Upper panel)
PhosphorImaging quantification of RL-5BoxB mRNA, normalized to GFP mRNA. (Bottom
panels) Representative Northern blot analysis. Values in A and B are means from three
independent experiments. Values for cells expressing HA-tagged proteins were set to 100%.
Human GW182 proteins and translational repression
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mutants also changed their mobility after incubation with
oligo(dT), consistent with them retaining the poly(A) tail
(Fig. 6B). These data indicate that the inhibitory effect of
tethering TNRC6C or DN1370 on translation is not due to
elimination of a stimulatory role of the poly(A)-binding
protein PABP on translation initiation (Kahvejian et al.
2005) or due to disruption of mRNA ‘‘circularization’’
(Wells et al. 1998) potentially caused by mRNA dead-
enylation.
The DN1370 fragment does not
interact with endogenous AGO
or TNRC6C proteins
We considered the possibility that the
inhibitory effect of DN1370 on protein
synthesis is due to the interaction of this
fragment with endogenous TNRC6 or
AGO proteins. If this were the case, the
inhibition would not be due to the
downstream function of DN1370 in
miRNA-mediated repression but due to
recruitment of the endogenous miRNP
complex to the reporter mRNA. Using
immunoprecipitation (IP) assays, we
first determined whether NHA-DN1370
expressed in HEK293 cells interacts with
endogenous AGO proteins or TNRC6C.
Neither AGO proteins nor TNRC6C
were pulled down with the anti-HA Ab
but, as expected (Behm-Ansmant et al.
2006; Till et al. 2007), the full-length
NHA-TNRC6C and its N-terminal GW-
rich fragment NHA-1–1034 very effec-
tively coimmunoprecipitated the endog-
enous Argonautes (Fig. 7A). Since specific
Abs recognizing TNRC6A and TNRC6B
proteins are not available, we have coex-
pressed HA-tagged versions of these pro-
teins together with either Flag-HA-tagged
DN1370 or Flag-HA-tagged AGO2, the
latter protein used as a control. IP experi-
ments with anti-Flag Abs revealed that
AGO2 but not DN1370 is able to inter-
act with TNRC6A and TNRC6Bproteins
(Fig. 7B). We conclude that the DN1370
fragment functions as an autonomous
repressive domain, the inhibitory effect
of which is not caused by interaction
with Argonautes or full-length TNRC6
proteins.
Cross-species repressive activity of
GW proteins and their mutants
In the accompanying manuscript, Che-
kulaeva et al. (2009) have identified three nonoverlapping
regions of theDrosophilaGW182 (dGW182) protein that are
able to repress protein synthesis effectively (five- to sixfold)
upon tethering to mRNA: the N-terminal GW-rich domain,
the Q-rich domain, and the C-proximal fragment containing
DUF and RRM domains (for a scheme of dGW182, see Fig.
1A). We tested the potential of the full-length dGW182 and
its active subfragments to inhibit the activity of the RL-
5BoxB reporter in HEK293 cells. Tethering of a full-length
FIGURE 4. Characterization of the TNRC6C deletion mutants. (A) Schematic representation
of TNRC6C and its deletion mutants. Mutants with progressive deletions from the (upper part
of scheme) N terminus and (lower part of scheme) C terminus. Numbers correspond to amino
acid positions. (B) The C-terminal domain of TNRC6C is sufficient to effectively repress
protein synthesis when tethered to mRNA. (Upper panel) Repressive activity of TNRC6C and
its N-terminal deletion mutants. HEK293 cells were co-transfected with plasmids expressing
N-HA fusions of TNRC6C or its fragments and plasmids encoding RL-5BoxB and FL
reporters. HA-TNRC6C served as a negative control. Activity of RL was normalized for
expression of FL. Values represent relative RL activities normalized to FL, with translation in
the presence of HA-TNRC6C set as 100%. (Lower panel) Expression levels of HA-TNRC6C
and NHA-TNRC6C and its mutants as assessed by Western blotting using anti-HA Ab.
Positions of protein size markers are indicated. (C) Analysis of progressive deletion mutants
from the C terminus and the 1080–1245 mutant reveals only moderate repressive activity of
GW- and Q-rich domains. Details of experiments are identical to those given in the legend to
Figure 4B. The values in B and C are means (6SEM) from four to 12 independent experiments.
Expression of the Q-rich domain was reproducibly weaker than of other domains.
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NHA-dGW182 repressed RL activity as efficiently as the
mammalian NHA-TNRC6C; expression of HA-dGW182
had no inhibitory effect. Interestingly, the N-terminal GW-
rich domain (mutant 1–605) of dGW182 was the most active
repressor in human cells; its repressive
activity (approximately sevenfold) was
comparable to that seen in Drosophila S2
cells (approximately sixfold). In contrast,
three further dGW182 fragments tested
(Q-rich domain, mutant 605–803, and
two C-terminal fragments encompassing
DUF and RRM domains, mutants 940–
1385 and 940–1215) repressed RL activity
in HEK293 cells only approximately two-
fold (Fig. 8).
In a reciprocal cross-species experi-
ment, different domains of TNRC6C
characterized in this work were tested in
DrosophilaS2 cells. A full-lengthTNRC6C
inhibited activity of the tethering reporter
approximately sixfold, while the GW-rich
(1–1034), Q-rich (1080–1245), and the
C-terminal DN1370 fragment repressed
protein synthesis z1.5-fold, eightfold,
and 20-fold, respectively (Chekulaeva
et al. 2009). Hence, although the full-
length dGW182 and TNRC6C proteins
exerted a similar strong repressive effect
irrespective of whether they were tested in
the homologous or heterologous system,
the contribution of individual domains to
this effect differed between human and
Drosophila proteins and cells (see Discus-
sion).
DISCUSSION
Proteins of the GW182 family play an
important role in the miRNA-mediated
repression in metazoa. They directly
interact with AGO proteins and appear
to function as downstream effectors in
the miRNA pathway, responsible for
inhibition of translation and accelera-
tion of mRNA decay (Jakymiw et al.
2005; Liu et al. 2005; Meister et al. 2005;
Rehwinkel et al. 2005; Behm-Ansmant
et al. 2006; Till et al. 2007; Zhang et al.
2007). In contrast to a single GW182
protein expressed in Drosophila, three
paralogs, TNRC6A, TNRC6B, and
TNRC6C, are encoded in mammalian
genomes but little is known about their
functions. In this study, we provide
evidence that TNRC6C, like TNRC6A
and TNRC6B studied previously, is expressed in HEK293
and HeLa cells and is essential for the efficient repression of
a target mRNA reporter by endogenous let-7 miRNP. More
important, we demonstrate that tethering of each human
FIGURE 5. Detailed characterization of the C-terminal DN1370 fragment of TNRC6C. (A)
Schematic representation of deletion mutants of the C-terminal DN1370 fragment of TNRC6C.
(B) Sequence alignment of RRM domains of selected GW182 proteins. Aromatic amino acids
mutated to alanines, either singly or in combination (mutantH1537/Y1556), are indicated. RNP1
and RNP2 motifs are overlined. Positions of a-helices and b-sheets predicted for the TNRC6C
RRMusing Phyre (http://www.sbg.bio.ic.ac.uk/phyre/) are shown below the alignment. (C, upper
panel) Repressive activity of mutants of the DN1370 fragment shown in panel A. Cells were co-
transfected with plasmids expressing NHA fusions of TNRC6C or the DN1370 fragment and its
mutants, and the reporter plasmids. Values represent the percent of translation as measured by
normalized RL activity, with translation in the presence of HA-TNRC6C taken as 100%. Error
bars show standard error (n = 3–12). Statistical significance (NHA-TNRC6C versus NHA-
DN1370 and NHA-DN1370 versus other deletion and RRM amino acid mutants) was calculated
using the nonparametricMann–Whitney–Wilcoxon test (NHA-TNRC6C versusNHA-DN1370)
or paired two-tailed Student’s t-test (all other comparisons); (*) P < 0.05; (**) P < 0.01. (Lower
panels) Expression levels of HA-TNRC6C, NHA-TNRC6C, and the C-terminal DN1370
fragment and its mutants as assessed by Western blotting using anti-HA Ab.
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TNRC6 protein to reporter mRNA strongly affects a pro-
cess of translation, with a more moderate effect on mRNA
stability. We show that the effect on translation is not due
to the remaining mRNA being deadenylated. We identify
DN1370, the C-terminal fragment of TNRC6C including
the RRM RNA-binding motif, as a key region mediating the
translational repression of TNRC6C. Two other domains,
GW-rich and Q-rich, also repress protein synthesis upon
tethering but only approximately twofold. The DN1370
fragment appears to function as an autonomous domain,
the inhibitory function of which does not involve interac-
tion with AGO or TNRC6 family proteins.
Human TNRC6A and TNRC6B were previously identi-
fied as AGO-interacting proteins, and their knockdown was
shown to affect the efficiency of miRNA-mediated repres-
sion (Jakymiw et al. 2005; Liu et al. 2005; Meister et al.
2005; Till et al. 2007). Results of knockdown and co-IP
experiments presented in this report extend these conclu-
sions to TNRC6C. Involvement of TNRC6C in miRNA
regulation is also supported by recent IP experiments of
Landthaler et al. (2008). Our demonstration that individual
tethering of each of the three TNRC6 proteins dramatically
inhibits mRNA translation adds further evidence to the
repressive functions of these proteins. It is intriguing that
individual knockdown of each of the three TNRC6 proteins
markedly interferes with miRNA repression despite their
similar domain organizations. It remains to be established
whether this is due to not entirely overlapping functions of
individual TNRC6 paralogs in miRNA repression or is a
consequence of the decreased total pool of TNRC6 proteins
in the cell. Following submission of our manuscript, Li
et al. (2008) reported that tethering of TNRC6A also
represses translation of FL reporter in HEK293 cells but
only by approximately threefold. In a total of 15 indepen-
dent transfection experiments performed by us in HEK293
cells, inhibition of RL reporter by tethering of TNRC6C
varied between 6.5-fold and 18-fold. In HeLa cells, the
effect varied between six- and 12-fold (H. Mathys and W.
Filipowicz, unpubl.).
Previous analyses of GW182 proteins identified domains
responsible for interaction with Argonautes or localization
to P-bodies (Behm-Ansmant et al. 2006; Till et al. 2007).
However, no information was available about domains
mediating the repression of protein synthesis. Deletion
analysis combined with tethering assays identified DN1370,
the C-terminal fragment of TNRC6C encompassing DUF
and RRM motifs, as a region with a dramatic, up to 20-fold,
repressive effect on the activity of an mRNA reporter.
Noteworthy, repression of protein synthesis by DN1370
was even stronger from that observed when a full-length
TNRC6C was tethered to mRNA, raising a possibility that
the N-terminal portion of TNRC6C may modulate inhibi-
tory activity of the C-terminal part. The integrity of DN1370
was essential to achieve maximal repression, since deletion of
either the DUF domain or 80 C-terminal amino acids
downstream from RRM decreased its inhibitory activity
severalfold. Likewise, mutation of evolutionarily conserved
aromatic residues of the RRM significantly lowered its
inhibitory potential.
Previous work has shown that the GW182 protein in
Drosophila S2 cells stimulates mRNA deadenylation and
decay, but also has a direct inhibitory effect on mRNA
translation (Behm-Ansmant et al. 2006; Eulalio et al.
2008b). We found that the inhibitory outcome of the
tethering of each human TNRC6C paralog is also a
combination of effects on mRNA translation and mRNA
level. More detailed analysis of TNRC6C and its DN1370
fragment showed that mRNA escaping the degradation
remained polyadenylated. Thus the inhibitory effect on
translation is not due to elimination of a stimulatory role of
the poly(A)-binding protein PABP on translation initiation
(Kahvejian et al. 2005) or mRNA ‘‘circularization’’ (Wells
FIGURE 6. (Legend on next page)
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et al. 1998), but rather results from a more direct
interference with the translation process. Interestingly,
comparison of the repressive effects of DN1370 and its
mutants bearing amino acid substitutions in the RRM
indicated that introduced mutations partially mitigate
translational repression but have no appreciable effect on
mRNA level. Hence, the RRM domain may play a more
important role in translational repression rather than in
mRNA destabilization. Our finding that DN1370 does not
interact with the endogenous TNRC6 or AGO proteins also
indicates that this fragment functions as an autonomous
inhibitory domain and not by recruiting the endogenous
miRNP complex to the reporter mRNA. This is consistent
with the findings of Behm-Ansmant et al. (2006) that
GW182 in Drosophila functions downstream from Ago1
and does not require Ago1 for inducing repression.
The DN1370 fragment contains two domains, DUF and
RRM, that are conserved in GW182-like proteins in many
but not all metazoan organisms. The DUF domain is
present in proteins of vertebrates, insects, and the worm
B. malayi (Fig. 1) but not in Caenorhabditis elegans (Zhang
et al. 2007). The function of the DUF domain is unknown,
and limited mutagenesis of the domain carried out within
the context of the DN1370 fragment failed to identify
amino acids important for the repression (Fig. 1B; data not
shown). The RRM domain is conserved in all GW182
proteins of vertebrates and insects but is absent from the
worm proteins. RRM domains are found in many RNA-
binding proteins and are directly involved in the recogni-
tion of specific RNA substrates, primarily via aromatic
amino acids of RNP1 and RNP2 motifs and via residues in
loops interconnecting structural elements of the RRM
(Clery et al. 2008). Several possible functions of the
GW182 RRM in translational repression could be envis-
aged. The RRM may interact with the mRNA target and
induce repression by contacting the cap or AUG regions of
mRNA. Alternatively, the RRM could contact other RNA
components participating in translation, such as initiator
tRNA or ribosomal RNA. However, RRM domains were
also shown to participate in protein–protein interactions
(Clery et al. 2008). Hence, it is possible that a primary role
of the GW182 RRM is to contact protein factors involved
in mRNA translation. In future, it will be interesting to
identify components of mRNA translation and/or decay
machineries that interact with DN1370.
FIGURE 7. DN1370 does not interact with endogenous Ago and
TNRC6C proteins. Cell extracts of HEK293 cells transiently expressing
the indicated fusion proteins were incubated with anti-HA Affinity
Matrix (Roche), and immunoprecipitated proteins (45% of the total
immunoprecipitate) were analyzed by Western blotting using the
indicated Abs. Note that anti-AGO mAb 2A8 recognizes all human
AGO proteins (Nelson et al. 2007). Inputs represent 1% (detection of
Ago) and 5% (detection of TNRC6C) of the cell extract used for IP.
Nontransfected cells served as a control. (B) DN1370 does not interact
with TNRC6A and TNRC6B proteins. Cell extracts of HEK293 cells
transiently expressing indicated epitope-tagged proteins were incu-
bated with anti-Flag M2-Agarose Affinity Gel (Sigma), and immuno-
precipitated proteins (45% of the total immunoprecipitate) were
analyzed by Western blotting using anti-HA 3F10 mAb. Inputs
represent 2% of the cell extract used for IP. Note that HA-TNRC6B
unspecifically binds to a-Flag beads and traces of it are present in IPs
from both DN1370-expressing and control cells. (*) The band most
probably represents the IgG heavy chain.
FIGURE 6. The DN1370 fragment acts mainly as a translational
repressor. (A) Tethering of DN1370 causes strong repression of
translation that is partially relieved by mutations in the RRM domain.
Indicated proteins were coexpressed with reporter plasmids in
HEK293 cells, and their effect on RL activity and RL-5BoxB mRNA
stability was analyzed using extracts originating from the same
transfections. (Upper panel) Effect of tethering on RL activity ([gray
bars] normalized to FL) and RL-5BoxB mRNA level ([black bars]
normalized to GFP mRNA). Values for transfection of HA-TNRC6C
were set to 100%. Calculated net repressive effects on translation are
shown below the bars (n = 3, with the exception of Northern analysis
for NHA-H1537A/Y1566A and NHA-LacZ performed only twice and
once, respectively). (Lower panels) Representative Northern analyses.
(B) Treatment with RNase H in the presence of oligo(dT) results in
faster mobility of both control mRNAs and mRNAs repressed by
tethering. RL-Con and RL-5BoxB mRNAs were coexpressed in
HEK293 cells with proteins indicated above the panels. RNA isolated
from transfected cells was incubated with RNase H in the absence or
presence of oligo(dT) and analyzed by Northern blotting. The same
blot was consecutively hybridized with probes specific for RL and b-
actin mRNAs. Note that RL-Con mRNA is 220 nt shorter than RL-
5BoxB. Hybridization signals (as measured by PhosphorImaging) in
lanes representing incubations without oligo(dT) were found to be
reproducibly weaker than those in the lanes with oligo(dT). This is
more pronounced for RL mRNAs than b-actin mRNA, and in the case
of RL mRNAs, it applies to the same extent to mRNAs that do and do
not undergo repression.
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In contrast to the C-terminal DN1370 fragment, which
repressed activity of the target mRNA 10- to 20-fold,
tethering of GW-rich and Q-rich domains had only an
approximately twofold inhibitory effect on protein synthesis.
This differs substantially from the situation in Drosophila
cells, where three nonoverlapping regions of dGW182, GW-
rich and Q-rich domains, and the C-terminal fragment
equivalent to DN1370 were identified as regions repress-
ing protein synthesis fivefold to sixfold upon tethering
(Chekulaeva et al. 2009). The results of cross-species experi-
ments indicated that tethering of a full-length dGW182
repressed protein synthesis in HEK293 cells as efficiently as
TNRC6C (Fig. 8). Likewise, repression by full-length
TNRC6C in Drosophila S2 cells was comparable to that of
dGW182 (Chekulaeva et al. 2009). However, the contribu-
tions of individual domains to repression differed substan-
tially between human and Drosophila proteins and cells. The
GW-rich domain of dGW182 was the strongest repressor in
human cells and was probably responsible for most of the
activity of intact dGW182; the effects of the remaining
domains were very limited. When different domains of
human TNRC6C were tested in Drosophila S2 cells, the Q-
rich domain and the C-terminal DN1370 fragment acted as
strong repressors, with the GW-domain having the least
effect (Chekulaeva et al. 2009). Hence, the N-terminal GW-
rich domain of dGW182 is a strong repressor in both S2 and
HEK293 cells, while the analogous domain of TNRC6C has
little effect in either cell type. In contrast, Q-rich domains
from both dGW182 and TNRC6C were strongly inhibitory
in Drosophila but not human cells, likely reflecting some
specific aspects of the repression pathway in fly cells.
Interestingly, the human DN1370 fragment was strongly
repressive in both systems, but its dGW182 counterpart had
a major effect only in homologous Drosophila cells. The
reasons for these protein-specific and cell-specific differences
remain to be established, but the observations are consistent
with a model proposed for Drosophila dGW182 according to
which individual repressive domains of dGW182 contribute
additivelyor cooperatively to the assemblyof a larger repressive
complex acting downstream from miRNPs (Chekulaeva et al.
2009). It will be interesting to dissect the repressive potential of
the two other TNRC6 paralogs, TNRC6A and TNRC6B. The
relative contributions to the repression of individual domains
of these two proteins may be different from those established
for TNRC6C.
MATERIAL AND METHODS
Cell culture, transfection, and luciferase assays
Human HEK293T cells (hereafter referred to as HEK293) were
grown in Dulbecco’s modified Eagle’s medium (DMEM; GIBCO
BRL) supplemented with 2 mM L-glutamine and 10% heat-
inactivated fetal calf serum (FCS). Generally, transfections were
performed in triplicates in six-well plates with z60% confluent
cells using Nanofectin (PAA Laboratories), following the manu-
facturer’s instructions. Unless indicated otherwise, amounts of
transfected plasmids per well were 50 ng of indicated RL reporter,
300 ng of FL-Con, and 20-100 ng of plasmid expressing indicated
HA- or NHA-tagged proteins; when indicated, in transfections
simultaneously used for Northern analysis, 200 ng of peGFP-C1
(Clonetech) were also included. In some experiments, amounts
of plasmids expressing TNRC6C deletion mutants were adjusted
to obtain comparable levels of overexpressed proteins. Cells
were lyzed 24 h post-transfection in Passive Lysis Buffer (PLB;
Promega) to measure RL and FL activities by Dual-Luciferase
Assay (Promega).
HeLa S3 cells were grown under similar conditions, but their
transfection with siRNAs and reporter plasmids was performed in
24-well plates using Lipofectamine 2000 (Invitrogen) with pro-
portionally lower amounts of indicated plasmids. Cells were
trypsinized 24 h post-transfection and seeded into wells of a
6-well plate. After 48 h, cells were lyzed as described above.
For RNAi, 100 nM a single siRNA (GCCUAAUCUCCGUGCU
CAATT and UUGAGCACGGAGAUUAGGCTG; sense and antisense
FIGURE 8. Effect of tethering of dGW182 and its deletion mutants
on activity of RL-5BoxB reporter in human cells. (Upper panel)
Tethering of dGW182 and its deletion mutants represses activity of
RL-5boxB reporter in HEK293 cells. Indicated plasmids expressing
human TNRC6C or Drosophila dGW182, or their mutants, were
transfected to cells together with RL-5boxB and FL-Con. Normalized
RL activity is indicated as the percentage of activity in cells expressing
HA-TNRC6C set as 100%. (Lower panel) Expression of fusion
proteins analyzed by Western blotting using anti-HA Ab. (Inset at
the bottom) Shows stronger exposure of the two lanes at far right,
indicating that the Q-rich domain (mutant 605-830) is expressed at a
much lower level than the remaining proteins. However, this low level
of NHA-605-830 appears to be sufficient to achieve maximal
repression since transfection of higher amounts of the plasmid
encoding NHA-605-830 did not result in stronger repression (data
not shown). The data represent means from three independent
experiments. We note that transfection of control NHA-lacZ plasmid
occasionally results in RL expression that is stronger (although not
significantly) than that of another control reporter, HA-TNRC6C.
The data were always normalized to RL expression in the presence of
HA-TNRC6C, which we consider as a more appropriate control than
NHA-lacZ.
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strands, respectively) were used in the case of TNRC6A, and mixtures
of two siRNAs, each 50 nM, were used for silencing of TNRC6B
(GGCCUUGUAUUGCCAGCAATT, UUGCUGGCAAUACAAGGC
CTT and GGAGUGCCAUGGAAAGGUATT, UACCUUUCCAUG
GCACUCCTT) and TNRC6C (GCAUUAAGUGCUAAACAAATT,
UUUGUUUAGCACUUAAUGCTT and CCAAGAGUUCUGUCU
AAUATT, UAUUAGACAGAACUCUUGGTT). All siRNAs were
obtained from Microsynth. Allstars Negative Control siRNA was
purchased from QIAGEN.
Plasmids
RL-5BoxB, RL-3xBulgeB, RL-3xBulgeBmut, RL-Con, and FL-Con
reporters (Pillai et al. 2005; Schmitter et al. 2006) and plasmid
expressing NHA-LacZ (Pillai et al. 2004) were previously
described. The plasmid encoding Flag/HA-Ago2 was a kind gift
of Gunter Meister (Max Planck Institute for Biochemistry)
(Meister et al. 2004).
Plasmids expressing HA- and NHA-tagged TNRC6A, TNRC6B,
and TNRC6C were prepared as follows. For TNRC6A, the XhoI–
NotI fragment excised from plasmid phrGFP/N1-GW182-A (kindly
provided by E. Chan, Department of Oral Biology, University of
Florida) (Eystathioy et al. 2002) was cloned into XhoI–NotI-
digested pCI-NHA or pCI-HA vector (pCI-NHA or pCI-HA
contain sequences encoding NHA or HA tags in pCIneo) (Pillai
et al. 2004) to yield pCI-NHA-TNRC6A and pCI-HA-TNRC6A,
respectively. The TNRC6A clones lack the N-terminal 312 amino
acids (Eystathioy et al. 2002). For TNRC6B, the SalI–NotI fragment
from the plasmid pDEST/Myc-GW182-B (kindly provided by G.
Meister, Max Planck Institute for Biochemistry) (Meister et al.
2005) was cloned into SalI–NotI-digested pCI-NHA or pCI-HA
vector to yield pCI-NHA-TNRC6B and pCI-HA-TNRC6B, respec-
tively. Plasmids expressing HA- and NHA-tagged TNRC6C, pHA-
TNRC6C, and pNHA-TNRC6C were prepared as follows: The EST
clone KIAA1582 (from Kazusa DNA Research Institute, Japan) was
digested with BstEII and NotI, and a 4.2-kb fragment correspond-
ing to the downstream ORF part was eluted from agarose gel.
The N-terminal ORF fragment was PCR-amplified using CGGAAT
TCATGGCTACAGGGAGTGCCCAGGG and TGACTGAACCCAG
AATTGCTATTTCC oligonucleotides as primers and digested with
EcoRI and BstEII. The two fragments were inserted into a pCI-
NHA vector pre-cut with EcoRI and NotI to yield pCI-NHA-
TNRC6C. pCI-NHA-TNRC6C has an XhoI site between sequences
encoding N and HA peptides, and two NheI sites: one upstream of
the N-peptide-encoding sequence and another in the ORF. The
plasmid was partially digested with NheI and the linearized DNA
eluted from a gel. The DNA was then digested with XhoI. The
desired 10.4-kb XhoI fragment was purified, the NheI and XhoI
overhang sequences filled in with Klenow polymerase, and the
plasmid religated.
Deletion mutants of TNRC6C were designed taking into account
structure propensity calculations (http://bioinf.cs.ucl.ac.uk/disopred/).
Mutants were obtained using the In-Fusion 2.0 Dry-Down PCR
Cloning Kit (Clontech) and pCI-NHA-TNRC6C as a template.
PCR products were cloned into linearized pCI-NHA. To prepare
pFLAG-NHA-DN1370, sequence encoding NHA-DN1370 was
PCR-amplified using pCl-NHA-DN1370 as a template and AGGCT
AGTCGACATGGACGCACAAACACGACG and AACCCTCACT
AAAGGGAAGC oligonucleotides as primers. Following digestion
with SalI andNotI, the fragment was inserted into SalI/NotI-digested
expression plasmid pCIneo1FLAG (kindly provided by Michael
Doyle of this laboratory).
Site-directed mutagenesis was performed by PCR using a pCI-
NHA-DN1370 plasmid and partially overlapping primers con-
taining desired mutations as described (Zheng et al. 2004). The
original template was digested by the methylation-dependent
enzyme DpnI and the PCR product was transformed into
competent cells.
To generate pCI-NHA-dGW182, the sequence encoding NHA-
dGW182 in a modified version of plasmid pAC5.1-lN-HA-
GW182 (Behm-Ansmant et al. 2006) was PCR-amplified and
cloned into pCIneo digested with NheI and NotI. Plasmids
encoding deletion mutants were generated in a similar way as
pCI-NHA-dGW182, using Drosophila plasmids expressing corre-
sponding dGW182 mutants as templates (Chekulaeva et al. 2009).
pCI-HA-dGW182 plasmid was generated from a pCI-NHA-
dGW182 plasmid by PCR amplification of the HA-dGW182
region, its digestion with SmaI and NotI, and cloning into pCIneo
digested with NheI and NotI.
Correctness of all plasmids was verified by sequencing.
Northern and RNase H analyses
Total RNA was isolated from cells 24 h post-transfection using
Trizol reagent (Invitrogen). Twelve micrograms of total RNA
from each transfection were resolved in a formaldehyde–1%
agarose gel and blotted to the Nylon membrane for 48 h using
103 SSC. The RL- GFP- and b-actin-specific DNA probes (0.9,
0.75, and 1.0 kb long, respectively) were 32P-labeled using the
Random-primed DNA labeling Kit (Roche) and used for hybrid-
ization. Radioactivity was quantified with a PhosphorImager
(Storm 860; Molecular Dynamics).
To analyze the polyadenylation status of mRNA, 20 mg of total
RNA isolated from transfected cells were annealed in the presence
or absence of 2 mg of oligo(dT) for 15 min at room temperature
and then treated with RNase H (New England Biolabs) in the
presence of RNasin Plus (Promega; 1 mL per reaction) for 45 min
at 37°C, following the manufacturer’s recommendations. RNA
was purified with Trizol LS (Invitrogen), separated on a denatur-
ing 1% agarose gel, and analyzed by Northern blotting.
Antibodies, Western blotting,
and immunoprecipitations
Antibodies against human TNRC6C were raised in rabbits by Euro-
gentec, using a mixture of two peptides, TGSAQGNFTGHTKKT
and TTIQDVNRYLLKSGG. The Abs were affinity-purified using
individual peptides coupled to Sepharose. For Western analysis,
aliquots of cell lysates in PLB were subjected to SDS-PAGE using a
pre-cast 4%–12% gradient (Invitrogen) (Figs. 4 and 5) or 6% linear
polyacrylamide gels (Figs. 2, 3; 10% for Fig. 8). Note thatmigration of
investigated proteins in relation to protein size markers differs
between these two types of gels. Anti-HA mAb 3F10 (Roche; 1:1000
dilution) or a combinationof anti-TNRC6C rabbitAbs (1:1000)were
usedasprimary antibodies, andgoat anti-ratAb coupled toHRP(MP
Biochemicals; 1:8000) and anti-rabbit Ab (GE Healthcare, 1:10,000)
as secondary Abs. Proteinswere detected using ECL (GEHealthcare).
For HA epitope IP reactions, cells were lysed with 50 mM Tris-
HCl (pH 7.5) containing 150 mM KCl, 5 mM MgCl2, 1 mM
CaCl2, 0.5% Triton X-100, 2 mM DTT, 40 U/mL RNaseOUT
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Recombinant Ribonuclease Inhibitor (Invitrogen), and EDTA-free
Protease Inhibitor Cocktail (Roche). The cleared lysate was
incubated with anti-HA Affinity Matrix (Roche). After washing
with 10 mM Tris-HCl (pH 7.5) containing 200 mM KCl, 5 mM
MgCl2, 1 mM CaCl2, proteins associated with the beads were
analyzed by Western blotting using anti-TNRC6C Abs, anti-HA
mAb 42F13 (FMI Monoclonal Antibody Facility), and mAb 2A8
(Nelson et al. 2007) recognizing human AGO proteins (kindly
provided by Z. Mourelatos, University of Pennsylvania School of
Medicine). Flag IPs were performed using the Flag Tagged Protein
Immunoprecipitation Kit (Sigma) according to the manufac-
turer’s protocol. Immunoprecipitated proteins and input fractions
were analyzed by Western blotting using anti-HA 3F10 antibody
(Roche).
Statistical analysis
Data were tested for Normality using the Shapiro test. The null
hypothesis for the Shapiro test is Normal data. Statistical
significances were calculated on the Normally distributed data
sets using a two-tailed paired Student’s t-test. When the Shapiro
test reported a P-value close to or below 0.05 (data are non-
Normal), we performed the nonparametric Mann–Whitney–
Wilcoxon test. The error bars plotted throughout show the
standard error of the mean (SEM). It follows from the central
limit theorem that the distribution of sample means will be
Normal even if the underlying sample distribution is not. So even
for these cases, the error of the sample means will still be correct.
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MicroRNAs (miRNAs) inhibit mRNA expression in
general by base pairing to the 30UTR of target mRNAs
and consequently inhibiting translation and/or initi-
ating poly(A) tail deadenylation and mRNA destabili-
zation. Here we examine the mechanism and kinetics
of miRNA-mediated deadenylation in mouse Krebs-2
ascites extract. We demonstrate that miRNA-medi-
ated mRNA deadenylation occurs subsequent to
initial translational inhibition, indicating a two-step
mechanism of miRNA action, which serves to consol-
idate repression. We show that a let-7 miRNA-loaded
RNA-induced silencing complex (miRISC) interacts
with the poly(A)-binding protein (PABP) and the CAF1
and CCR4 deadenylases. In addition, we demon-
strate that miRNA-mediated deadenylation is depen-
dent upon CAF1 activity and PABP, which serves
as a bona fide miRNA coactivator. Importantly, we
present evidence that GW182, a core component
of the miRISC, directly interacts with PABP via its
C-terminal region and that this interaction is required
for miRNA-mediated deadenylation.
INTRODUCTION
MicroRNAs (miRNAs) are short single-stranded RNAs (21 nt in
length) encoded within the genome of species ranging from
protozoans to plants to mammals (Bartel, 2004; Molnar et al.,
2007). miRNAs play key roles in a broad range of biological
processes including hematopoiesis, insulin secretion, apoptosis,
and organogenesis (Bartel, 2004). When assembled together
with Argonaute (Ago) proteins into the miRNA-induced silencing868 Molecular Cell 35, 868–880, September 25, 2009 ª2009 Elseviecomplex (miRISC), miRNAs base pair with and repress mRNA
expression through mechanisms that are not fully understood
(Eulalio et al., 2008a; Filipowicz et al., 2008).
miRNAs were reported to employ different mechanisms to
inhibit expression of targeted mRNAs (Eulalio et al., 2008a; Fili-
powicz et al., 2008). Some data indicate that miRNAs interfere
with mRNA translation at the initiation step (Chendrimada
et al., 2007; Ding and Grosshans, 2009; Humphreys et al.,
2005; Mathonnet et al., 2007; Pillai et al., 2005; Thermann and
Hentze, 2007; Wang et al., 2008), whereas other studies
concluded that the miRNA machinery represses translation at
postinitiation steps (Gu et al., 2009; Lytle et al., 2007; Maroney
et al., 2006; Nottrott et al., 2006; Olsen and Ambros, 1999;
Petersen et al., 2006). miRNAs have been observed, although
not in every study, to mediate deadenylation and/or decay of tar-
geted mRNAs (Behm-Ansmant et al., 2006; Giraldez et al., 2006;
Wakiyama et al., 2007; Wu et al., 2006).
In addition to Ago proteins, GW182 proteins also play key roles
in miRNA-mediated repression. One GW182 protein (Gawky)
exists in Drosophila, and three GW182 paralogs (TNRC6A,
TNRC6B, and TNRC6C) are present in mammals. Direct interac-
tion of GW182 with Ago proteins is critical for miRNA-mediated
translation repression and mRNA decay (Eulalio et al., 2008b).
Studies conducted with either TNRC6C or Gawky artificially teth-
ered to a reporter mRNA demonstrated that a region within their
C termini is required for repression of translation (Chekulaeva
et al., 2009; Eulalio et al., 2009b; Zipprich et al., 2009).
Cell culture-based assays invariably measure miRNA effects
hours or days after the initial mRNA target site recognition,
making it difficult to ascertain the temporal order and contribu-
tion of the different proposed mechanisms to mRNA repression.
Moreover, RNAi-based approaches for identifying miRNA-
associated factors may perturb cellular transcriptional programs
in such a way that it becomes difficult to determine direct
contributions. Thus, developing an in vitro system that faithfullyr Inc.
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necessary to elucidate the biochemistry of miRNA mechanisms
of action, especially at early time points. Such systems have
recently been reported (Mathonnet et al., 2007; Thermann and
Hentze, 2007; Wakiyama et al., 2007; Wang et al., 2006).
To explore the mechanisms that miRNAs utilize to repress
mRNA expression in mammals, we utilized an in vitro translation
extract frommouse Krebs-2 ascites cells (referred to throughout
as Krebs extract). We showed before that the earliest detectable
effect of miRNA action is the inhibition of cap-dependent
translation initiation (Mathonnet et al., 2007). We demonstrate
here that miRNA-mediated deadenylation follows the initial inhi-
bition of cap-dependent translation. We further show that
Ago2 interacts with the CNOT7/CAF1 (hereafter referred to as
CAF1) deadenylase and poly(A)-binding protein (PABP) in an
RNA-independent manner, and that both proteins are required
to facilitate miRNA-mediated deadenylation. Importantly, we
show that PABP physically interacts with the miRISC by
directly binding the C terminus of GW182 and is required for
deadenylation.
RESULTS
miRNA-Mediated Deadenylation Follows Initial
Translation Inhibition
We previously described an in vitro translation extract derived
from Krebs-2 ascites cells that contains high levels (150 pM)
of the let-7a (referred throughout as let-7) miRNA and displays
a faithful let-7 miRNA response (Mathonnet et al., 2007). The
Krebs extract manifests reduced translation initiation of
in vitro-transcribed let-7-targeted mRNAs starting within the first
15 min of incubation without detectable mRNA degradation
(Mathonnet et al., 2007). Since miRNAs were also reported to
induce mRNA deadenylation (Eulalio et al., 2009a; Giraldez
et al., 2006; Wakiyama et al., 2007; Wu et al., 2006), and since
deadenylation generally results in translational repression (Wor-
mington, 1993), we wished to determine whether miRNA-medi-
ated deadenylation can be recapitulated in a Krebs extract and
study the temporal relationship between translation inhibition
and deadenylation. A polyadenylated RL-6xBmRNA (Figure 1A),
labeled uniformly with 32P-UTP, was incubated in a Krebs
extract, and its integrity was analyzed by denaturing polyacryl-
amide-gel electrophoresis (PAGE) followed by autoradiography.
A new RNA band migrating faster than the full-length mRNA was
detected after1 hr of incubation (Figure 1B, lanes 3–7, and see
Figure S1 available online). Formation of the new RNA species
was dependent on let-7 miRNA as (1) inclusion of anti-let-7
20-O-methylated oligonucleotide (20-O-Me), but not anti-
miR122 20-O-Me, in the Krebs extract blocked the generation
of this product (lanes 8 and 9, respectively); and (2) a reporter
containing mutations in nucleotides complementary to the let-7
‘‘seed’’ sequence (RL-6xBMut-pA; see Figure 1A and Figure 1B,
lanes 1–7), and a reporter devoid of let-7 sites (RL-pA; Figure S1)
failed to give rise to this band. Cloning and sequencing of the
new RNA species using an oligonucleotide-ligation RT-PCR
strategy (FigureS2) demonstrated that it represents adeadenyla-
tion product of the RL-6xB-pA mRNA. Thus, let-7 miRNA medi-
ates deadenylation of the targeted mRNA in the Krebs extract,Molecbut with the earliest detection only after 1.3 hr of incubation.
As translational inhibition (55%) occurs within the first hour of
incubation in the same Krebs extract in which deadenylation
has been monitored (Figure 1C; see also Mathonnet et al.
[2007]), it appears that miRNA-mediated inhibition of cap-
dependent translation precedes mRNA deadenylation. When
translation of RL-6xB-pA mRNA was allowed to proceed for
longer times, the degree of translation repression increased
from 55% at 1 hr to 77% at 2 hr (Figure 1C; three different
experiments). These data indicate that deadenylation may
consolidate the initial inhibition of cap-dependent translation.
Next, we asked whether deadenylation is dependent on trans-
lation. To this end, translation was inhibited in the Krebs extract
by the addition of either cycloheximide (Figure 1B, lanes
10–12), which blocks translation elongation, or hippuristanol
(lanes 13–15), which inhibits translation initiation (Bordeleau
et al., 2006). Inhibiting either step of translation failed to block
let-7-induced deadenylation of RL-6xB-pA mRNA. We then
examined whether the m7GpppG-cap structure is required for
miRNA-mediated deadenylation. Deadenylation assays were
conducted with RL-6xB-pA and RL-6xBMUT-pA mRNAs pos-
sessing an ApppG-cap, which cannot be bound by eIF4E but
protects the RNA against degradation by 50-30 exonucleases.
Neither the time course nor the extent of deadenylation of A-cap-
ped RL-6xB-pA significantly differed fromRL-6xB-pA bearing an
m7GpppG structure (Figure 1B). Since miRNA-mediated deade-
nylation is an m7GpppG-cap- and translation-independent
event, we examined whether any RNA element upstream of the
RL-6xB-pA 30UTR is required for miRNA-mediated deadenyla-
tion. ApppG-capped 30UTR transcripts were generated that
lack an open reading frame and contain six either functional
(6xB-30UTR) or mutated (6xBMUT-30UTR) let-7 sites and a 98 nt
poly(A) tail (Figure 1D). The 6xB-30UTR RNA recapitulated both
the time course and the deadenylation pattern observed for the
full-length RL-6xB-pA mRNA (Figure 1D). Deadenylation was
dependent on let-7 miRNA as (1) addition of anti-let-7a 20O-Me
oligonucleotide, but not a nonspecific anti-miR122 20-O-Me
oligonucleotide (Figure 1D, lanes 12 and 13, respectively), abro-
gated thedeadenylationof 6xB-30UTRRNA; and (2) the6xBMUT-
30UTRRNAwas not deadenylated (Figure 1D). A 6xB-30UTRRNA
with a longer poly(A) tail (150 nt, 6xB-30UTR*) behaved similarly to
the 6xB-30UTRRNA vis-a-vis the time course and the deadenyla-
tionpattern (Figure 1E). Taken together, our findingsdemonstrate
that no RNA determinant other than the let-7 target sites is
required for miRNA-mediated deadenylation.
Argonaute Proteins Interact with CAF1 and CCR4
Deadenylases
We used several approaches to identify the deadenylase(s)
involved in themiRNA-mediateddeadenylation. In oneapproach,
Myc-tagged Ago1 and Ago2 were stably transfected into
HEK293 cells. Tagged Ago proteins were immunopurified, and
theassociatedproteinswere identifiedbyusingmultidimensional
protein identification technology (MuDPIT) (Washburn et al.,
2001; Wolters et al., 2001). This method was validated by the
identification of known Ago2-interacting proteins such as
HSP90, DICER, TRBP, and GW182 (Figure 2A) (Chendrimada
et al., 2005; Landthaler et al., 2008; Liu et al., 2005; Meisterular Cell 35, 868–880, September 25, 2009 ª2009 Elsevier Inc. 869
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MicroRNA-Induced Deadenylation by CAF1 in MammalsFigure 1. Deadenylation Mediated by let-7 miRNA in a Krebs Extract
(A) Schematic representation of the Renilla luciferase (Rluc) reporter mRNAs. Sequences of the let-7-binding sites (RL-6xB) and mutated seed sites (RL-6xBMut)
are shown below the drawings.
(B) Time course of RL-6xB-pA and RL-6xBMUT-pAmRNA deadenylation as determined by autoradiography. Reporter mRNAswere incubated in the presence or
absence of 10 mM cycloheximide, 1 mM hippuristanol, or 10 nM 20-O-Me oligonucleotide (either anti-let-7a or anti-miR122).
(C) A time course of translation of RL-pA, RL-6xB-pA, and RL-6xB-pA in the presence of anti-let-7 20-O-Me. Average percentage repression is labeled below each
time point. Error bars represent the standard deviation of three independent experiments.
(D) Schematic representation of the 6xB-30UTR reporter RNA and time course of 6xB-30UTR and 6xBMUT-30UTR RNA deadenylation in a Krebs extract as deter-
mined by autoradiography. Reporters were incubated in the presence or absence of 10 nM 20-O-Me oligonucleotide (either anti-let-7a or anti-miR122), and their
stability was monitored by autoradiography.
(E) Schematic representation of the 6xB-30UTR reporter RNAs with either 98As or 150As (*). Time course of 6xB-30UTR and 6xB-30UTR* deadenylation in a Krebs
extract as determined by autoradiography. Polyadenylated and deadenylated mRNAs are marked on the right of the figure.et al., 2005). In addition, PABP was identified in both Ago1 and
Ago2 immunopurifications (Figure 2A) (Hock et al., 2007; Land-
thaler et al., 2008). One identified protein that was not reported
before to interact with Ago proteins was CAF1 deadenylase. To
validate this interaction, we performed coimmunoprecipitation
experiments using a micrococcal nuclease-treated Krebs870 Molecular Cell 35, 868–880, September 25, 2009 ª2009 Elsevieextract. When endogenous Ago2 was immunoprecipitated from
the Krebs extract, the precipitated fraction contained Ago2
and CAF1, but not eIF4E (Figure 2B). When endogenous CAF1
was immunoprecipitated from Krebs extracts, the precipitated
fraction contained CAF1, CCR4 (a CAF1-associated deadeny-
lase [Tucker et al., 2001]), and Ago2, but not eIF4E (Figure 2C).r Inc.
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MicroRNA-Induced Deadenylation by CAF1 in MammalsFigure 2. Ago Proteins Interact with PABP
and the CAF1/CCR4 Deadenylase Complex
(A) MuDPIT analysis of Ago1- and Ago2-interact-
ing proteins. Identified proteins are listed along
with corresponding peptide coverage for Ago1
and Ago2 coimmunoprecipitations.
(B) Immunoprecipitation of endogenous Ago2
protein from micrococcal nuclease-treated Krebs
extract using anti-Ago2 antibody. Immunoprecipi-
tated complexes were subjected to SDS-PAGE
and probed with anti-Ago2 antibody, anti-CAF1
antibody, anti-PABP antibody, or anti-eIF4E anti-
body.
(C) Immunoprecipitation of endogenous CAF1
protein from micrococcal nuclease-treated Krebs
extract using anti-CAF1 antibody. Immunoprecip-
itated complexes were subjected to SDS-PAGE
and probed with anti-Ago2 antibody, anti-CAF1
antibody, anti-CCR4 antibody, or anti-eIF4E
antibody.
(D) Pulldown of Ago2, CCR4, and CAF1 from
micrococcal nuclease-treated Krebs extracts
using biotin-conjugated anti-let-7 20-O-Me oligo-
nucleotide and streptavidin Dynabeads. Isolated
complexes were subjected to SDS-PAGE and
probed with anti-Ago2 antibody, anti-CAF1 anti-
body, anti-CCR4 antibody, anti-Tob antibody, or
anti-eIF4E antibody.To determine whether the CAF1 and CCR4 deadenylases can
be recruited by the let-7-loaded Ago2, we used a 20-O-Me RNA
target ‘‘bait’’ pulldownassay (Hutvagner et al., 2004). Biotinylated
20-O-Me oligonucleotides, which mimic partially complementary
mRNA target sites for let-7 or miR122 (a liver-specific miRNA
[Lagos-Quintana et al., 2002] that can pull down Ago2 from
lysates derived from Huh7 liver cells [Figure S3]), were incubated
in Krebs extract and pulled down using streptavidin beads. The
associated proteins were eluted and analyzed by western blot-
ting. Ago2 bound specifically to the anti-let-7 20-O-Me beads
and failed to bind to control beads or anti-miR122 20-O-Mebeads
(Figure2D, lanes2–4). Importantly, in thesepulldownexperiments
a similar pattern of enrichmentwasobserved forCAF1andCCR4,
but not for eIF4Eor Tob (a protein that can associatewithCAF1 to
enhance deadenylation [Ezzeddine et al., 2007; Mauxion et al.,
2008]). These results demonstrate that CAF1 and CCR4 can be
specifically recruited to the target-bound let-7-loaded Ago2.
miRNAs Require CAF1 Activity to Promote
Deadenylation
To determine whether CAF1 is required for miRNA-mediated
deadenylation, it was immunodepleted (80%) from the Krebs
extract using an affinity-purified CAF1 antibody (Figure S4).
Analysis of the depleted extract (Figure 3) demonstrated that
miRNA-mediated translation inhibition is partially relieved in
both CAF1- and Ago2-depleted extracts (37.8% [Figure 3B]
and 14.9% repression [Figure 3D], respectively, after 3 hr incuba-
tion) when compared to the corresponding control-depleted
extracts (68.9% [Figure 3A] and 54.5% [Figure 3C] repression
after 3 hr incubation). The Ago2-depleted extract was dramati-Moleccally impaired in its ability to deadenylate the 6xB-30UTRRNA, in-
asmuch asdeadenylationwasbarely detectable even after 6 hr of
incubation (Figure 3E, lane5). A similar decrease indeadenylation
wasdetected in aKrebs extract depleted ofCAF1 (Figure 3F, lane
10). These deadenylation defects were specific, because in
a mock-depleted extract, 6xB-30UTR RNA was deadenylated
in a let-7-dependent manner (Figures 3E and 3F, lanes 1–3).
miRNA-mediated deadenylation was modestly restored (2.2-
fold increase; from5% to12%deadenylation) by the addition
of affinity-purified wild-type HA-CAF1 to the CAF1-depleted
extract (Figure 3F, lane 11), while wild-type HA-CAF1 had no
noticeable effect on mock-depleted extract (lane 4). Modest
restoration was most likely due to a small fraction of affinity-puri-
fied wild-type HA-CAF1 being bound to let-7-loaded miRISC. In
contrast, addition of affinity-purified catalytically inactive
HA-CAF1 mutant (D40A) (Zheng et al., 2008) decreased miRNA-
induced deadenylation in both mock- and CAF1-depleted
extracts (Figure 3F, lanes 5 and 12, respectively). This is likely
due to HA-CAF1(D40A) acting as a dominant-negative mutant
in both mock- and CAF1-depleted extracts. Taken together,
these results show that miRNA-induced deadenylation is
executed, at least in part, by the CAF1 deadenylase.
Ago2-GW182 Interaction Is Essential
for miRNA-Mediated Deadenylation
The Ago-binding protein GW182 is required for efficient miRNA-
mediated silencing in C. elegans and in Drosophila S2 cells
(Behm-Ansmant et al., 2006; Ding and Han, 2007; Eulalio et al.,
2008b). GW182 is required for the assembly of P bodies,
protein-RNA assemblies thought to contribute to translationular Cell 35, 868–880, September 25, 2009 ª2009 Elsevier Inc. 871
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MicroRNA-Induced Deadenylation by CAF1 in MammalsFigure 3. let-7-Mediated Deadenylation Requires CAF1, Ago2, and GW182
(A–D) Time course of RL-pA and RL-6xB-pA translation in rabbit anti-HA- (A), rabbit anti-CAF1- (B), mouse anti-HA- (C), and mouse anti-Ago2-depleted Krebs
extracts (D). Average percentage repression is labeled below each time point. Error bars represent the standard deviation of three independent experiments.
(E) 6xB-30UTR RNA deadenylation in the presence or absence of 10 nM anti-let-7a 20-O-Me in control (mouse anti-HA) or anti-Ago2-depleted Krebs extract. 6xB-
30UTR RNA deadenylation was followed by autoradiography. Polyadenylated and deadenylated mRNAs are marked on the right of the figure.
(F) 6xB-30UTR RNA deadenylation in control (rabbit anti-HA) or anti-CAF1-depleted extract in the presence or absence of either 10 nM anti-let-7a 20-O-Me oligo-
nucleotide, or WT or D40A HA-CAF1 protein.
(G) Wild-type and mutant hook peptides derived from GW182.
(H) 6xB-30UTR RNA deadenylation in Krebs extract in the presence or absence of either GST or GST hook peptides at concentrations ranging from 0.1 to 2.0 mg
per reaction, respectively.inhibition andmRNA destabilization (Behm-Ansmant et al., 2006;
Ding and Han, 2007; Jakymiw et al., 2007; Liu et al., 2005; Pillai
et al., 2005; Rehwinkel et al., 2005). CAF1 also localizes to
P bodies in mammalian cells (Zheng et al., 2008). We therefore
investigated whether the GW182 interaction with Ago2 plays
a role in miRNA-mediated deadenylation in vitro. To this end, we872 Molecular Cell 35, 868–880, September 25, 2009 ª2009 Elsevieused a 22 amino acid fragment of GW182 (called ‘‘Ago hook’’)
(Figure 3G) that competes with GW182 for Ago binding and
inhibits miRNA-mediated repression in vivo (Till et al., 2007).
A Krebs extract was incubated with either GST alone, GST fused
toAgohook (GST-WThook), orGST fused toamutant hook (GST-
MUThook) containing two Trp to Leumutations that abrogate ther Inc.
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MicroRNA-Induced Deadenylation by CAF1 in MammalsFigure 4. let-7-Dependent Deadenylation
Requires PABP
(A) Western blot analysis of Krebs-2 extracts
depleted with either GST (Control Extract) or
GST-Paip2 (PABP-depleted Extract) probed with
anti-PABP antibody and anti-b-actin antibody.
(B) A-capped 6xB-30UTR RNA incubated in either
mock-depleted (lanes 1–2) or PABP-depleted
extract (lanes 3–6). PABP-depleted extract was
supplemented with recombinant GST, GST-
PABP (100 ng, which is the equivalent of roughly
50% of endogenous PABP present in an in vitro
reaction), and RNA stability was monitored by
autoradiography. Polyadenylated and deadeny-
lated mRNAs are marked on the right of the panel.ability of the hook to bind toAgo (Till et al., 2007) (Figure S5). Addi-
tion of a recombinant GST-WT hook, but not GST alone or GST-
MUT hook to the Krebs extract, impaired the deadenylation of
6xB-30UTR RNA in a concentration-dependent manner (Fig-
ure 3H, lanes 7–9 compared to lanes 4–6 and 10–12, respec-
tively). These findings indicate that miRNA-mediated deadenyla-
tion in vitro requires GW182 contact with Ago2 at the hook site.
PABP Is Required for miRNA-Mediated Deadenylation
Since the MuDPIT analysis identified PABP as an Ago-interact-
ing protein, it was pertinent to determinewhether PABP is neces-
sary for miRNA-induced deadenylation. A Krebs extract was
depleted (>95%) of endogenous PABP using a GST-tagged
PABP-interacting protein 2 (Paip2) affinity matrix (Figure 4A).
Paip2 is a strong translational inhibitor and acts by sequestering
PABP and blocking PABP-poly(A) tail and PABP-eIF4G interac-
tions in vitro (Karim et al., 2006; Khaleghpour et al., 2001).
GST-Paip2 coupled to a resin was previously used to efficiently
deplete PABP from a Krebs extract, resulting in reduced transla-
tion (Kahvejian et al., 2005). Strikingly, the PABP-depleted
extract was severely impaired in its ability to deadenylate the
6xB-30UTR RNA (Figure 4B, compare lane 4 to lane 1). This
was a specific consequence of PABP depletion as a mock-
depleted extract still deadenylated the reporter RNA and was
responsive to the addition of anti-let-7 20-O-Me oligonucleotide
(Figure 4B, lanes 1 and 2, respectively). Moreover, addition of
recombinant GST-PABP (50% of endogenous PABP levels in
a Krebs extract [Figure S6]) to the PABP-depleted extract (lane
6), but not GST alone (lane 5), completely rescued miRNA-medi-
ated deadenylation of 6xB-30UTR RNA. The rescue was pre-
vented by the addition of anti-let-7 20-O-Me oligonucleotide
(Figure S7, lane 8). These findings clearly show that PABP is
essential for miRNA-mediated deadenylation in vitro.
PABP Function in miRNA-Mediated Deadenylation
Is Antagonized by eIF4G
How does PABP facilitate miRNA-mediated deadenylation?
PABP is probably not required for miRISC target site recognition,
as the let-7-loaded Ago2 can be pulled downwith anti-let-7 20-O-
Me oligonucleotide from a PABP-depleted Krebs extract almost
as well as from a nondepleted extract (Figure 2D, compare lanes
3 and 7). Moreover, PABP is required for recruiting neither CAF1
nor CCR4 as they are pulled down in similar amounts fromMolecPABP-depleted extracts with anti-let-7 20-O-Me oligonucleotide
(Figure 2D, compare lanes 3 and 7). It is unlikely that PABP’s role
is to compete with other proteins for poly(A) tail binding, as add-
ing free poly(A) to PABP-depleted extracts (Figure S8) does not
rescue miRNA-mediated deadenylation.
The N-terminal region of PABP can interact with the translation
initiation factor eIF4G, and this interaction stimulates translation
(Imataka et al., 1998; Wakiyama et al., 2000). To determine
whether this interaction might antagonize deadenylation, Krebs
extract was incubated with increasing concentrations of either
an N-terminal eIF4G fragment (GST-eIF4G 41-244wt) that binds
the N terminus of PABP or a mutant eIF4G fragment (GST-eIF4G
41-244mut) that does not bind to PABP (Kahvejian et al., 2005)
(Figures 5A and S9). Addition of a wild-type (lanes 3–6), but not
the mutant eIF4G fragment (lanes 7–10), impaired the deadeny-
lation of 6xB-30UTR RNA in a concentration-dependent manner.
We next examined whether the effect of GST-eIF4G 41-244wt
on miRNA-mediated deadenylation was a result of its binding to
PABP. PABP-depleted extracts were supplemented with either
wild-type or PABP M161A that cannot bind eIF4G (Groft and
Burley, 2002) (Figures 5B, 5C, and S9). miRNA-mediated deade-
nylation in PABP-depleted extracts can be rescued equally well
with PABP M161A as compared to wild-type PABP (Figure 5B,
compare lanes 5–7 with lanes 10–12). Addition of GST-eIF4G
41-244wtblockeddeadenylation inaPABP-depletedextract sup-
plemented with wild-type PABP (lane 8) but decreased it only
minimally when supplementedwith PABPM161A (lane 13). These
findings suggest that the eIF4G-PABP interaction is not required
for, but rather interferes with, miRNA-mediated deadenylation.
PABP Interacts with the C-Terminal Region of GW182
GW182 is a core component of miRISC, and its contact with Ago
is required for miRNA-mediated repression (Eulalio et al., 2008b;
Till et al., 2007). Mammalian and C. elegans GW182 protein
orthologs were previously shown to coimmunoprecipitate with
PABP (Landthaler et al., 2008; Zhang et al., 2007), but whether
these associations were direct has not been determined. To
test for a direct interaction between GW182 and PABP, we
performed GST pulldown experiments using recombinant
His-taggedPABPand fourGST- andFLAG-taggedpartially over-
lapping fragments (covering amino acids 1–500, 400–900, 800–
1360, and 1260–1690) of the human GW182 protein TNRC6C
(Figure 6A). GST on its own and fusions with TNRC6C fragmentsular Cell 35, 868–880, September 25, 2009 ª2009 Elsevier Inc. 873
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contrast, the C-terminal 1260–1690 of TNRC6C, which harbors
both the domain of unknown function (DUF; Zipprich et al.,
2009) andRRMdomains of TNRC6Cpulled downPABP very effi-
ciently (20% of input; Figure 6A). GST pulldown experiments
using overlapping fragments of another human GW182 paralog
(TNRC6A) and PABP yielded similar results (data not shown).
We next investigated whether the C-terminal region of
TNRC6C interacts with PABP in transfected HEK293 cells. Of
the HA-tagged fragments spanning different regions of TNRC6C
Figure 5. eIF4G Contact with PABP Antagonizes miRNA-Mediated
Deadenylation
(A) 6xB-30UTR RNA deadenylation in Krebs extract in the presence or absence
of increasing concentrations (0.15, 0.5, 1.0, and 3.0 mg per reaction) of wild-
type or mutant GST-eIF4G 41-244.
(B) 6xB-30UTR RNA deadenylation in mock- or PABP-depleted Krebs extract
in the presence or absence of increasing concentrations (25, 50, or 100 ng per
reaction, respectively) of either wild-type (lanes 5–7) or M161A PABP (lanes
10–12) and/or wild-type (lanes 8 and 13) or mutant (lanes 9 and 14) GST-
eIF4G (41-244).
(C) Quantification of deadenylated bands as a percentage of total RNA in (B) is
shown in bar graphs (with standard deviations).874 Molecular Cell 35, 868–880, September 25, 2009 ª2009 Elsevie(Figure 6B), only the C-terminal fragment, DN1370, encompass-
ing residues 1370–1690, pulled down endogenous PABP
(Figure 6B, lane 8). In additional experiments, lysates from cells
expressing GST-DN1370 were used for GST pulldowns. In the
absence of micrococcal nuclease treatment, GST-DN1370
pulled down both PABP and eIF4G. However, in nuclease-
treated lysatesGST-DN1370 pulled down only PABP (Figure 6C),
demonstrating theRNA independence of the interaction between
TNRC6C and PABP. Taken together, these data indicate that the
C-terminal region of the GW182 protein TNRC6C interacts
directly with PABP in an RNA-independent manner.
GW182 Contact with the PABP C-Terminal Domain Is
Required for Maximal miRNA-Mediated Deadenylation
We next performed a sequence analysis of the C terminus of
GW182 proteins to identify any potential PABP-interacting
motifs. We observed a short sequence within the DUF that
shows similarity to the Paip2 PAM2 motif (Figure 7A) that
is required for Paip2 to bind the second half of the PABP
C terminus (C2) (Khaleghpour et al., 2001; Kozlov et al., 2004).
GST pulldown experiments were subsequently carried out using
recombinant GST-tagged C-terminal PABP fragments (GST-C1
and GST-C2) and the FLAG-tagged TNRC6C C terminus
(covering amino acids 1260–1690 [Figure 7B]). The PABP GST-
C1 fusion did not pull down the GW182 1260–1690 fusion. In
contrast, GST-C2 pulled down the TNRC6CC-terminal fragment
very efficiently (40% of input).
To determine whether miRNA-mediated deadenylation
requires GW182 contact with the PABP C2 domain, a Paip2-
derived PAM2 peptide that specifically binds the C2 domain
(Figure 7C) was used. Addition of increasing concentrations of
wild-type, but not mutant PAM2 peptide (F117A [Kozlov et al.,
2004]) to GST-PABP incubated with TNRC6C 1260–1690 frag-
ment, blocked, albeit not completely, the binding of the TNRC6C
C terminus to PABP (lanes 6–8 compared to lanes 9–11). Consis-
tently, addition of the wild-type, but not the mutant PAM2
peptide to a Krebs extract, interfered with miRNA-mediated
deadenylation in vitro in a dose-dependent manner (Figure 7D,
lanes 3–6 compared to lanes 7–10). Taken together, these find-
ings demonstrate that maximal miRNA-mediated deadenylation
in vitro requires GW182 contact with the PABP C2 domain.
To further assess the function of the GW182 C terminus in
miRNA-mediated deadenylation, we added the C-terminal
recombinant 1260–1690 fragment to in vitro deadenylation reac-
tions. The fragment dramatically enhanced miRNA-mediated
deadenylation in vitro (Figure 7E, lanes 7–10 as compared to
lane 2). The enhancement is specific, since adding a TNRC6C
fragment 800–1360 that overlaps the 1260–1690 fragment but
cannot bind PABP inhibited rather than enhanced the deadeny-
lation in the same assays (lanes 11–14 as compared to lane 2).
These data demonstrate the key role that the PABP-GW182
interaction plays in miRNA-mediated deadenylation.
DISCUSSION
In this report we used a mammalian cell-free extract to demon-
strate that miRNAs mediate deadenylation of a target mRNA
subsequent to initial inhibition of cap-dependent translation.r Inc.
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MicroRNA-Induced Deadenylation by CAF1 in MammalsBiochemical methods and functional assays in this in vitro
system elucidated some of the protein and RNA requirements
for miRNA-mediated mRNA deadenylation.
CAF1 and CCR4 Are Mammalian miRISC-Associated
Deadenylases
miRNAs have previously been implicated in the deadenylation of
targeted mRNAs in mammalian cells (Wu et al., 2006). Onemajor
deadenylase complex in mammals is the multisubunit CCR4-
NOT complex, which contains two proteins having deadenylase
activity, CCR4 and CAF1 (Yamashita et al., 2005; Zheng et al.,
2008). Although CCR4 is the active deadenylase in the yeast
CCR4-NOT complex (Tucker et al., 2001, 2002), mammalian
CAF1 is also a processive deadenylase that regulates mRNA
decay (Bianchin et al., 2005; Funakoshi et al., 2007; Schwede
et al., 2008; Viswanathan et al., 2004; Zheng et al., 2008).
Previous work carried out in Drosophila S2 cells demonstrated
that the CCR4-NOT complex (which contains CAF1) facilitates
miRNA-mediated deadenylation (Behm-Ansmant et al., 2006).
Our results bolster these findings and show that the association
of the miRISC with the deadenylase complex is conserved
between Drosophila and mammals. Moreover, we provide
biochemical evidence that both deadenylases physically interact
with the mammalian miRISC, and that CAF1 activity is respon-
sible, at least in part, for miRNA-mediated deadenylation. As
CAF1 interacts with both Ago1 and Ago2 in HEK293 cells, this
suggests that both Ago proteins are involved in facilitating
miRNA-mediated deadenylation in mammals.
Figure 6. The C Terminus of TNRC6C
Directly Binds PABP
(A) Schematic representation of human TNRC6C
and GST- and FLAG-tagged recombinant protein
fragments. Western blot analysis of GST pull-
downs of PABP incubated with GST or various
fragments of GST-TNRC6C-FLAG and probed
with anti-PABP and anti-GST antibodies.
(B) Schematic representation of human TNRC6C
HA-tagged fragments transfected into HEK293
cells. Cell extracts of HEK293 cells, transiently
expressing the indicated fusion proteins, were
incubated with Anti-HA Affinity Matrix (Roche),
and immunoprecipitated proteins were analyzed
by western blotting using the indicated antibodies.
Inputs represent 1% of the cell extract used for IP.
Nontransfected cells served as a control.
(C) Cell extracts of HEK293 cells transiently
expressing GST-DN1370 were pulled down using
glutathione Sepharose resin in the presence or
absence of micrococcal nuclease. GST pulldowns
were analyzed by western blotting using anti-
PABP, anti-eIF4G, and anti-GST antibodies. Non-
transfected cells served as a control.
PABP as a Coactivator of
miRNA-Mediated Deadenylation
Studies aimed at characterizing miRISC-
associated proteins have previously iden-
tified PABP by mass spectrometry of
immunoprecipitates not subjected to
ribonuclease treatment (Hock et al., 2007; Landthaler et al.,
2008; Zhang et al., 2007). We show that PABP is required for
miRNA-mediated deadenylation and physically interacts with
themiRISC via direct contact with GW182. Moreover, our results
suggest that PABP-GW182 interaction is required to facilitate
miRNA-mediated deadenylation. Previous studies have shown
that PABP augments the activity of different deadenylases.
PABP helps to recruit the PAN2/3 deadenylase complex to
poly(A) tails in both yeast and mammalian systems via a direct
interaction between the PAN3 subunit and the PABP C-terminal
domain (Lowell et al., 1992; Uchida et al., 2004). The PABP C-
terminal domain directly binds to the CAF1-interacting protein
Tob, which may contribute to the CCR4-CAF1-mediated deade-
nylation of somemRNAs (Ezzeddine et al., 2007; Simon and Ser-
aphin, 2007). In contrast to these modes of PABP-dependent
deadenylation, our data show that PABP is not required for
recruitment of either themiRISCor themiRISC-associated dead-
enylase complex to miRNA-targeted mRNAs (Figure 2D).
Furthermore, while CAF1 is recruited to the miRISC, Tob is not
(Figure 2D).
PABP-GW182 Interaction and miRNA-Mediated
Repression
GW182 is a core component of the miRISC and is critical for
miRNA-mediated repression. All three mammalian paralogs of
GW182 (TNRC6A, TNRC6B, and TNRC6C) are involved in
miRNA-mediated repression (Jakymiw et al., 2007; Lazzaretti
et al., 2009; Liu et al., 2005; Till et al., 2007; Zipprich et al.,Molecular Cell 35, 868–880, September 25, 2009 ª2009 Elsevier Inc. 875
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a reporter mRNA demonstrated that a C-terminal fragment of
TNRC6C, harboring both the DUF and RRM domains, represses
protein synthesis as effectively (>10-fold) as a full-length
TNRC6C protein (Zipprich et al., 2009). Experiments performed
with Drosophila GW182 protein in S2 cells also pointed to the
importance of the protein C terminus for repression of protein
synthesis (Chekulaeva et al., 2009; Eulalio et al., 2009b), implying
functional conservation. We demonstrate that the mammalian
GW182 C terminus directly binds PABP in an RNA-independent
manner. Importantly, we show that GW182-PABP contact
through the PABP C2 domain is required for efficient miRNA-
mediated deadenylation. Because PABP functions as a bona
fide translation initiation factor (Kahvejian et al., 2005), these
data provide evidence that themammalian miRISC directly inter-
acts with a component of the translation initiation machinery. It is
possible that PABP binding to GW182 may compete with eIF4G
binding, as adding an eIF4G fragment that binds to the N
terminus of PABP blocks miRNA-mediated deadenylation
in vitro (Figure 5). In addition, it is conceivable that PABP binding
to GW182 may function to juxtapose the poly(A) tail against the
miRISC-associated deadenylase complex (see model, Figure 8).
Although intriguing, these possibilities are still speculative at this
point and await future experimental validation.
Temporal Mode of miRNA Action
miRNAs inhibit translation and/or mediate deadenylation and
decay of target mRNAs (Filipowicz et al., 2008). In previous
studies, mostly carried out in cultured cells, it was impossible
Figure 7. GW182 Binding to PABP Is
Required for miRNA-Mediated Deadenyla-
tion
(A) Alignment of GW182 DUF sequences with
Paip2 PAM2 motif.
(B) Western blot analysis of GST pulldowns of
TNRC6C (1260-1690)-FLAG incubated with
various C-terminal (C1 and C2) fragments of
GST-PABP and probed with anti-FLAG and anti-
GST antibodies.
(C) Western blot analysis of GST pulldowns of
GST-PABP incubated with TNRC6C (1260-
1690)-FLAG and/or wild-type or mutant PAM2
peptide and probed with anti-FLAG and anti-
GST antibodies.
(D) 6xB-30UTR RNA deadenylation in Krebs
extract in the presence of increasing concentra-
tions (1, 10, 50, and 100 mM) of wild-type ormutant
(F > A) Paip2 PAM2 peptides.
(E) 6xB-30UTR RNA deadenylation in Krebs
extract, as determined by autoradiography, in
the presence of increasing concentrations (0.5,
1.0, and 2.0 mg per reaction) of GST, TNRC6C
(1260-1690), or TNRC6C (800-1360).
to determine the earliest events leading
to the miRNA-mediated repression
(Behm-Ansmant et al., 2006; Giraldez
et al., 2006; Humphreys et al., 2005; Pe-
tersen et al., 2006; Pillai et al., 2005). We
have demonstrated that miRNAs inhibit translation initiation as
early as 15–40 min after addition of mRNA to the Krebs extract
(Mathonnet et al., 2007, and this study). As shown in this work,
the miRNA-induced deadenylation of targeted mRNAs in vitro
is a slower event, which follows themiRISC-mediated repression
of translation initiation. These results indicate that miRNAs can
function by two complementary and likely sequential mecha-
nisms, first by inhibiting initiation of cap-dependent translation,
which is then followed by the deadenylation of the target
mRNA. As miRNA-mediated repression in Krebs extract further
increases between 1 and 2 hr of incubation and miRNA-medi-
ated translation repression is partially inhibited in CAF1-depleted
extract, it is possible that deadenylation has an additional
repressive effect supplementary to the initial inhibition of cap-
dependent translation.
EXPERIMENTAL PROCEDURES
DNA Constructs and Protein Purification
Myc-Ago1 and Ago2 DNA constructs have been described (Liu et al., 2005).
HA-CAF1 wild-type and HA-CAF1 D40A constructs have been described
(Zheng et al., 2008). pGST-Paip2 and pGST-PABP full-length and fragments
C1 andC2 have been described (Khaleghpour et al., 2001). Plasmids encoding
wild-type and mutant HA-fused CAF1 proteins were transfected into HeLa
cells and proteins were eluted with HA peptide (Anaspec). Eluted proteins
were analyzed by western blot analysis using CAF1 and Ago2 antibodies.
The plasmids pCI-NHA-1-405, pCI-NHA-1-1034, pCI-NHA-1-1368, pCI-
NHA-DN1370, and pCI-NHA-1505-1610 were previously described (Zipprich
et al., 2009). To generate the plasmid pEBG-DN1370, the sequence
encoding a C-terminal part of TNRC6C was PCR amplified using CCCGTCG
GATCCCGTGCCAAATCTGACAG TGA and AACCCTCACTAAAGGGAAGC876 Molecular Cell 35, 868–880, September 25, 2009 ª2009 Elsevier Inc.
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was digested with BamHI and NotI and inserted into pEBG-Piwi (Tahbaz et al.,
2004; Zipprich et al., 2009) precut with BamHI and NotI.
To generate the plasmids used for bacterial expression of GST-FLAG-
TNRC6C fragments (pGST-TNRC6C1-500, pGST-TNRC6C400-900, pGST-
TNRC6C800-1360, and pGST-TNRC6C1260-1690), the appropriate DNA
was amplified by PCR using pCI-NHA-TNRC6C as template and the following
primer pairs: GGCCGGCCGTCGACTCATGGC TACAGGGAGTGCCCAGGG
CAAC and CTTGTCATCGTCGTCCTTGTAGTCAGCA CTGTTCATGATGGAC
CCATCGTTCTTC (1–500), GGCCGGCCGTCGACTCAGTG ATGGTTCTGGC
AACCACAATGAAG and CTTGTCATCGTCGTCCTTGTAGTCAG CCACGTC
CCCTTCTTCATCCTCCCACTG (400–900), GGCCGGCCGTCGACTCTC ATC
AGGCTGGGGAGAAATGCCTAATG and CTTGTCATCGTCGTCCTTGTAGTC
AGCGGGAGGACTGGCTGGTGACTCACTGTTC (800–1360), and GGCCGGC
CGTC GACTCAACACCTTTGCTCCTTACCCTCTCGCTG and CTTGTCATCG
TCGTCCTT GTAGTCAGCCAGGGACTCCCCGCTGAGCAGGTCCCC (1260–
1690). These PCR products were subjected to a second round of PCR ampli-
fication using the original forward primer and a new reverse primer (CCGGC
CGCGGCCGCTCACTTGTCATCGT CGTCCTTGTAGTCAGC). The product
of these PCR reactions was then gel purified, digested with SalI and NotI
Figure 8. Model for Temporal Stepwise miRNA-Mediated Gene
Silencing
(i) mRNA circularization via eIF4G-PABP interaction stimulates cap-dependent
translation by enhancing eIF4E’s binding to the mRNA 50 cap structure (strong
binding [Kahvejian et al., 2005]).
(ii) miRISC binds to its target site in the 30UTR. GW182 binds to PABP, hypo-
thetically inhibiting its interaction with eIF4G, thereby repressing cap-depen-
dent translation by decreasing eIF4E’s binding to the 50 cap structure (weaker
binding), and sequestering the poly(A) tail into the vicinity of CAF1 and CCR4
deadenylases (illustrated by an arrow) to facilitate deadenylation of the mRNA.
The interaction between CAF1/CCR4 and Ago2 is probably indirect through
other proteins (depicted as question marks).Molerestriction enzymes, and ligated into similarly digested pGEX-6P-1 expression
vector (GE Healthcare). This strategy resulted in constructs that express the
appropriate fragment of TNRC6C carrying N-terminal GST and C-terminal
FLAG epitopes. TNRC6C fragments were expressed in Rosetta-2(DE3)
E. coli cells (EMD Biosciences) and purified by two sequential affinity chroma-
tography steps, first over glutathione Sepharose 4B resin (GE), followed by
M2-FLAG affinity resin (Sigma).
In Vitro Transcription
Plasmids that lack or contain six let-7 target sites (RL and RL-6xB, respec-
tively) were described (Pillai et al., 2005). A 98 base pair poly(A) sequence
was added to the 30UTR of both constructs. RL-6xBMut was constructed as
previously published (Mathonnet et al., 2007; Pillai et al., 2005). A 150 base
pair poly(A) sequence was synthesized (IDT) and added to the 30UTR of
RL-6xB (RL-6xB-pA*). For in vitro transcription, plasmids were linearized
with ApaI and filled in using the Klenow fragment. Transcription reactions
were performed using MAXIscript In Vitro Transcription Kit (Ambion) in 20 ml
at 37C according to the manufacturer’s protocol in the presence of the cap
analog m7(30-O-methyl)(50)Gppp(50)G (anti-reverse cap analog, ARCA; New
England Biolabs). ApppG-capped mRNAs were synthesized using ApppG
(New England Biolabs) instead of ARCA. 6xB-30UTR and 6xBMUT-30UTR tran-
scripts were generated from PCR products derived from RL-6xB-pA and
RL-6xBMUT-pA templates and T7-30UTR (GGCGCCTAATACGACTCACTAT
AGGGGTAAGTACATCAAGAGCTTCG) andOligo 3R() (GGTGACACTATAGA
ATAGGGCCC) primers. PCR products were digested with ApaI and filled
in using the Klenow fragment. To synthesize radiolabeled mRNAs, UTP was
substituted with [a-32P]UTP (800 Ci/mmol, 10 mCi/ml; PerkinElmer) according
to the manufacturer’s protocol. The mRNA was loaded on a mini Quick Spin
RNA Column (Roche) to remove unincorporated nucleotides.
In Vitro Translation Assays
Krebs-2 ascites cell extract was prepared as previously described (Svitkin and
Sonenberg, 2004). Translation reactions were performed in a total volume of
10 ml at 30C. A typical reaction mixture contained 7 ml extract, 1 ml mRNA,
and, where indicated, 20-O-Me oligonucleotide complementary to let-7a or
miR-122a or poly(A)30 oligonucleotide (Dharmacon) in water. The mixture
was preincubated for 20 min at 16C and then at 30C for 120 min. When
the 20-O-Me oligonucleotide was added, the extract was first incubated at
30C for 20 min in the absence of mRNA to allow for the annealing of the oligo-
nucleotide with its target miRNA. The reaction was stopped by addition of 20 ml
cold 1 3 PBS. For time course experiments, the reaction was scaled up to
80 ml, and 10 ml was withdrawn at each time point. Luciferase activity was
measured by using the Dual-Luciferase Reporter Assay System (Promega)
according to the manufacturer’s protocol.
mRNA Stability Assay
Radiolabeled RNA (0.1 ng) was incubated in Krebs-2 ascites in a total volume
of 10 ml in the absence or presence of 10 nM let-7 20-O-Me oligonucleotide.
Aliquots of the reaction mixture were withdrawn at specific intervals, and the
RNA was extracted using TRIzol reagent (Invitrogen) and loaded on a 4% or
4.5% polyacrylamide/urea gel. The gel was dried and analyzed using
a Typhoon PhosphorImager (GE Healthcare).
Oligonucleotide Ligation-Mediated Cloning of RNA
Radiolabeled RNA from Krebs extract was extracted with TRIzol and loaded
on a 4% polyacrylamide/urea gel. Specific RNA bands were cut from the gel
and eluted in 2x proteinase K buffer (100 mM Tris-HCl, pH 8.3; 25 mM
EDTA, pH 8.0; 300 mM NaCl; 2% (w/v) SDS), purified and ligated to a miRNA
universal linker (NEB) using T4 RNA ligase 1 in the absence of ATP. Ligation
products were purified and reverse transcribed with Superscipt III (Invitrogen),
and amplified using Titanium DNA polymerase (Clontech). PCR products were
cloned and sequenced.
Immunodepletion Assay, GST Pulldown Assay, Western Blotting,
and Antibodies
protein G-Sepharose (GE Healthcare) (20 ml) was washed and incubated in
100 ml of Krebs extract with 6 mg of either mouse monoclonal anti-HAcular Cell 35, 868–880, September 25, 2009 ª2009 Elsevier Inc. 877
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Chemicals), or affinity-purified rabbit polyclonal anti-CAF1 with gentle agita-
tion for 2 hr at 4C. The resin was then centrifuged at 500 3 g, and the super-
natant was collected. GST pulldown assays of Krebs extract have been
described (Kahvejian et al., 2005). Antibodies and their working dilutions for
western blotting were as follows: rabbit polyclonal anti-Ago2, 1:1000; rabbit
polyclonal anti-PABP, 1:1000 (Cell Signaling Technologies); mouse mono-
clonal anti-Actin, 1:5000 (Sigma); mouse monoclonal anti-FLAG, 1:5000
(Sigma); mouse monoclonal anti-CAF1, 1:1000; mouse monoclonal anti-Tob
4B1, 1:1000 (Sigma); and mouse monoclonal anti-CCR4, 1:1000. For the
GST pulldown assay with HEK293 cell extracts, cells were lysed with 50 mM
Tris-HCl (pH 7.5) containing 150 mM KCl, 0.5% Triton X-100, 2 mM DTT,
and complete EDTA-free protease inhibitor cocktail (Roche). The cleared
lysate was incubated with glutathione Sepharose 4B (GE Healthcare) followed
by washing with 50 mM Tris-HCl (pH 7.5), containing 150 mMKCl, 0.1% Triton
X-100, 2 mM DTT, and complete protease inhibitor cocktail (Roche). Proteins
associated with glutathione Sepharose beads were eluted with 50 mM gluta-
thione in the same buffer as used for washing the beads and analyzed by
western blotting using anti-PABP1 antibody (Cell Signaling Technology),
anti-eIF4GI antibody (Gradi et al., 1998), and anti-GST antibody (GE Health-
care). To examine RNA dependence of protein-protein interactions, cleared
lysates were treated with micrococcal nuclease (Roche) (10 mg/ml) for 25 min
at room temperature in the presence of 1 mM CaCl2 before incubation with
glutathione Sepharose 4B beads.
Anti-let-7 20-O-Me Oligonucleotide Biotin Pulldown Assay
M-280 streptavidin magnetic Dynabeads (Invitrogen) were washed three times
in buffer D (25 mM HEPES-KOH [pH 7.3], 2 mM MgCl2, 50 mM KCl, 75 mM
KOAc) and resuspended in buffer D with 2 mM DTT and 1 M NaCl and incu-
bated with biotin-labeled anti-let-7 20-O-Me, anti-miR122 20-O-Me, or anti-
miR35 20-O-Me oligonucleotide (Integrated DNA Technologies) for 60 min at
4C. 20-O-Me-bound beads were washed three times in buffer D and then
incubated in aliquots of Krebs extract containing protease inhibitors at 30C
for 60 min. Beads were washed three times in buffer D with 0.5% NP-40 and
boiled in SDS sample buffer and analyzed by SDS-PAGE and western blotting.
Cell Lines
HEK293 cells were transfected withMyc-Ago1 andMyc-Ago2DNA constructs
using LT-1 transfection reagent according to the manufacturer’s instructions
(Mirus). All constructs contain a G418 resistance cassette. Stable transfec-
tants were selected with 500 mg/ml G418 (Roche) for at least 2 weeks prior
to being used in experiments.
Other HEK293T cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM; GIBCO-BRL) supplemented with 2 mM L-glutamine and 10% heat-
inactivated fetal calf serum (FCS). Transfections were performed in 10 cm
cell culture dishes with60% confluent cells using Nanofectin (PAA Laborato-
ries), following the manufacturer’s instructions. For mass spectrometry anal-
ysis, cells in one 10 cm cell culture dish were transfected with 6 mg of the
plasmid pEBG-DN1370. For IP experiments, cells in 10 cm cell culture dishes
were transfectedwith 6 mg of the plasmids pCI-NHA-1505-1610 and pCI-NHA-
DN1370 and 20 mg of the plasmids pCI-NHA-1-405, pCI-NHA-1-1034, and
pCI-NHA-1-1368. For the GST pulldown experiment cells, 10 cm cell culture
dishes were transfected with 4 mg of the plasmid pEBG-DN1370.
Mass Spectrometry Analysis
Cells were lysed with 50 mM Tris-HCl (pH 7.5) containing 150 mM KCl, 5 mM
MgCl2, 1 mM CaCl2, 0.5% Triton X-100, 2 mM DTT, and EDTA-free protease
inhibitor cocktail (Roche). The cleared lysate was incubated with glutathione
Sepharose 4B (GE Healthcare) followed by washing with 50 mM Tris-HCl
(pH 7.5) containing 150 mM KCl, 5 mM MgCl2, 1 mM CaCl2, 0.5% Triton
X-100, 2mMDTT, and EDTA-free protease inhibitor cocktail (Roche). Cysteine
residues of proteins associated with the beads were reduced and alkylated
prior to gel separation. The Coomassie-stained bands were digested with
trypsin, and tryptic peptides were analyzed by nano-HPLC (Agilent 1100
nanoLC system, Agilent Technologies, Santa Clara, CA) coupled to a 4000 Q
TRAP mass spectrometer (Applied Biosystems, Foster City, CA). Peptides878 Molecular Cell 35, 868–880, September 25, 2009 ª2009 Elseviewere identified searching UniProt database (version 13.8) restricted to human
using Mascot (version 2.1, Matrix Science, London).
MuDPIT and Coimmunoprecipitation Analysis
Samples were prepared as follows: HEK293 cells were harvested and washed
with phosphate-buffered saline (PBS). Cells were washed once in hypotonic
lysis buffer (10 mM Tris-HCl [pH 7.5], 10 mM KCl, 1.5 mM MgCl2, 5 mM
DTT, and EDTA-free protease inhibitor cocktail [Roche]) and allowed to swell
for 20 min on ice prior to homogenization. Cell extracts were centrifuged in
a tabletop centrifuge at 10,000 rpm for 30 min at 4C to clarify the lysate.
The salt concentration in the extract was raised to 100 mM KCl. To immuno-
precipitate Ago and Ago-interacting proteins, Myc-agarose beads (Sigma)
were added to the extract and allowed to incubate for 6 hr with gentle rotation.
Immunoprecipitates were washed (wash buffer, 10 mM Tris-HCl [pH 7.5],
100 mM KCl, 1.5 mM MgCl2, 5 mM DTT, and EDTA-free protease inhibitor
cocktail [Roche]) four times for 30 min each. Immunocomplexes were eluted
from Myc-agarose beads by two serial washes in elution buffer (100 mM
Tris-HCl [pH 8.0], 8M urea). Proteins in eluates were precipitated with trichloro-
acetic acid and submitted for MuDPIT analysis (Washburn et al., 2001).
Samples analyzed for coimmunoprecipitation of Ago and Ago-interacting
proteins from HEK293 cells were prepared as above. In cases in which immu-
noprecipitates were subjected to RNase A treatment, immunoprecipitation
was performed as described, but the next to last washing step was done in
the presence of RNase A (10 units/ml in wash buffer). Samples were washed
an additional two times prior to SDS-PAGE andwestern blot analysis. Samples
analyzed for coimmunoprecipitation of Ago2- and CAF1-interacting proteins
from Krebs extracts were prepared as follows: Krebs extracts were treated
with micrococcal nuclease (Roche) in the presence of CaCl2 for 30 min at
20C and subsequently with EGTA as previously described (Svitkin and
Sonenberg, 2004). Krebs extracts were then mixed with protein G Dynabeads
(Invitrogen) already bound to either mouse monoclonal anti-HA (Covance),
rabbit anti-HA (Sigma), mouse monoclonal anti-Ago2 (Wako Chemicals), or
affinity-purified rabbit anti-CAF1 and gently mixed at 30C for 60 min. Immu-
noprecipitates were washed five times with buffer D containing 0.5% NP-40
prior to SDS-PAGE and western blot analysis. For HA epitope IP reactions,
cells were lysed with 50 mM Tris-HCl (pH 7.5) containing 150 mM KCl, 0.5%
Triton X-100, 2 mM DTT, and protease inhibitor cocktail (Roche). The cleared
lysate was incubated with Anti-HA Affinity Matrix (Roche). After washing
with 10 mM Tris-HCl (pH 7.5) containing 200 mM KCl, proteins associated
with the beads were analyzed by western blotting using anti-HA 3F10
antibody (Roche) and PABP1 antibody (Cell Signaling Technology) (Polacek
et al., 2009).
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